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1.  Introduction and Aim of the Thesis 
 
 
1.1. Ion channels 
 
Ion channels constitute a class of proteins that is ultimately responsible for 
generating and orchestrating the electrical signals passing through the thinking brain, 
the beating heart, and the contracting muscle (Ackerman & Clapham, 1997). They 
are macromolecular protein tunnels that span the lipid bilayer of the cell membrane. 
Small conformational changes gate a single channel from closed to open, allowing 
up to 10 million ions to flow into or out of the cell each second. A few pico amps (10
-
12 A) of current are generated by the flow of highly selected ions each time the 
channel opens. Since ion channels are efficient, their numbers per cell are relatively 
low; a few thousand of a given type is usually sufficient. Ion channels are usually 
classified according to the type of ion they allow to pass - sodium, potassium, 
calcium, or chloride - although some are less selective. They may be gated by 
extracellular ligands such as neurotransmitters (ligand-gated ion channels), or 
changes in transmembrane voltage (voltage-gated ion channels). 
 
 
1.1.1. The families of neurotransmitter-gated ion channels 
 
Neurotransmitter-gated ion channels are receptors that rapidly mediate signaling 
across the synapse of the central and peripheral nervous system (Leite & Cascio, 
2001). These ionotropic receptors are divided into families based on their high 
sequence homology and are classified as the ligand-gated ion channel superfamily 
(LGICS). One such subset is the nicotinic acetylcholine receptor family (Le Novere & 
Changeux, 1999), which includes the glycine receptors (GlyRs), the nicotinic 
acetylcholine receptors (nAchRs), the 5-HT3 receptors, and the GABA receptors. 
Typically, these receptors assemble as heteropentamers of different gene products 
and/or splice variants. Biochemical analysis revealed that each of the ion channel 
subunits from this family share several features such as a conserved cysteine loop in 
the extracellular N-domain, four putative transmembrane regions (M1-M4), and a 
short extracellular C-terminus (Karlin, 1993). The second of the transmembrane 1. Introduction and Aim of the Thesis      2 
regions (M2) is the main contributor to the ion channel (Hucho et al., 1986). Another 
family, the glutamate receptors (GluRs) are grouped into kainic acid, α -amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and N-methyl-D-aspartic acid 
(NMDA) subtypes based on amino-acid sequence and agonist pharmacology 
(Hollmann & Heinemann, 1994). The ionotropic glutamate receptors share similar 
channel properties and have analogues transmembrane domains like the nicotinic 
acetylcholine receptors, but the extracellular domain is bigger and has no obvious 
sequence identity with the nicotinic acetylcholine receptor family (Cockcroft et al., 
1993). The third family of ligand-gated ion channels, the P2X receptor family, has 
neither structural nor sequence homology with the first two superfamilies, but shares 
structural similarities with a family of ion channels with two hydrophobic segments as 
described in the next chapter (Nicke et al., 1999). 
 
 
1.1.2. The superfamilies of ion channels with two hydrophobic segments 
 
Ion channels with two membrane-spanning domains per subunit fall into four main 
structural families (North, 1996). These are the inward-rectifier potassium channels 
(Kirs), epithelial sodium channels (ENaCs), the mechanosensitive channel of 
Escherichia coli (mscL), and the P2X receptors (reviewed in chapter 1.2). Inward-
rectifier potassium channels comprise a large ion channel family. They have 
relatively long intracellular amino and carboxyl termini, short extracellular loops, and 
a pore-forming (P) region between the two transmembrane domains (Doupnik et al., 
1995). ENaC subunits have about 650–700 amino acids each, and contain two 
extended hydrophobic regions (M1 and M2) separated by a region of about 450 
amino acids which contains 16 conserved cysteine residues (Garty, 1994). 
Quantitative analysis of cell surface expression of EnaC α , β , and γ  subunits has 
indicated a tetrameric structure in which two α  subunits are separated by the β , and γ  
subunits (Firsov et al., 1998). The mscL protein is 136 amino acids long, with two 
hydrophobic domains and a hydrophilic C-terminal domain. Its extracellular domain 
is extremely short and it does not have any significant sequence homology with 
members of the extended ENaC family, or with P2X receptors (Sukharev  et al., 
1994). While previous data had suggested that the functional MscL complex might 
be a hexamer, a recent crystallographic study of the MscL homologue from M. 1. Introduction and Aim of the Thesis      3 
tuberculosis revealed a pentameric structure (Chang et al., 1998). Additionally, in 
another study, MscL in the membrane could be chemically cross-linked. The cross-
linking agents used at saturating concentrations invariably generated pentamers as 
the largest product (Sukharev & McCaslin, 1999). 
 
 
1.2. Purinergic receptors (P receptors) and the role of ATP in signaling 
 
The concept of chemical synaptic transmission began to develop over a century ago, 
when researchers showed that stimulation of certain peripheral nerves produced 
responses in their target organs. In most cases, the release of acetylcholine or 
noradrenaline mediated these responses in their target organs (Khakh, 2001). A role 
for extracellular purines had been described by Drury and Szent-Györgyi in 1929 
(Drury & Szent-Györgyi, 1929) soon after the discovery of ATP (Embden & 
Zimmerman, 1927). ATP is an amphiphilic compound showing both hydrophilic and 
strong hydrophobic interfaces. Autonomic nonadrenergic and noncholinergic nerves 
(Burnstock et al., 1963) were proposed to contain ATP, and a tentative model of 
storage and release was proposed (Burnstock, 1972). Nerve cells that employ ATP 
as their principal transmitter were termed “purinergic”. Adenine nucleotides are 
continually present in inconsistent amounts in the extracellular space of many 
organs. There is strong evidence supporting the idea that ATP is a cotransmitter in 
sympathetic nerves. Other possible sources of the nucleotide include the following: 
1) ischemic myocytes (Williams & Forrester, 1983), 2) activated platelets (Holmsen, 
1985), 3) nerve terminals (Holton, 1995), 4) inflammatory cells (Di Virgilio et al., 
1996), 5) erythrocytes (Bergfeld & Forrester, 1992), 6) endothelial cells (Bodin & 
Burnstock, 1996), and 7) smooth muscle cells (Katsuragi  et al., 1991). The 
mechanism by which ATP is transported across the cell membrane or released from 
muscle cells is not fully understood. In living cells, the electrochemical gradient 
supporting ATP efflux is near nine orders of magnitude (versus 6 for Ca
2+) 
considering intra- and extracellular ATP concentrations to be 10 mM and 10 nM, 
respectively. Thus, membrane permeability to ATP should be very low, which is in 
agreement with the negative charge of ATP (Vassort, 2001). ATP can be released by 
exocytosis from platelets and nerves like other neurotransmitters. It can also leak out 
during cell lysis (Gordon, 1986; Dubyak et al., 1993). 1. Introduction and Aim of the Thesis      4 
1.2.1. Purinergic receptors (P receptors) 
 
In 1971, Burnstock proposed the existence of nerves that use purines as a 
transmitter. Meanwhile it is widely accepted that purines (ATP, ADP and adenosine) 
and pyrimidines (UTP and UDP) act as extracellular messengers via plasma 
membrane receptors termed purinergic receptors (P receptors) (Stojilkovic, 2001). 
There are two main groups of purinergic receptors: adenosine-activated P1-
receptors (also called A receptors) and ATP-, ADP-, UTP- and/or UDP-activated P2 
receptors (P2 receptors). This classification was originally introduced by Burnstock 
(1978). Molecular, physiological and pharmacological data propose the existence of 
four mammalian A-receptor subtypes (denoted A1-, A2A-, A2B-, and A3-receptors), 
which all signal through G-protein-dependent pathways. 
P2 receptors belong to one of two families: G-protein-coupled receptors (P2Y 
receptors), originally identified by Dubyak (1991), and ligand-gated P2X ion channels 
(P2X receptors), identified by Benham & Tsien (1987). P2Y receptors are seven-
membrane-spanning proteins, 328 to 379 amino acids long corresponding to 
molecular masses of 41 to 53 kD after glycosylation (Ralevic & Burnstock, 1998; 
Webb  et al., 1993). The N-terminal domain is located on the extracellular 
environment, and the C terminus is on the cytoplasmic side of the plasma 
membrane. Signal transduction takes place via the pathways used also by other 
seven-membrane-spanning receptors: activation of phospholipase C and/or 
stimulation/inhibition of adenylate cyclase. All of the P2Y receptors are triggered by 
ATP, but at two of them, P2Y4 and P2Y6, UTP is more potent (Communi et al., 1996 
a & b; Chang et al., 1995), and at P2Y2 ATP and UTP are equipotent (Lustig et al., 
1993). At P2Y1 receptor, UTP is inactive and ADP is reported to be equipotent or 
even more potent than ATP (Henderson et al., 1995), at P2Y11 receptor ATP is more 
potent than ADP and UTP is inactive (Communi et al., 1997). With respect to the 
signal transduction pathway, P2Y1 and P2Y2 receptors are coupled to stimulation of 
phospholipase C and inhibition of adenylate cyclase via Gq/11  and Gi proteins, 
respectively (Ralevic & Burnstock, 1998). P2Y4 and P2Y6 receptors appear to only 
couple to phosphoinositide breakdown, whereas P2Y11 receptor rather stimulates 
activation of both the phosphoinositide and the adenylate cyclase pathways (Qi et 
al., 2001). 1. Introduction and Aim of the Thesis      5 
1.2.2. P2X receptors 
 
P2X receptors are ATP-gated ion channels first characterized in and cloned from 
excitable cells (Brake et al., 1994; Valera et al., 1994) and then reported to be nearly 
ubiquitous expressed (Soto et al., 1997). P2X receptors mediate fast permeability 
changes to monovalent and divalent cations (Na
+, K
+, and Ca
2+). 
 
 
1.2.2.1. Molecular physiology of P2X receptor subunits 
 
Currently, seven ATP-gated P2X receptor subunits are known (Table 1.1), which are 
encoded by different genes (Buell et al., 1996). Each subunit has a topology that is 
different from that of other identified ligand-gated channels. The seven P2X isoforms 
comprise 379–595 amino acids in length. 
Subunit topology. The P2X polypeptides possess  two hydrophobic 
transmembrane domains with a large extracellular hydrophilic loop and two 
intracellularly located termini (Fig. 1.1). The extracellular domain starts 
approximately at position 52 and ends near the proline at position 329.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: Schematic representation of a P2X receptor subunit comprising intracellular N- and C-
termini, two transmembrane spanning domains (M1 and M2) and a large extracellular loop containing 
10 conserved cysteine residues, which may form disulfide bonds. 
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The N-terminal domain. The amino-terminal tails of P2X subunits are 
relatively short, comprising about 20-30 amino acids. All of the P2X subunits contain 
in their N-domain a protein kinase C site, which was shown to be important for P2X2 
function (Boue-Grabot et al., 2000).  
The C-terminal domain. The C-terminal domain of P2X subunits differs 
markedly in length from 28 (P2X4) to 242 (P2X7) residues. Deletions, mutations or 
splicing of this region have been shown to affect the kinetics, permeations and 
desensitization of P2X channels (Brandle et al., 1997; Smith et al., 1999).  
The extracellular domain. Between the transmembrane segments, there is 
an extracellular region with ten cysteine residues (Fig 1.2), which are fully conserved 
among all seven P2X isoforms (Newbolt  et al., 1998;  Torres  et al., 1998  a). 63 
residues are fully conserved, of which 15 are glycine residues (Fig 1.3). In addition, 
many residues are almost completely conserved. The extracellular domain is 
separated into two disulfide cross-linked domains (Hansen et al., 1997). Alterations 
in ATP potency was observed upon by systematic mutagenesis of extracellularly 
located, positively charged amino acids of human P2X1 receptor and a subset of 
basic amino acids (
68K, 
70K, 
292R) were found to contribute to the ATP potency 
(Ennion  et al., 2000). Additional analysis proposes that the ATP binding site is 
located in a region near the lysine residues at positions 69 and 71 (Jiang et al., 
2000). Consensus sites for N-linked glycosylation (Asn-X-Ser/Thr) are found in the 
extracellular loop of all P2X isoforms. Interestingly, some of these sites are well 
conserved in mouse, rat, and human clones of the P2X family (Rettinger  et al., 
2000), suggesting that the binding of carbohydrate moieties to the protein may be 
important for the expression or the function of the channel. Nicke (1998) reported 
that only four of the five putative N-glycosylation sites are used when of the rat P2X1 
subunit is expressed in Xenopus oocytes (Fig. 1.2).  1. Introduction and Aim of the Thesis      7 
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Fig.1.2: Linear model of rat P2X1 showing approximate positions of N-glycosylation sequons 
and cysteine residues. N, cytoplasmic N terminus; M1 and M2, membrane spanning segments; N1-
N5, asparagine residues of NXT/S tripeptides at position 153 (N1), 184 (N2), 210 (N3), 284 (N4), and 
300 (N5). The 10 cysteine residues (S) which are conserved among all seven P2X isoforms and 
which are assumed to form five intra-molecular disulfide linkages are also indicated; an additional 
conserved cysteine residue (not shown) is located in M2 (Rettinger et al., 2000). 
 
 
The P2X receptor pore. P2X receptors are generally cation-selective channels with 
significant permeability to Ca
2+ and equal permeability to Na
+ and K
+ (Evans et al., 
1996). The substituted cysteine accessibility method has been employed to identify 
parts of the molecule that contribute to the ionic pore of the P2X2 receptor 
(Rassendren et al., 1997). 
338L and 
349D, amino acid residues conserved among all 
the seven P2X receptors, are on either side of the channel gate with 
349D positioned 
near the middle of the channel (Fig. 1.3). Thus, it might be possible that 
349D is the 
site of permeant cation binding and responsible for ionic selectivity (Ding & Sachs, 
1999). The asparagine residue 
333N was shown to regulate the conductance. The 
unitary conductance of 80 pS in 100 µM Na
+ was approximately halved when this 
asparagine was substituted by isoleucine (N
333I) (Nakazawa et al., 1998). In P2X2 
receptors, the second transmembrane domain (TM2), which appears to line the pore, 
has a α -helical conformation (Egan et al., 1998). 
Remarkable permeation properties were observed for P2X7 receptors, that 
change their permeability to organic cations on a timescale of seconds (Suprenent et 
al., 1996). Changes in permeability are further observed for heterologously 
expressed P2X2 and P2X4 receptors or native P2X receptors in neurons, as 
measured electrophysiologically or with dye uptake studies (Khack  et al., 1999; 
Rassendren et al., 1997) 
The stoichiometry of P2X receptors. P2X2 and P2X3 subunits co-assemble 
to form a distinct heteromeric channel (Lewis et al., 1995; Radford et al., 1997) with 
specific properties (Virginio et al., 1997 & 1998). Likewise, heteromeric assembly 
was suggested by in situ hybridization studies for P2X1 and P2X5 isoforms, PX2 and 
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P2X6 isoforms, and P2X4 and P2X6 isoforms (Torres et al., 1998 a; Collo et al., 
1996; King et al., 2000). P2X4 and P2X7 subunits do not form heteromers, whereas 
P2X6 subunit needs to be associated in heteromers either with P2X1, 2, 4, 5 subunits 
to form an active channel.  
From gel filtration experiments with the recombinant P2X2 extracellular loop, it 
has been deduced that the P2X2 receptor exists as a tetramer (Kim et al., 1997). In 
contrast, using cross-linkers and the blue native PAGE analysis, it was shown that 
full length P2X1  and P2X3 receptors form stable trimers (Nicke  et al., 1998). By 
investigating single channel properties of P2X2 receptor, Ding & Sachs (1999) found 
that the channel proceeds through three ATP binding steps before opening and that 
the three ATP binding sites are not independent, but positively cooperative, 
supporting the view for a trimeric structure for this receptor. 
 1. Introduction and Aim of the Thesis       9 
rP2x1 -MARRLQDELSAFFFEYDTPRMVLVRNKKVGVIFRLIQLVVLVYVIGWVFVYEKGYQTSS-DLISSVSVKLKGLAVTQL-------QGLGPQVWDVADYV 91 
rP2x2 –MVRRLARGCWSAFWDYETPKVIVVRNRRLGFVHRMVQLLILLYFVWYVFIVQKSYQDSETGPESSIITKVKGITMS------------EDKVWDVEEYV 87 
rP2x3 -------MNCISDFFTYETTKSVVVKSWTIGIINRAVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGFGR------------YANRVMDVSDYV 81 
rP2x4 --MAGCCSVLGSFLFEYDTPRIVLIRSRKVGLMNRAVQLLILAYVIGWVFVWEKGYQETD-SVVSSVTTKAKGVAVTNT-------SQLGFRIWDVADYV 90 
rP2x5 -MGQAAWKGFVLSLFDYKTAKFVVAKSKKVGLLYRVLQLIILLYLLIWVFLIKKSYQDIDTSLQSAVVTKVKGVAYTNT-------TMLGERLWDVADFV 92 
rP2x6 MASAVAAALVSWGFLDYKTEKYVMTRNCWVGISQRLLQLGVVVYVIGWALLAKKGYQEWDMDPQISVITKLKGVSVTQV-------KELEKRLWDVADFV 93 
rP2x7 ----MPACCSWNDVFQYETNKVTRIQSVNYGTIKWILHMTVFSYVS-FALMSDKLYQRKE-PLISSVHTKVKGVAEVTENVTEGGVTKLVHGIFDTADYT 94 
                               !         !    !                !         !    !                  !   
rP2x1 FPAHGDSSFVVMTNFIVTPQQTQGHCAENP-EGG-ICQDDSGCTPGKAERKAQGIRTGNCVPFNGTVK-TCEIFGWCPVEVDDKIPSPALLREAENFTLF 188 
rP2x2 KPPEGGSVVSIITRIEVTPSQTLGTCPESMRVHSSTCHSDDDCIAGQLDMQGNGIRTGHCVPYYHGDSKTCEVSAWCPVEDGTSDN-HFLGKMAPNFTIL 187 
rP2x3 TPPQGTSVFVIITKIIVTENQMQGFCPENE--EKYRCVSDSQC--GPERFPGGGILTGRCVNYSSVLR-TCEIQGWCPTEVDTVEM--PIMMEAENFTIF 176 
rP2x4 IPAQEENSLFIMTNMIVTVNQTQSTCPEIP-DKTSICNSDADCTPGLRDTHSSGVATGRCVPFNESVK-TCEVAAWCPVENDVGVPTPAFLKAAENFTLL 188 
rP2x5 IPSQGENVFFVVTNLIVTPNQRQGICAEREGIPDGECSEDDDCHAGESVVAGHGLKTGRCLRVGNSTRGTCEIFAWCPVETKSMPTD-PLLKDAESFTIF 192 
rP2x6 RPSQGENVFFLVTNFLVTPAQVQGRCPEHPSVPLANCWADEDCPEGEMGTYSHGIKTGQCVAFNGTHR-TCEIWSWCPVESSAVPRK-PLLAQAKNFTLF 192 
rP2x7 LPLQG-NSFFVMTNYLKSEGQEQKLCPEYP-SRGKQCHSDQGCIKGWMDPQSKGIQTGRCIPYDQKRK-TCEIFAWCPAEEGKEAPRPALLRSAENFTVL 191 
 
                                  !        !                                !        ! 
rP2x1 IKNSISFPRFKVNRRNLVEEVNGTYMKKCLYHKIQHPLCPVFNLGYVVRESGQDFRSLAEKGGVVGITIDWKCDLDWHVRHCKPIYQFHGLYG---EKNL 288 
rP2x2 IKNSIHYPKFKFSKGNIASQKSD-YLKHCTFDQDSDPYCPIFRLGFIVEKAGENFTELAHKGGVIGVIINWNCDLDLSESECNPKYSFRRLDP--KYDPA 285 
rP2x3 IKNSIRFPLFNFEKGNLLPNLTDKDIKRCRFHPEKAPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDGVSEKSSV 274 
rP2x4 VKNNIWYPKFNFSKRNILPNITTSYLKSCIYNAQTDPFCPIFRLGTIVEDAGHSFQEMAVEGGIMGIQIKWDCNLDRAASLCLPRYSFRRLDTRDLEHNV 288 
rP2x5 IKNFIRFPKFNFSKANVLETDNKHFLKTCHFSSTN-LYCPIFRLGSIVRWAGADFQDIALKGGVIGIYIEWDCDLDKAASKCNPHYYFNRLDNK-HTHSI 290 
rP2x6 IKNTVTFNKFNFSRTNALDTWDNTYFKYCLYDSLSSPYCPVFRIGDLVAMTGGDFEDLALLGGAVGINIHWDCNLDTKGSDCSPQYSFQ-LQE------- 291 
rP2x7 IKNNIDFPGHNYTTRNILPGMNI--S--CTFHKTWNPQCPIFRLGDIFQEIGENFTEVAVQGGIMGIEIYWDCNLDSWSHRCQPKYSFRRLDDKYTNESL 287 
 
 
rP2x1 SPGFNFRFARHFVQNG-TNRRHLFKVFGIHFDILVDGKAGKFDIIPTMTTIGSGIGIFGVATVLCDLLLLHILP------------------KRHYYKQK 384 
rP2x2 SSGYNFRFAKYYKINGTTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSIGVGSFLCDWILLTFMN------------------KNKLYSHK 383 
rP2x3 SPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLK------------------GADHYKAR 374 
rP2x4 SPGYNFRFAKYYRDLAGKEQRTLTKAYGIRFDIIVFGKAGKFDIIPTMINVGSGLALLGVATVLCDVIVLYCMK------------------KKYYYRDK 388 
rP2x5 SSGYNFRFARYYRDPNGVEFRDLMKAYGIRFDVIVNGKAGKFSIIPTVINIGSGLALMGAGAFFCDLVLIYLIR------------------KSEFYRDK 389 
rP2x6 -RGYNFRTANYWWAASGVESRSLLKLYGIRFDILVTGQAGKFALIPTAITVGTGAAWLGMVTFLCDLLLLYVDR------------------EAGFYWRT 382 
rP2x7 FPGYNFRYAKYYKENG-MEKRTLIKAFGVRFDILVFGTGGKFDIIQLVVYIGSTLSYFGLATVCIDLIINTYASTCCRSRVYPSCKCCEPCAVNEYYYRK 386 
 
rP2x1 KFKYAEDMGPGEGEHDPVATSSTLGLQENMRTS 399 
rP2x2 KFDKVRTPKHPSSRWPVTLALVLGQIPPPPSHYSQDQPPSPPSGEGPTLGEGAELPLAVQSPRPCSISALTEQVVDTLGQHMGQRPPVPEPSQQDSTSTDPKGLAQL 472 
rP2x3 KFEEVTETTLKGTASTNPVFASDQATVEKQSTDSGAYSIGH 397 
rP2x4 KYKYVEDYEQGLSGEMNQ.388 
rP2x5 KFEKVRGQKEDANVEVEANEMEQEQPEDEPLERVRQDEQSQELAQSGRKQNSNCQVLLEPARFGLRENAIVNVKQSQILHPVKT 455 
rP2x6 KYEEARAPKATTNSA 379 
rP2x7 KCEPIVEPKPTLKYVSFVDEPHIWMVDQQLLGKSLQDVKGQEVPRPQTDFLELSRLSLSLHHSPPIPGQPEEMQLLQIEAVPRSRDSPDWCQCGNCLPSQ 436 
rP2x7 LPENRRALEELCCRRKPGQCITTSELFSKIVLSREALQLLLLYQEPLLALEGEAINSKLRHCAYRSYATWRFVSQDMADFAILPSCCRWKIRKEFPKTQGQYSGFKYPY 595
M2 
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Fig. 1.3: Amino acid sequence alignment of the cloned rat P2X receptor subunits. The 
alignment was made using ClustalW software (http://searchlauncher.bcm.tmc.edu). Identical amino 
acids are high lighted by shaded boxes. The triangles indicate the conserved cysteine residues. The 
rectangle indicates the sole consensus sequence for N-glycosylation that is conserved among all 
isoforms except P2X5. The two putative transmembrane domains (M1 and M2) are indicated by 
horizontal ban. Proposed recognition sequences for serine kinases and two proline rich sequences 
that could associate with the SH3 domains are dark shaded. 
 
 
1.2.2.2. Chromosomal localization of human P2X receptor genes  
 
The genes for the cloned human P2X receptors have been mainly mapped to three 
distinct chromosomes (for review see Soto et al., 1997). Some of the P2X genes 
appear in clusters in a similar manner to several nAChR and GABA receptor subunit 
genes (Boulter  et al., 1990; McLean et al., 1995). The hP2X3 gene has been 
localized on chromosome 11, region q12 (Garcia-Guzman et al., 1997). The hP2X5 
and the hP2X1 genes are located on chromosome 17, region p13.3 (Valera et al., 
1995). The hP2X4 and hP2X7 genes are located on chromosome 12, region p24 
(Garcia-Guzman  et al., 1997;  Talabot  et al., 1997). By applying radiation 
hybridization mapping, it was attempted to correlate mutations in P2X receptors with 
human diseases and the localization of hP2X1, hP2X4, hP2X5 and hP2X7 genes has 
been linked to several polymorphic markers (Talabot et al., 1997).  1. Introduction and Aim of the Thesis       11 
Table 1.1: Listing of cloned P2X isoforms. * indicates splicing variants 
(Soto et al., 1997) 
Gene  Species / Tissue of 
cloning 
Number of 
amino 
acids 
Potential 
N-glycosylation 
sites 
Accession 
numbers 
(GenBank) 
Reference 
Rat vas deferens  399  5  X80477  Valera et al., 1994 
Human urinary 
bladder 
399 5  X83688  Valera et al., 1995 
Human platelets  399  5  AF020498  Sun et al., 1998 
Human heart*  348 5    Soto et al., 1997 
P2X1 
Mouse urinary bladder  399  5  X84896  Valera et al., 1995 
Rat PC12 cells  472  3  U14414  Brake et al., 1994 
P2X2  Rat pituitary* 
361 3  L43511 
Housley et al., 
1995 
Rat dorsal root ganglia  397  4  X90651  Chen et al., 1995 
Human heart 
397 4  Y07683 
Garcia-Guzman 
et al., 1997  P2X3 
Mouse 
397 4   
Souslave et al., 
1997 
Rat hippocampus  388  5  X91200  Bo et al., 1995 
Rat superior cervical 
ganglia 
388 5  X87763  Buell et al., 1996 
Rat brain 
388 5  U32497 
Seguela et al., 
1996 
Rat brain  388  5  X93565  Soto et al., 1996 
Rat pancreatic islets  388  5  U47031  Wang et al., 1996 
Human brain 
388 5  Y07684 
Garcia-Guzman 
et al., 1997 
P2X4 
Human placenta 
388 5   
Talabot et al., 
1997 
Rat celiac ganglia  455  3  X92070  Collo et al., 1996 
Rat heart 
455 3  X97376 
Garcia-Guzman 
et al., 1996  P2X5 
Human fetal brain 
398 2   
Talabot et al., 
1997 
Rat superior cervical 
ganglia 
379 3  X92070 
Collo et al., 1996 
b  P2X6 
Rat brain  379  3  X97376  Soto et al., 1996 
P2X7 
Rat autonomic ganglia 
595 6  X95882 
Surprenant et al., 
1996 1. Introduction and Aim of the Thesis       12 
1.2.2.3. Pharmacological properties of P2X receptor subunits 
 
P2X receptors can be divided into two broad groups according to whether they show 
fast desensitization within 100–300 ms or no desensitization (Table 1.1). Rapidly 
desensitizing P2X receptors are activated by ATP, α ,β -met-ATP, and 2-MeSATP. 
They comprise recombinant P2X1 and P2X3 receptors. The nondesensitizing α ,β -
met-ATP-insensitive P2X receptors are the expressed cloned P2X2, P2X4, P2X5, and 
P2X7 receptors. 
 
P2X1 Receptor. In 1994, two papers reported the cloning of two members of 
a novel family of ligand-gated ion channels, one of which was the 399 amino acid-
long P2X1 receptor (Brake et al., 1994; Valera et al., 1994). The P2X1 receptor, 
heterologously expressed in Xenopus oocytes, activates and desensitizes rapidly 
(50–150 ms) and shows a relative high permeability for Ca
2+. The order of agonist 
potency is 2-MeSATP ≥  ATP > α ,β -met-ATP > ADP, UTP, GTP (Vassort, 2001). 
Both suramin and pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic acid (PPADS), 
but not amiloride, block this current (Lambrecht, 2000). The conductance, 19 pS at 
negative potential, shows anomalous inward rectification (Surprenant, 1996). These 
electrophysiological properties are close to those observed for a native ATP-
activated channel in smooth muscle (Bean, 1992).  
 
P2X2 Receptor. The P2X2 receptor was first cloned by Brake et al. (1994) 
from a DNA library constructed from the mRNA of PC12 cells and examined in 
Xenopus oocytes. The homomeric P2X2 channel is characterized by its insensitivity 
to α ,β -met-ATP and its lack of desensitization during ATP applications of up to 10 s. 
Its conductance is 21 pS at -100 mV in 150 mM NaCl (Surprenant, 1996). 
Desensitization of P2X2 receptors expressed in either Xenopus oocytes or HEK cells 
is obviously accelerated by increasing ATP concentrations (Zhou  et al., 1998). 
Desensitization of P2X2 receptor is suggested to be controlled by alternative splicing 
(Brandle et al., 1997). The splice isoform P2X2b or P2X2–2R , which lacks a stretch of 
C-terminal amino acids (
370V-
438Q), displays rapid and complete desensitization, 
whereas the wild-type channel desensitizes slowly (Simon et al., 1997). The 
373P-
376P sequence of P2X2R isoform represents a functional motif that is crucial for the 
development of the slow desensitization profile (Koshimizu  et al., 1999). The 1. Introduction and Aim of the Thesis       13 
behavior of the P2X2 receptor approximates native P2X receptors of PC12 cells, but 
differes from those on vascular smooth muscle and vas deferens, where α ,β -met-
ATP acts as a potent agonist. ATPγ S, and 2-MeSATP are roughly equipotent 
agonists. CTP and 2’-deoxy-ATP (dATP) elicite small currents, whereas UTP, GTP, 
ADP, and AMP are inactive. In neurons, extracellular Zn
2+ potentiates the ATP effect 
on the recombinant receptor by changing the EC50 for ATP to 15 µM (Cloues, 1995).  
 
P2X3 Receptor. The P2X3 receptor cDNA was cloned from rat dorsal root 
ganglion cDNA library (Chen et al., 1995). Both ATP and α ,β -met-ATP evoke fast-
activating and rapidly desensitizing currents. Direct evidence for heteromeric 
assembly of P2X2 and P2X3 subunits is presented by co-purification of the two 
subunits from Baculovirus-infected SF9 cells (Radford  et al., 1997). This co-
expression yields ATP-activated currents, which closely resemble the α ,β -met-ATP-
sensitive, non-desensitizing current that are detected in sensory neurons. 
Expression of a truncated P2X3 clone lacking the intracellular N-domain yield 
functional channels that do not desensitize in oocytes (King  et al., 1997 a). 
Desensitization of the ATP-gated cation channel P2X3 is abolished by removal of 
external Ca
2+ or by cyclosporin pretreatment (King  et al., 1997 b). The rate of 
desensitization is also decreased by injection of the autoinhibitory peptide 
CaNA457–481 in the oocyte. Thus, it is thought that P2X3 desensitizes through a 
Ca
2+–dependent calcineurin-mediated phosphorylation on N–terminal residues (King 
et al., 1997 b). 
 
P2X4 Receptor. The P2X4 subunit was initially cloned from rat brain (Bo et al., 
1995) and shown to be distantly related to P2X1, P2X2, and P2X3 subunits (Soto et 
al., 1996). Its expression leads to an ATP-activated cation-selective channel that is 
highly sensitive to Ca
2+ and whose agonist sensitivity is potentiated by Zn
2+ without 
altering maximal response (Soto  et al., 1996). Its conductance is nine pS. This 
ligand-gated channel is activated by ATP > ATPγ S > 2-MeSATP > ADP ∼  α ,β -met-
ATP.  A particular feature is its insensitivity to the presently used P2X receptor 
antagonists, suramin, PPADS, and reactive blue 2 (RB2). The agonist response of 
the mouse ortholog of the P2X4 receptor (mP2X4) is potentiated by suramin, RB2, 
and in part by PPADS (Townsend-Nicholson et al., 1999).  1. Introduction and Aim of the Thesis       14 
P2X5  Receptor. The ATP-induced current after expression of the P2X5 
receptor in HEK-293 cells showed rapid activation with minimal desensitization and a 
lack of effect of α ,β -met-ATP (Collo et al., 1996). Like with P2X1 and P2X2 receptors, 
this current was inhibited by suramin and PPADS (Torres et al., 1999).  
 
P2X6 Receptor. When heterologously expressed in HEK 293 cells, only very 
small ATP-evoked currents were observed (Collo et al., 1996). Currently, there is 
general agreement that homomeric P2X6 channels are not formed in Xenopus 
oocytes (Le et al., 1998; Torres et al., 1999). 
 
P2X7 Receptor. The P2X7 receptor was originally cloned from rat and human 
macrophages and brain (Surprenant  et al., 1996; Rassendren et al., 1997). The 
P2X7 receptors shows exclusive characteristics, which have been attributed to its 
240 amino acids long intracellular C-terminal tail, of which at least 177 are involved 
in the induction of the nonselective cation channel and do not contain any known 
signaling motifs. P2X7 receptors share many characteristics with receptors 
previously named P2Z receptors, through which ATP permeabilizes macrophages 
and other cells and leads to cell death (Di Virgilio, 1995). Thus, P2X7 and P2Z 
receptors show both high sensitivity to BzATP relative to ATP and marked 
potentiation of the responses at reduced external divalent cation concentration, 
suggesting that ATP
4- rather than MgATP acts as an agonist (Cockcroft & Gomperts, 
1979). Indeed, the binding of ATP
4- to P2X7 receptors induces within milliseconds 
the opening of a channel selective for small cations and within seconds a larger pore 
whose single-channel conductance is 409 pS in macrophages and which is 
permeable to molecules up to 900 D (Coutinho-Silva & Persechini, 1997; Surprenant 
et al., 1996). These effects of ATP are antagonized by PPADS, but not by suramin 
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Table 1.2: Selected properties of recombinant rat P2X receptors. 
(Dunn, Zhong, & Burnstock, 2001; Soto et al., 1997) 
Kinetics Agonist  Antagonist  Modulator  Isoform 
Activation Desensitization 
ATP 
(EC50)  ααααβ βββ -
MetATP 
(EC50) 
Suramin 
(IC50) 
PPADS 
(IC50) 
H
+ Zn
2+ 
P2X1  Fast  Fast  1 µM  1-3 µM  1 µM  < 30µM  Inhibition  - 
P2X2  Fast  Slow  60 µM  > 100 µM  10 µM  1-5 µM  Potentiation  Increase 
P2X3  Fast  Fast  0.5µM  1 µM  3 µM  1.5 µM  Inhibition   
P2X4  Biphasic  Moderately slow  10 µM  >> 100 
µM 
> 300 µM  >50 µM  Inhibition  Increase 
(< 10 µM) 
P2X5  Fast  Slow  15 µM  >> 100 
µM 
4 µM  3 µM  -  - 
P2X7 Biphasic  None  115µM  >>  300 
µM 
~ 500 µM  45 µM  Inhibition  Decrease 
P2X2/3  Fast  Slow  1 µM  1 µM  -  2 µM  Potentiation  - 
P2X1/5  Fast  Biphasic  10 µM  5 µM    -  Inhibition  - 
P2X4/6  Fast  Moderately slow  15 µM  30 µM  -  -  Inhibition  Increase 
(10 µM) 
P2X2/6  Biphasic  Biphasic  30 µM  Inactive  6 µM  -  Potentiation  Increase 
 
 
1.2.2.3. Localization and possible physiological implications of P2X receptors 
in different tissues 
 
P2X receptors in muscle tissue  
Smooth muscle. The presence of P2X receptors has been demonstrated in 
several smooth muscle containing tissues, such as arteries, vas deferens, and 
urinary bladder of a variety of species (Dubyak & El-Moatassim, 1993). The ATP-
elicited contractions in these tissues are short-lasting due to rapid desensitization of 
the P2X receptors subtypes. ATP is released as a cotransmitter together with 
noradrenaline or acetylcholine, suggesting that ATP might only have a modulatory 
function by potentiating the effect of other neurotransmitters.  
Skeletal muscle. P2X receptors have been functionally determined in 
embryonic myoblasts and myotubes of the chick (Henning et al., 1993). In these 
tissues, ATP activates P2X receptors as a fast excitatory cotransmitter of 
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Heart muscle. RT-PCR on micro-dissected tissues from various areas of the 
heart confirms the presence of P2X1, P2X2, P2X3 subunit mRNAs (Nori et al., 1998). 
Furthermore, two splice variants of the P2X2 subunit were identified. Northern blot 
and RT-PCR analysis demonstrate P2X4 transcripts in many tissues of the rat 
including blood vessels and heart (Soto et al., 1996). Moreover, the P2X5 receptor 
was cloned from rat heart (Garcia-Guzman et al., 1996).  
 
Functional responses in the CNS 
Postsynaptic. Patch-clamp recording of P2X-mediated synaptic currents has 
been reported in neurons in six different central regions: medial habenula (Edwards 
et al., 1992) lamina II cervical dorsal horn (Bardoni et al., 1997), superficial spinal 
cord dorsal horn (Jo & Schlichter, 1999), hippocampal CA1 (Pankratov et al., 1998) 
hypothalamus (Jo & Schlichter, 1999) and CA3 (Nieber et al., 1997). Furthermore, 
intracellular voltage recordings of a synaptic current in locus coeruleus have been 
reported to show a PPADS-sensitive and a suramin-sensitive component (Nieber et 
al., 1997). In recent years, the development of selective antibodies against P2X 
subtypes has also allowed visualization of these receptors in specific synapses 
within the CNS (Atkinson et al., 2000).  
Presynaptic. Presynaptic modulation of transmitter release is evidently a 
central component of P2X receptor function in the CNS. The existence of such 
presynaptic receptors has been established electrophysiologically (Pintor  et al., 
1999) with Ca
2+ imaging (Troadec  et al., 1998), and structurally using selective 
antibodies against the receptors (Atkinson et al., 2000). Activation of P2X receptors 
has been shown to modulate the release of glutamate, GABA, glycine and 
vasopressin (Khakh & Henderson, 2000) 
Glial responses. It has been revealed that glia has a wide variety of voltage 
and ligand-gated channels as well as metabotropic receptors (Verkhratsky et al., 
1998), which can contribute to the cellular communication pathways. Glial cells are 
considered to use the phenomenon of calcium waves to communicate with each 
other and to modulate neuronal activity. ATP has been shown to act as an 
extracellular signal, which mediates this form of communication both in the 
peripheral nervous system (Robitaille, 1995; Stevens & Fields, 2000), and in cultured 
glia from the CNS (Newman & Zahs, 1997). A recent review outlines the actions of 1. Introduction and Aim of the Thesis       17 
P2 receptors on glia-neuron communication both in the CNS and PNS (Fields & 
Stevens, 2000). 
 
 
1.2.2.4. Therapeutic aspects of P2X receptor function 
 
Auditory function. P2 receptors are found in the vestibular system, and 
some P2X2 receptor splice variants are present in rat and guinea pig cochlea 
(Housley et al., 1995). The latter are present on the endolymphatic surface of the rat 
cochlear endothelium, an area associated with sound transduction (Vlajkovic et al., 
1996). ATP has the potential to regulate fluid homeostasis, hearing sensitivity, and 
development. Perilymphatic ATP lowers the sound-evoked gross compound action 
potential of the auditory nerve and the distortion product otoacoustic emission, the 
latter being a measure of the active process of the outer hair cells (Kujawa et al., 
1984).  
 
Pain. ATP is implicated in the processing of nociceptive sensory information 
and may be directly involved in the pain associated with causalgia, reflex 
sympathetic dystrophy, angina, migraine, and cancer (Burnstock, 1996). ATP is also 
a mediator of neurogenic inflammation, acting via P2 receptors on neutrophils, 
macrophages, and monocytes to provoke cytokine and prostaglandin release 
(Dubyak & El Moatassim, 1993). Peripheral administration of ATP produces pain at 
the site of administration (Bland-Ward & Humphrey, 1997), and assists nociceptive 
responses to other noxious stimuli (Driessen  et al., 1994; Hamilton, Wade & 
McMahon, 1999). These effects are blocked by the P2 antagonists suramin and 
PPADS (Sawynok & Reid, 1997). ATP released in response to a tissue trauma can 
activate P2X3 receptors that initiate and contribute to the peripheral and central 
sensitization associated with cutaneous and visceral nociception (Driessen et al., 
1994; Hamilton, Wade & McMahon, 1999). Homomeric P2X3 and heteromeric P2X2/3 
receptors are highly restricted on sensory ganglia (Guo et al., 1999; Vulchanova et 
al., 1997) and can be regulated by extracellular Ca
2+ concentrations (Cook et al., 
1998). P2X3 receptor expression is up-regulated in sensory afferents and spinal cord 
following damage to peripheral sensory fibers (Kassotakis  et al., 1996), whereas 
neonatal capsaicin treatment diminishes P2X3 message in the dorsal root ganglion 1. Introduction and Aim of the Thesis       18 
(Ralevic & Burnstock, 1998) and abolishes ATP-mediated acute nociceptive 
responses (Chen et al., 1995). P2X3 receptor antagonists thus have potential as 
novel analgesics.  
 
Trophic actions of ATP and neurodegenerative disorders. Trophic factors 
ensure neuronal viability and regeneration and are increased following neural injury 
(Neary et al., 1996). ATP can proceed synergistically with growth factors to excite 
astrocyte proliferation, contributing to the process known as reactive astrogliosis, a 
hypertrophic/hyperplastic response related with brain trauma, stroke/ischemia, 
seizures, and neurode-generative disorders. In reactive astrogliosis, astrocytes 
undergo process elongation and express the transitional filament protein, glial 
fibrillary acidic protein, with an increase in astroglial cellular proliferation. ATP, like 
basic fibroblast growth factor, increases astrocyte glial fibrillary acidic protein and 
AP-1 complex formation (Neary et al., 1996). ATP and GTP provoke trophic factor 
(nerve growth factor, neurotrophin-3, fibroblast growth factor) synthesis in astrocytes 
and neurons, an effect that is not consistent with the profile of any known P2 
receptor. The P2X7 receptor is a unique member of the P2X receptor family that 
functions as a non-selective ion pore in mast cells, platelets, macrophages, and 
lymphocytes (Dubyak et al., 1996). P2X7 receptor activation triggers apoptosis and 
stimulates the release and maturation of interleukin-1b from macrophages by 
activating interleukin-1b convertase. P2X7 receptors are present in the microglia 
within the superior cervical ganglia and spinal cord, and cerebral artery occlusion 
increases P2X7 immunoreactive cells in the stroke penumbra (Collo et al., 1997). 
ATP also induces P2X7 receptor-mediated cytolysis in macrophages infected with 
Mycobacterium via both apoptotic and necrotic events (Lammas et al., 1997). This 
anti-microbial activity of ATP may have potential use in the treatment of tuberculosis 
and also may provide a more fundamental understanding of P2X7 receptor-mediated 
apoptotic events than can be observed in more complex mammalian cell systems. 
 
Neurourology.  The urinary bladder is controlled by both sympathetic and 
parasympathetic nervous system input. ATP mimics the effects of parasympathetic 
stimulation, resulting in bladder contraction (Burnstock et al., 1978; Dean & Downie, 
1978) via activation of P2X receptors present in the smooth muscle of the urinary 
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Detrusor malfunction can lead to urge urinary incontinence (UUI), a major health 
problem in the aging female population. Micturition involves urethral relaxation, in 
which ATP operates as a co-transmitter with NO. NO mediates the first stage of 
relaxation (Pinna, Puglis & Burnstock, 1998) and ATP the second, acting via P2 
receptors. P2X receptors are also present in the bladder urothelium, and serosal 
ATP release occurs in the rabbit bladder because of the hydrostatic pressure 
changes associated with bladder filling (Yoshimura & de Groat, 1997). Muscarinic 
receptors mediate 15% of rat urinary bladder neurogenic contraction, and another 
50% is mediated by P2X receptor mechanisms (Hashimoto et al., 1995). Muscarinic 
antagonists such as oxybutynine and tolteridine are the mainstay treatment for UUI 
and have typical muscarinic side effects. P2X receptor antagonists may be 
potentially superior agents for the treatment of UUI, if their side-effect profile is 
tolerable. 
 
P2X and male fertility. Mulryan et al. (2000) produced a “knockout” mouse 
lacking the gene for the P2X1 receptor. The obvious effect of this gene deletion was 
a 90% decrease in the fertility of the male animals, which was caused by a low 
sperm count in the ejaculated semen. Thus, mutant females did not become 
pregnant when mated with mutant males, but normal rates of conception were 
observed when they mated with wild type or heterozygous males. The sperm from 
the mutant male mice were, however, viable and able to fertilize ova in vitro. The 
authors have therefore suggested that the selective pharmacological blockade of 
P2X1 receptors should generate a similar effect, and might thus present a means for 
developing a non-hormonal male contraceptive pill. 
 
 
1.3. Aspects of membrane protein synthesis and assembly 
 
Multimeric transmembrane proteins, including ligand-gated ion channels represented 
by P2X receptors, generally require subunit assembly to be transported beyond the 
endoplasmic reticulum (ER) in the secretory pathway leading to the cell surface. The 
P2X polypeptide is classified as a type II multi-spanning membrane protein, because 
it lacks a cleavable signal sequence and the C-terminal portion of the first 
transmembrane segment is located in the ER lumen (Nicke et al., 1998). The lumen 1. Introduction and Aim of the Thesis       20 
of the ER is the site where translocated proteins assume their secondary and tertiary 
structure and where assembly of oligomeric complexes occurs. Additionally, newly 
synthesized proteins undergo co-translational and posttranslational modifications in 
the lumen of the ER, some of which allow transient interactions of the folding 
polypeptide chains with a set of ER-resident proteins (Hammond & Helenius, 1995). 
Only after acquiring a fully folded, native conformation can proteins complete their 
passage through the secretory pathway (Hurtley & Helenius, 1989).  
 
 
1.3.1. Assembly and disulfide bond formation of membrane proteins 
. 
A polypeptide chain can adopt many conformations. Yet, the sequence of its amino-
acid residues directs folding to a particular native state (Anfinsen, 1973). The loss of 
conformational entropy associated with folding destabilizes the native conformation. 
This destabilization is overcome by the hydrophobic effect, hydrogen bonds, other 
noncovalent interactions, and (for many proteins) disulfide bonds (Dill, 1990). The 
extracellular domains of many transmembrane proteins include intrachain disulfide 
bonds, which are considered to contribute to the formation and stabilization of their 
mature conformation (Jaenicke, 1991). In some cases these bonds are established 
co-translationally, as soon as the participating cysteine residues appear in the lumen 
of the endoplasmic reticulum (ER), while in other cases the arrangement of disulfide 
bonds does not occur until an substantial interval after translation (Huth et al., 1992), 
or even after assembly of monomers (Segal  et al., 1992). The oxidizing 
microenvironment required for this modification is offered by the lumen of the ER. 
This organelle also holds the enzymes that assist formation of disulfide bonds and 
support in protein folding including “foldases” such as protein disulfide isomerase 
and peptidylprolyl isomerase, and molecular chaperones such as calnexin and 
calreticulin (Hurtley & Helenius, 1989). In addition, the ER is the location of assembly 
of most oligomeric membrane and secretory proteins, which exit to the Golgi 
complex and are transported to the cell surface only after the completion of 
assembly.  
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1.3.2. N-glycosylation of membrane proteins 
 
1.3.2.1. Protein folding and core glycosylation in the ER 
 
N-Glycan processing was shown to be an important event in the folding of the 
nascent protein chain. N-glycosylation starts in the ER compartment by the co-
translational  en bloc attachment of the core glycan, Glc3Man9GlcNAc2 to an Asn 
residue in the Asn-X-Ser(Thr) consensus sequence of a nascent protein, where X 
can be any amino acid other than proline (Kobata, 1992). These glycoproteins 
carrying three glucose residues on each glycan are co-translationally trimmed by the 
sequential action of ER glucosidases II and I. Monoglucosylated glycoproteins then 
bind type I membrane protein calnexin and/or the soluble protein calreticulin (Chevet 
et al., 1999; Michalak, 1999). These two lectins share the same glycan specificity 
and bind monoglucosylated N-linked oligosaccharides with a GlcMan9GlcNAc2 
structure (Vassilakos et al., 1998). Calnexin and calreticulin operate as chaperones 
in the quality control of newly synthesized glycoproteins in two opposing ways. They 
ensure that correctly folded glycoproteins leave the ER, but they can also mediate 
glycoprotein degradation in cases where correct protein folding is not possible 
(Trombetta & Helenius, 1998). The lectin-assisted glycoprotein folding involves a 
cycle of de- and reglycosylation (Ellgaard, Molinari & Helenius, 1999). 
Monoglucosylated glycoproteins bind calnexin and calreticulin and are presented to 
Erp57. Glucosidase II removes the remaining glucose residue such that the lectin-
glycoprotein interaction becomes abolished. If the glycoprotein is correctly folded, it 
will leave the ER, if not, it will be recognized by the ER enzyme UDP-
glucose:glycoprotein glucosyltransferase (GT) and reglycosylated. The 
deglycosylation and reglycosylation rounds continue until the properly folded 
glycoprotein is able to leave the cycle (Trombetta & Helenius, 1998). GT functions as 
a folding sensor, because it recognizes glycoproteins in their non-native but not in 
their native conformation (Parodi, 1999). GT is able to distinguish between different 
non-native conformations with a distinct preference for partially structured folding 
intermediates (Trombetta & Helenius, 2000). The deglycosylation and 
reglycosylation cycle continues until correct folding is achieved (Fig. 1.4).  
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Fig. 1.4: A model for a calnexin/calreticulin binding cycle involved in protein folding and 
quality control. Trimming of glucose residues (G) from the N-linked oligosaccharides of newly 
synthesized proteins by glucosidases II and I allows binding of proteins to calnexin and calreticulin, 
lectins that recognize monoglucosylated oligosaccharides. Glucosidase II removes glucose residues 
and allows the protein to dissociate. Partially folded proteins are reglycosylated by UDP–glucose: 
glycoprotein glucosyltransferase (UDP–Glc transferase), which allows rebinding to 
calnexin/calreticulin and retention. Once a protein is folded correctly, it is no longer recognized by the 
glucosyltransferase and is released from the cycle by glucosidase II (scheme taken from: Trombetta & 
Helenius, 1998). 
 
 
1.3.2.2. Oligosaccharide chains are terminally processed in the Golgi 
apparatus 
 
The N-linked oligosaccharides are attached en bloc to the glycoproteins in the ER 
and this N-glycan is then trimmed, while the protein is still in the ER. Further 
modifications and additions occur in the Golgi apparatus. In the cis-Golgi, 
mannosidase I first removes three mannoses, and in the medial-Golgi  N-
acetylglucosamine transferase I then adds an N-acetylglucosamine, which enables 
mannosidase II to remove two additional mannoses in the medial-Golgi (Alberts et 
al., 1994). At this stage, the bond between the two N-acetylglucosamine in the core 
becomes resistant to digestion by the highly specific endoglucosidase (Endo H). 
Since all later structures in the pathway are also Endo H-resistant, treatment with 
this enzyme is generally used to differentiate complex from core-type and high 
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which are then elongated in the trans-Golgi, to create much of the observed 
structural diversity of mature complex-type N-glycans (Fig 1.5). In addition to tissue-
specific expression of Golgi enzymes, variability in glycan chain elongation and 
completion results in further structural heterogeneity (Dennis et al., 1999). Figure 1.5 
illustrates some of the key elements in the N-glycosylation pathways. 
  After acquisition of complex-type carbohydrates in the Golgi apparatus, the 
membrane proteins are transported from trans-Golgi to the cell surface and 
integrated into the plasma membrane by vesicle fusion by vesicle fusion. 
 
 
Figure 1.5: Schematic drawing of N-linked glycan biosynthesis showing the Golgi 
compartments and the four classes of N-glycans: high-mannose-, hybrid-, bisected-, and 
complex-type. Abbreviations: OT, oligosaccharyltransferase; GI and GII, α -glucosidases I and II; TI, 
TII, TIII, TIV, TV, T(i), T(I), β -N-acetylglycosaminyltransferases; MI, α 1, 2mannosidase; MII, MIII, 
α 1,3/6mannosidases; Gal-T, b1,4-galactosyltransferases; Fuc-T, α -fucosyltransferase; ST, α -
sialyltransferase. The terminal sequences are added to N-glycans by β 1,4Gal-T;  β 1,3GlcNAc-T(i); 
β 1,6GlcNAc-T(I); α 2,3ST, α 1,3Fuc-T. A number of substrate-product relationships govern N-glycan 
biosynthesis. Briefly, the GlcNAc-TI product is required for substrate recognition by α -mannosidase II 
and GlcNAc-TII, and necessary for biosynthesis of the complex-type glycans. GlcNAc-TIII substitutes 
the core β -mannose residue, redirects the pathway into ‘‘bisected glycans’’ (Dennis et al., 1999). 
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1.4. Aim of the thesis 
 
The P2X receptor family of ligand-gated cation channels currently comprises seven 
isoforms (P2X1 – P2X7) that are products of seven distinct genes (Rettinger et al., 
2000). The heterologously expressed P2X receptors form functional homomeric or 
heteromeric complexes. By using biochemical techniques, Dr. A. Nicke had shown 
that trimers represent an essential structural element of P2X1 and P2X3 receptors 
(Nicke et al., 1998). In addition, a trimeric structure was shown for the P2X1, P2X4 
and P2X7 receptors that were cloned from human B-lymphocytes (Büttner, 2001). In 
this thesis, it was aimed to determine the quaternary structure of the remaining P2X 
receptor subtypes, namely P2X2, P2X5, and P2X6. The expression of these P2X 
receptors in Xenopus oocytes was verified by SDS-PAGE and their function was 
examined by two-electrode voltage-clamp analysis. The quaternary structure of the 
oocyte-expressed and either metabolically labeled or radio-iodinated P2X receptors 
was investigated by two different biochemical techniques: chemical cross-linking and 
blue native PAGE analysis.  
To examine whether N-glycans are important for P2X1 receptor assembly, 
surface expression, or ligand recognition, the respective N-glycosylation sites 
located on the ectodomain of the receptor subunit were eliminated by site-directed 
mutagenesis and the oligomerization and ATP-gated currents were analyzed in 
Xenopus oocytes by SDS-PAGE, blue native PAGE, and two-electrode voltage 
clamp measurements, respectively. An additional aim of the study was to examine 
the effect of N-glycans on the migration of P2X receptor complexes in the blue native 
PAGE system. 
The P2X1 receptors are membrane proteins with large ectodomains that fold 
inside the ER lumen. The ectodomain of P2X receptor family proteins is 
characterized by the existence of two cysteine-rich
  domains (Hanson, 1997), 
consisting of ten highly conserved cysteine residues that may contribute to the 
formation of five intrachain disulfide bonds. In this study, it was aimed to verify 
whether disulfide bonds affect the expression or function of the P2X1 receptor. 
Therefore, various single, double and triple cysteine deletion mutants of His-P2X1 
receptors were constructed by site-directed mutagenesis, and their synthesis and 
function was analyzed in Xenopus oocytes by SDS-PAGE, blue native PAGE, and 
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agent dithiothreitol (DTT) was applied to study the contribution of the ER redox 
environment to the posttranslational processing and intracellular transport of oocyte-
expressed P2X1 receptors.  
In addition, the hetero-oligomeric assembly of P2X1 and P2X2 subunits was 
examined. Therefore, a co-purification assay was exploited, in which the 
hexahistidyl-tagged rat P2X2 subunit was co-expressed with non-tagged P2X1 
subunit and vice versa in Xenopus oocytes. The isolated polypeptides were analyzed 
by SDS-PAGE and their oligomeric state was examined by blue native PAGE 
analysis and by chemical cross-linking using glutardialdehyde.  
To observe the subcellular localization and membrane targeting of P2X1 
receptor, the His-P2X1 receptor subunit was tagged N- or C-terminally with the green 
fluorescent protein (GFP). These fusion proteins were then expressed in Xenopus 
oocytes and visualized by the use of a confocal laser-scanning microscope. In 
addition, the fusion proteins were biochemically analyzed by SDS-PAGE and BN-
PAGE. 
Furthermore, various non-desensitizing P2X receptor chimeras were 
constructed and studied by SDS-PAGE, BN-PAGE, and two-electrode voltage 
clamping. The aim of these studies was to prove or disprove whether P2X receptors 
with non-desensitizing phenotype (Werner  et al., 1996) have a propensity to 
assemble to hexamers rather than to trimers. 
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2. Material and Methods 
 
 
2.1. Compounds, materials, and buffers 
 
2.1.1. Compounds and materials 
 
Detergents, cross-linkers and amino-reactive compounds 
•  Digitonin, water soluble (serva, Heidelberg, Germany), (Sigma-Aldrich, 
Steinheim, Germany) 
•  n-Dodecyl-β -D-maltoside (Biomol, Hamburg, Germany) 
•  Lithium dodecyl sulfate for biochemical use [LiDS] (Merck, Darmstadt, 
Germany) 
•  Sodium dodecyl sulfate, electrophoresis purity reagents [SDS] (Biorad 
Laboratories, München, Germany) 
•  n-Octyl-β -D-glucopyranoside (Biomol, Hamburg, Germany) 
•  Glutardialdehyde (Roth, Karlsruhe, Germany) 
•  Sulfosuccinimidyl-3-(4-hydroxyphenyl)propionate [Sulfo-SSHP]  
(Pierce, Rockford, IL, USA) 
 
Enzymes for protein biochemistry and oocyte preparation 
•  Collagenase (serva, Heidelberg, Germany) 
•  Endoglycosidase H [endo H] (New England Biolabs, Schwalbach, Germany) 
•  Peptide:N-glycosidase F [PNGase F] (New England Biolabs, Schwalbach, 
Germany) 
 
Reagents for protein purification and polyacrylamide gel electrophoresis 
•  6-Amino-n-caproic acid (Merck, Darmstadt, Germany) 
•  Ammonium persulfate [APS] (Sigma-Aldrich, Steinheim, Germany) 
•  Combitheck
  Calibration proteins: aldolase, bovine Serum albumin, catalase, 
ferritin, hen’s egg albumin (Boehringer Mannheim, Germany) 
•  Coomassie Brillant blue G-250 (Serva, Heidelberg, Germany) 
•  Dithiothreitol [DTT] (Roth, Karlsruhe, Germany) 2. Material and Methods       27 
•  Iodoacetamide (Sigma, St. Louis, MO, USA) 
•  Ni
2+-Nitriloacetic acid agarose [Ni
2+ NTA agarose] (Qiagen, Hilden, Germany) 
•  Pefabloc (Merck, Darmstadt, Germany) 
•  Antipain (Biomol, Hamburg, Germany) 
•  Pepstain (Biomol, Hamburg, Germany) 
•  Rainbow  coloured protein molecular weight markers 14,300-220,000 D 
(Amersham Buchler, Braunschweig, Germany) 
•  N, N, N’, N’-Tetramethylethylendiamin [TEMED] (Merck, Darmstadt, 
Germany) 
•  Urea (Sigma, St. Louis, MO, USA) 
 
Radioactive compounds 
• 
125Iodine sodium salt (Amersham Buchler, Braunschweig, Germany) 
•  L-[
35S]Methionine (Amersham Buchler, Braunschweig, Germany) 
•  Rainbow  [
14C]methylated protein molecular weight markers 14,300-220,000 
D (Amersham Buchler, Braunschweig, Germany) 
 
Equipment  
•  Autoclave: Bioclav (KSG, Olching, German) 
•  Centrifuge 5430 (Eppendorf, Hamburg, Germany) 
•  Sequi-Gen  Sequencing Cell (Biorad Laboratories, München, Germany) 
•  Power supply for Sequencing cell: Power Pac 3000 (Biorad Laboratories, 
München, Germany) 
•  Power supplies for gel electrophoresis: Phero-stab.300 (Biotec Fischer, 
Reiskirchen), Power supply 250/250 (Desaga, Heidelberg, Germany) 
•  Microinjector: Drummond “Nanoject” (Drummond Scientific, Broomall, PA, 
USA; Bachofer Laboratoriumsgeräte, Reutlingen, Germany) 
•  Micropipette puller: Model PP-830 (Narishige, Japan) 
•  Sample cups for metabolic labeling and binding (Sarstedt, Nürmbrecht, 
Germany) 
•  Tissue culture dishes for oocyte cultivation: Cell+ (Sarstedt, Nürmbrecht, 
Germany) 
•  Incubator: Kelvitron kl (Heraeus, Hanau, Germany) 2. Material and Methods       28 
•  Vertical slab gel electrophoresis apparatus 8 x 16 cm (Phase, Lübeck, 
Germany) 
•  X-ray films: Biomax  MR films for gels with 
35S samples, Biomax  MS films 
for gels with 
125I samples or 
35S samples in combination with screen (Eastman 
Kodak, Rochester, New York, USA) 
•  Biomax TransScreenn-LE (Eastman Kodak, Rochester, New York, USA) 
•  Developer, Replenisher: GBX reagents (Eastman Kodak, Rochester, New 
York, USA) 
•  Microwave R-3V10 (Sharp, Hamburg, Germany) 
•  Thermocycler: Thermal reactor (Hybaid, Heidelberg, Germany) 
•  pH-meter: PHM  62 (Radiometer, Copenhagen, Denmark) 
•  Pipettes: Pipetman (Abimed, Langenfeld, Germany) 
•  Shaker: Vibrax (IKA, Staufen, Germany) 
•  Thermal shaker for bacterial cultures: Controlled Environmental Incubator 
Shaker (New Brunswick Scientific, USA) 
•  Vacuum pump: Vapor Trap (Biorad, München, Germany) 
•  Gel dryer, Model 583 (Biorad, München, Germany) 
•  Water bath (GFL, Burgwedel, Germany) 
•  Weighing-machine: PR 503 Delta Range (Mettler Toledo, Greifensee, 
Switzerland) 
 
 
2.1.2. Media and buffer solution 
 
Unless otherwise noted, all media, buffers and solutions were made from 
commercially available chemicals of analytical grade purity and purified water 
(Millipore Milli-Qplus) or double distilled water. Reaction buffers for modification of 
DNA or RNA and elution/storage buffers for samples of DNA, RNA, and purified 
protein were prepared from ultra pure water (Gibco, Karlsruhe, Germany). Media and 
buffer solutions were either autoclaved or sterile filtered. 2. Material and Methods       29 
2.1.2.1. Media and buffers used for cultivation of bacteria and genetic 
engineering 
 
LBamp-medium  (Luria-Bertani medium) 
20 g of broth base (Gibco BRL Life Technologies, Berlin, Germany) was solubilized 
in 1 liter of deionized water. A pH of 7.0 is adjusted without manipulation. The 
solution was autoclaved. Ampicillin with the final concentration of 50 mg/l was added 
to the LB-medium just before use.  
 
LBamp-agar plates 
1.5% Agar Bacteriological Grade (Gibco BRL Life Technologies, Berlin, Germany) 
was added to the previously prepared LB-medium. The solubilization of agar was 
achieved by autoclaving the media. Ampicillin with the final concentration of 100 mg/l 
was added to the chilled (< 50°C) medium. The solution was poured into petri dishes 
and the solution was left to solidify. 
 
Tris-acetate-EDTA-buffer for agarose gel electrophoresis (TAE-buffer) 
50 x TAE-buffer 
Tris base  242 g 
Acetic acid  57.1 ml 
EDTA (0.5 M), pH 8.0  100 ml 
Filled up to 1 liter with Milli-Qplus water 
The solution was diluted 1:50 with Milli-Q plus water before use. 
 
Tris-EDTA-buffer (TE-buffer) 
100 x TE-buffer 
Tris base  1 M 
EDTA   0.1 M 
In Milli-Qplus water, adjusted to pH 8.0 with 1 M HCl 
and autoclaved 
The solution was diluted 1:100 with Milli-Q plus water before use. 2. Material and Methods       30 
2.1.2.2. Incubation and washing media for oocytes 
 
Oocyte Ringer solution 
(ORi) 
Ca
2+-free Oocyte Ringer 
solution (Ca
2+-free ORi) 
Oocyte phosphate-
buffered saline 
(Oocyte PBS) 
NaCl  90 mM  NaCl  90 mM  NaCl  70 mM 
KCl  1 mM  KCl  1 mM  Na2HPO4 30  mM 
CaCl2 1  mM  MgCl2 2  mM  MgCl2 1  mM 
MgCl2  1 mM  HEPES  5 mM  CaCl2 0.1  mM 
HEPES 5  mM       
Gentamycin 
(optional) 
50 µg/ml       
 
In Milli-Qplus water, adjusted to pH 7.4 with 1 M NaOH 
and autoclaved  
In Milli-Qplus water, 
adjusted to pH 8.0 with  
1 M NaH2PO4 and 
autoclaved 
 
 
2.1.2.3.  Buffers used for protein biochemistry 
 
Buffers used for purification of His-tagged protein 
Ni
2+ -NTA binding buffer 
(0.1 M phosphate buffer, pH 8.0) 
Na2HPO4 93.2  mM 
NaH2PO4 6.8  mM 
 
Non-denaturing elution buffer 
Tris/HCl (pH 7.4)  20 mM 
Imidazole 200  mM 
Buffers used for SDS-PAGE 
5 X SDS-PAGE sample buffer 
Tris/HCl (pH 6.8)  0.3 M 
SDS 5% 
Glycerol 50% 
Bromphenol blue  1% 
DTT (optional)  100mM 
10 X SDS-PAGE running buffer 
Tris/HCl (pH 8.3)  0.25 M 
Glycin 1.92  M 
SDS 1  % 
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Buffers used for Blue Native-PAGE 
5 X Blue Native-PAGE sample buffer 
Na-aminocaproate 100  mM 
Coomassie Serva 
Blue G 
1% 
Glycerol 50% 
 
 
3 X Blue Native-PAGE gel buffer 
Na-aminocaproate 1.5  M 
BisTris pH 7.0  150 mM 
 
 
1 X Blue Native-PAGE anode buffer 
BisTris pH 7.0  50 mM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Staining solution  
Coomassie blue 
R250  
0.1% 
Methanol 45% 
Water 45% 
Acetic acid  10% 
 
Destaining solution  
Methanol 10% 
Water 80% 
Acetic acid  10% 
 
1X Blue Native-PAGE cathode buffer 
Tricine 50  mM 
BisTris pH 7.0  15 mM 
Serva blue G  0.005% 
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2.2. Animals and cells 
 
2.2.1. Xenopus laevis  
Xenopus laevis (South African clawed frog) females were imported directly from the 
African Xenopus facility, Noordhoeck, Republic of South Africa. They were kept in 
water tanks at a temperature of 16-20°C. Fresh tap water was delivered twice daily 
for 2 h. An artificial 12-hour light-dark cycle was installed. The frogs were fed twice 
per week with raw bovine heart cut into small pieces and supplemented with 
Multisanostol
  (Roland, Hamburg, Germany). 
 
2.2.2. E.coli strains 
 
Competent cells of the bacterial strains Top 10 and XL-1 Blue (Invitrogen, 
Groningen, Netherlands) prepared by the CaCl2 method (according to Sambrook, 
Fritsch, & Maniatis, 1989) were used for plasmid DNA amplification and cDNA 
cloning. 
 
 
2.3. DNA sources 
 
•  Vectors pNKS2, pNKS4 (Prof. G. Schmalzing, Technical University Aachen, 
Dept. of Pharmacology and Toxicology), (Gloor, Pongs, & Schmalzing, 1995) 
•  cDNA encoding N-terminally hexahistidyl-tagged rat P2X1 (His-rP2X1) in 
pNKS2, rat P2X2 in pNKS2 vector, rat P2X3-pNKS2, and human P2X4-pNKS2 
(Prof. G. Schmalzing, Technical University Aachen, Dept. of Pharmacology 
and Toxicology) 
•  cDNA encoding rat P2X5 and rat P2X6 in vector pSP64 (Dr. F. Soto, Max-
Planck-Institute for Experimental Medicine, Göttingen, Germany) 
•  His-P2X1-GFP-pSPS64polyA (Dr. Helmut Reiländer, Max-Planck-Institute for 
Biophysics, Department of Molecular Membrane Biology, Frankfurt, Germany) 
•  Vector pEGFP-pCMV (Clontech, SanDiego, USA) 
•  Oligonucleotides were purchased from Sigma-ARK Scientific (Darmstadt, 
Germany) or MWG Biotec (Ebersberg, Germany). For sequences of the 2. Material and Methods      
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numbered oligonucleotides described under genetic engineering, see 
appendix. 
 
 
2.4. Methods 
 
2.4.1. Genetic engineering 
 
cDNA constructs were generated by using standard molecular biology techniques 
(Sambrook, Fritsch, & Maniatis, 1989). Enzymes for genetic engineering of plasmid 
DNA were purchased from New England Biolabs (Schwalbach, Germany) and 
utilized as recommended by the supplier. If a change of buffer was necessary 
between enzymatic reactions, the samples were desalted by using MicroSpin S-50 
columns (Pharmacia Biotech, Freiburg, Germany). DNA fragments were extracted 
from a preparative 1% agarose gel using the Qiaex DNA Extraction kit (Qiagen, 
Hilden, Germany). Oligonucleotides and plasmid DNA were stored in 1 x TE buffer 
(pH 8.0) at -20
oC. 
Plasmid DNA was purified from bacterial culture by using the SeqLab (Göttingen, 
Germany) or the GFX
  Micro Plasmid prep kit (Pharmacia Biotech, Freiburg, 
Germany). 
To generate double-stranded oligonucleotides, the single-stranded 
oligonucleotides were combined and diluted to a final concentration of 5 µ M of each 
oligonucleotide. After heating this mixture at 95°C for 5 min, it was cooled down 
slowly (1°C per min) to allow for annealing of the oligonucleotides. 0.5 µ l of the 
annealed oligonucleotide mixture was used for ligation with about 200 ng of vector in 
a final volume of 20 µ l. Ligations were performed using the T4 DNA ligase (New 
England Biolabs Schwalbach, Germany) according to the protocol of the supplier. 
cDNA constructs were sequenced either by the dideoxynuleotide method (T7 
Sequencing kit, Pharmacia Biotech, Freiburg, Germany) using a 6% sequencing gel 
(Acrylamide 4K Sequencing kit, Applichem, Darmstadt, Germany), or by cycle 
sequencing (ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction kit; 377 
Sequencer Perkin Elmer/Applied Biosystems; Institute of Pharmaceutical Biology, 
University of Frankfurt). 
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Construction of cDNAs in vector pNKS2 with an optimized 5’-non-translated 
region.  
Some of the constructs were optimized in the 5’-non-translated sequence of vector 
pNKS2 just prior to the open reading frame of the gene of interest. To this end, a 
double-stranded oligonucleotide (#423 and #424) encoding the optimized 5’-non-
translated region followed by an Aat II site was introduced in frame between the 
unique Hind III and Nco I sites of the vector pNKS2. The cDNA sequence used has 
been reported to support efficient protein synthesis because of lack of secondary 
structure (Kozak, 1994). The vector pNKS2 was renamed into pNKS2* after the 
optimization of the 5’-non-translated region. This optimization step was conducted for 
all pNKS2 constructs except the cysteine and N-glycan mutants of His-rP2X1-
pNKS2. 
 
 
2.4.1.1. Construction of cDNAs for tagged and mutant rat P2X1 
 
In general the Quick Change  mutagenesis Kit (Stratagene, Heidelberg, Germany) 
was used for site-directed mutagenesis. The kit can be used to make point 
mutations, switch amino acids, and delete or insert single or multiple amino acids. 
The mutagenesis method is performed using Pfu DNA polymerase, which replicates 
both plasmid strands with high fidelity, the mutant oligonucleotide primers, and a 
thermal cycler. The procedure utilizes a supercoiled, double-stranded DNA vector 
with an insert of interest and two synthetic oligonucleotide primers containing the 
desired mutation. The oligonucleotide primers, each complementary to opposite 
strands of the vector, extend during temperature cycling by means of Pfu DNA 
polymerase. On incorporation of the oligonucleotide primers, a mutated plasmid 
containing staggered nicks is generated. Following temperature cycling, the product 
is treated with Dpn I. The Dpn I endonuclease (target sequence: 5’-G
m6ATC-3’) is 
specific for methylated and hemimethylated DNA and is used to digest the parental 
DNA template and to select for mutation-containing DNA. The nicked vector DNA 
incorporating the desired mutation is then transformed into E. coli (XL-1 Blue 
supercompetent cells). 
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Rat P2X1 mutants lacking one or several consensus sequences for N-
glycosylation. His-P2X1 mutants lacking one or several consensus sequences for 
N-glycosylation were generated by changing the asparagine of existing NXS/T 
codons to glutamine using site directed mutagenesis (Table 2.1). All mutations were 
verified by dideoxynucleotide sequencing. The final mutant in this table describes a 
substitution of a proline residue following the consensus sequence 
284NLS by an 
alanine residue. 2. Material and Methods      
 
36 
Table 2.1: Mutants lacking one or several consensus sequences for N-glycosylation. 
Mutated construct 
(Sequenced cDNA construct) 
Parent 
construct 
Abbreviated 
name of 
construct 
Primer 
used 
His-P2X1-N
153Q-pNKS2 
(2-1907) 
His-P2X1-pNKS2  ∆ N1  492 / 493 
His-P2X1-N
184Q-pNKS2 
(1-0606) 
His-P2X1-pNKS2  ∆ N2  494 / 495 
His-P2X1-N
210Q-pNKS2 
(1-1407) 
His-P2X1-pNKS2  ∆ N3  506 / 507 
His-P2X1-N
284Q-pNKS2 
(2-2206) 
His-P2X1-pNKS2  ∆ N4  508 / 509 
His-P2X1-N
300Q.pNKS2 
(1-2705) 
His-P2X1-pNKS2  ∆ N5  519 / 520 
His-P2X1-N
184Q / N
210Q-pNKS2 
(1-1709) 
∆ N3  ∆ N23  494 / 495 
His-P2X1-N
184Q / N
284Q-pNKS2 
(3-2007) 
∆ N4  ∆ N24  494 / 495 
His-P2X1-N
184Q / N
300Q-pNKS2 
(1-1809) 
∆ N5  ∆ N25  494 / 495 
His-P2X1-N
210Q / N
300Q-pNKS2 
(1-2009) 
∆ N3  ∆ N35  519 / 520 
His-P2X1-N
153Q / N
210Q-pNKS2 
(1-1904) 
∆ N3  ∆ N13   492 / 493 
His-P2X1-N
153Q / N
300Q-pNKS2 
(1-2104) 
∆ N5  ∆ N15   492 / 493 
His-P2X1-N
153Q / N
184Q-pNKS2 
(1-2410) 
∆ N2  ∆ N12  492 / 493 
His-P2X1-N
153Q / N
184Q / N
210Q-
pNKS2 (1-2510) 
∆ N23  ∆ N123  492 / 493 
His-P2X1-N
153Q / N
184Q / N
284Q-
pNKS2 (2-1408) 
∆ N24  ∆ N124  492 / 493 
His-P2X1-N
184Q / N
210Q / N
300Q-
pNKS2 (1-3003) 
∆ N23  ∆ N235   519 / 520 2. Material and Methods      
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Mutated construct 
(Sequenced cDNA construct) 
Parent 
construct 
Abbreviated 
name of 
construct 
Primer 
used 
His-P2X1-N
153Q / N
184Q / N
210Q / 
N
284Q-pNKS2 
(2-0809) 
∆ N124  ∆ N1234  506 / 507 
His-P2X1-N
153Q / N
184Q / N
210Q / 
N
284Q / N
300 Q-pNKS2 
(1-1909) 
∆ N1234 
 
∆ N12345 
 
519 / 520 
His-P2X1-P
287A-pNKS2 
(1-3011) 
His-P2X1-pNKS2  +N4  606 / 607 
In column one, the name of the mutant and the sequenced clone are indicated. The positions of the 
asparagine residues are derived from the sequence of the wild type rat P2X1 sequence. The 
oligonucleotide numbers used for site-directed mutagenesis are indicated in column four. 
 
 
 
Rat P2X1 mutants lacking one or several cysteine residues. His-P2X1 mutants 
lacking one or several cysteine residues were generated by changing the cysteine 
residue to serine by site-directed mutagenesis (Table 2.2). 
 
 
Table 2.2: Mutants lacking one or several cysteine residues.  
Mutated construct 
(Sequenced cDNA construct) 
Parent 
construct 
Abbreviated 
name of 
construct 
Primer 
used 
His-rP2X1-C
117S-pNKS2 
(1-0704)  
His-P2X1-pNKS2  ∆ C1  642 / 643 
His-rP2X1-C
126S-pNKS2  
(1-1405) 
His-P2X1-pNKS2  ∆ C2  652 / 653 
His-rP2X1.C
132S-pNKS2  
(1-1505) 
His-P2X1-pNKS2  ∆ C3  654 / 655 
His-rP2X1.C
149S.pNKS2  
(2-2805) 
His-P2X1-pNKS2  ∆ C4  656 /657 
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Mutated construct 
(Sequenced cDNA construct) 
Parent 
construct 
Abbreviated 
name of 
construct 
Primer 
used 
His-rP2X1-C
159S-pNKS2  
(1-1605) 
His-P2X1-pNKS2  ∆ C5  658 / 659 
His-rP2X1-C
165S-pNKS2  
(1-1705) 
His-P2X1-pNKS2  ∆ C6  660 / 661 
His-rP2X1-C
217S-pNKS2  
(1-0906) 
His-P2X1-pNKS2  ∆ C7  678 / 679 
His-rP2X1-C
227S-pNKS2  
(1-1106) 
His-P2X1-pNKS2  ∆ C8  680 / 681 
His-rP2X1-C
261S-pNKS2  
(1-1206) 
His-P2X1-pNKS2  ∆ C9  682 / 683 
His-rP2X1-C
270S-pNKS2 
(1-1006)  
Hi-P2X1-pNKS2  ∆ C10  684 / 685 
His-rP2X1-C
353S-pNKS2  
(1-1306) 
Hi-P2X1-pNKS2  ∆ C11  686 / 687 
His-rP2X1-C
117S / C
126S-pNKS2 
(B1-2710) 
∆ C1  ∆ C1+2  652 / 653 
His-rP2X1-C
117S / C
165S-pNKS2 
(C61-1008) 
∆ C1  ∆ C1+6  660 / 661 
His-rP2X1-C
126S / C
132S-pNKS2 
(C23-0908) 
∆ C3  ∆ C2+3  652 / 653 
His-rP2X1-C
126S / C
149S-pNKS2 
(A1-2710)  
∆ C4  ∆ C2+4  652 / 653 
His-rP2X1-C
126S / C
159S-pNKS2 
(E1-2109) 
∆ C2  ∆ C2+5  658 / 659 
His-rP2X1-C
132S / C
149S-pNKS2 
(B1-2109) 
∆ C3  ∆ C3+4  656 /657 
His-rP2X1-C
132S / C
159S-pNKS2 
(D1-2508) 
∆ C3  ∆ C3+5  658 / 659 
His-rP2X1-C
149S / C
159S-pNKS2 
(C1-2109) 
∆ C5  ∆ C4+5  656 /657 
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Mutated construct 
(Sequenced cDNA construct) 
Parent 
construct 
Abbreviated 
name of 
construct 
Primer 
used 
His-rP2X1-C
117S / C
126S / C
165S-
pNKS2 (A1-2003) 
∆ C1+6  ∆ C1+2+6  652 / 653 
His-rP2X1-C
126S / C
132S / C
149S-
pNKS2 (B2-2003) 
∆ C3+4  ∆ C2+3+4  652 / 653 
His-rP2X1-C
126S / C
149S / C
159S-
pNKS2 (C1-2003) 
∆ C4+5  ∆ C2+4+5  652 / 653 
His-rP2X1-C
159S / C
165S-pNKS2 
(C1-2710) 
∆ C6  ∆ C5+6  658 / 659 
In column one, the name of the mutant and the sequenced clone are indicated. The positions of the 
cysteine residues are derived from the sequence of the wild type rat P2X1 sequence. The 
oligonucleotide numbers used for site-directed mutagenesis are indicated in column four.  
 
 
Construction of cDNAs for GFP-tagged His-P2X1. 
His-rP2X1-GFP in vector pNKS2*  
The cDNA of His-P2X1 with a C-terminal GFP-tag in pSP64polyA was provided by 
Dr. Helmut Reiländer (Max-Planck-institute for Biophysics, Frankfurt, Germany). His-
rP2X1-GFP-pSP64polyA was first cut with Not I, blunted by T4 DNA polymerase 
treatment, and then cut with BamH I. Finally, this cDNA fragment including the entire 
coding region was sub-cloned between the BamH I and Sma I cleavage sites of the 
oocyte expression vector pNKS2. 
 
GFP-His-rP2X1 in vector pNKS2*  
cDNA encoding an N-terminal GFP sequence fused in frame with a hexahistidyl-
tagged rat P2X1 was constructed as follows: using overlap extension polymerase 
chain reaction (PCR) (flanking primers # 886 and # 887), an Aat II site in the 5’-non-
translated region 12 nucleotides upstream the initiation ATG and a Nco I site at the 
C-terminus of GFP were introduced. Subsequently, this fragment was ligated in 
frame between Aat II and Nco I cleavage sites of  the His-P2X1.pNKS2*.   2. Material and Methods      
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2.4.1.2. Construction of cDNAs for tagged, mutant, and truncated rat P2X2 
 
His-rP2X2-pNKS2* 
To generate a cDNA encoding N-terminally hexahistidyl-tagged rat P2X2 (His-rP2X2) 
in vector pNKS2*, the endogenous Nco I site within the coding region of the rat P2X2 
cDNA was deleted by site-directed mutagenesis using oligonucleotides # 488 and # 
489 without changing the respective amino acid, 
184H. Then, the double-stranded 
oligonucleotide (# 423 and # 424) encoding the optimized 5’-non-translated region 
followed by an Aat II site was introduced between the Hind III of the vector pNKS2 
and the Nco I cleavage site at the starting ATG of the rP2X2 cDNA. Finally, the 
hexahistidyl-tag was directionally inserted using double-stranded oligonucleotides 
(#496 and #497) between the Aat II and Nco I sites of r2X2-pNKS2*. 
 
His-rP2X2-N
239Q-pNKS2* 
Using site-directed mutagenesis, a His-rP2X2 mutant lacking one of the three 
existing consensus sequences for N-glycosylation was generated by changing the 
asparagine at the position 239 to glutamine, using the oligonucleotides # 947 and # 
948. 
 
His-rP2X2 
1-409-pNKS2* 
For construction of a C-terminally truncated rat P2X2  receptor with a N-terminal 
hexahistidyl sequence, the coding sequence of rat P2X2 after the amino acid 
409G 
was deleted using singular Eco  NI and Xba  I cleavage sites. Then, a double-
stranded oligonucleotide (# 719 and # 720) was ligated in frame between the Eco NI 
and the Xba I sites of His-rP2X2 in vector pNKS2* to introduce a stop codon after the 
amino acid 
409G. 
 
 
2.4.1.3. Construction of cDNAs for tagged rat P2X5 and rat P2X6 
 
His-rP2X5 in vector pNKS4* 
The complete coding sequence of rat P2X5 was first subcloned from the original 
pBSK vector into the pNKS4 vector. To this end, a unique Nco I recognition site was 
introduced at the start codon of rat P2X5 by site-directed mutagenesis 
(oligonucleotides # 535 and # 536). The P2X5 coding sequence could then be 2. Material and Methods      
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excised with Nco I and Apa I, and subcloned into the corresponding sites of vector 
pNKS4. To insert a N-terminal hexahistidyl-tag into rP2X5-pNKS4, a double stranded 
oligonucleotide (# 547 and # 548) encoding the optimized 5’-non-translated region 
followed by six histidine residues was directionally inserted between the unique  
Hind III and Nco I sites of rP2X5-pNKS2*.  
 
His-rP2X6 in pNKS2* 
The coding sequence of rat P2X6 was isolated by using endogenous Nco I and Xho I 
cleavage sites and subcloned into the pNKS2* vector. To generate a cDNA encoding 
N-terminally hexahistidyl-tagged P2X6, the annealed oligonucleotides # 496 and # 
497 encoding six histidine residues were directionally inserted between the unique 
Aat II and Nco I sites of P2X6-pNKS2*. 
 
 
2.4.1.4. Construction of cDNAs for P2X receptor chimera 
 
His-rP2X2/rP2X1-pNKS2 
A chimeric cDNA encoding a hexahistidyl-tag followed by the first 47 N-terminal 
amino acids of rat P2X2  joined with 352 amino acids of the C terminus of the rat 
P2X1 polypeptide was constructed by first introducing a unique SnaB I site at codon 
48V of the rat P2X1-pNKS2 plasmid by site-directed mutagenesis (oligonucleotides # 
502 and # 503). Then, a SnaB I site at codon 
47V of the N-terminally hexahistidyl-
tagged rat P2X2 was introduced by site-directed mutagenesis (oligonucleotides # 
503 and # 504). Finally, the N-terminal His-rP2X2 sequence was excised with Hind III 
and SnaB I and ligated in frame between the Hind III of the vector and engineered 
SnaB I cleavage sites of rat P2X1-pNKS2.  
 
His-rP2X1[TM(1)P2X2]-pNKS2 
To generate a chimeric cDNA encoding a N-terminally hexahistidyl-tagged rat P2X1 
subunit with the sequence for the predicted first transmembrane region of the rat 
P2X2 subunit, a unique BspE I site at position 
25R (oligonucleotides # 525 and # 526) 
and a unique SnaB I site at position 
48V of the His-rP2X1-pNKS2 (oligonucleotides # 
502 and # 503) were introduced by site-directed mutagenesis. No amino acid of the 
coding sequence was changed by introduction of the restriction sites. Finally, a 
double stranded oligonucleotide (# 529 and # 530) derived from the first 2. Material and Methods      
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transmembrane region of rat P2X2 encoding the amino acids 
43NRRLGFVHRMVQLLILLYFVWY
65 were directionally inserted between the 
engineered BspE I and SnaB I sites. 
 
His-rP2X2/rP2X3-pNKS2* 
A chimeric cDNA encoding a hexahistidyl-tag followed by the first 47 N-terminal 
amino acids of the rat P2X2 subunit and joined with 356 amino acids of the C 
terminus of the P2X3 polypeptide was constructed as follows: to delete the 
endogenous  SnaB I site in the 3’-non-translated region of the rat P2X3 gene in 
pNKS2 the construct was opened with Apa  I and SnaB I, blunted by T4 DNA 
polymerase treatment and religated. Then, a SnaB I site at the position 
41V was 
introduced into rat P2X3-pNKS2 by site-directed mutagenesis (oligonucleotides # 
527 and # 528). Finally, the rat P2X3 fragment between the engineered SnaB I and 
EcoR I site was excised and the rat P2X1 fragment of the construct His-rP2X2/rP2X1-
pNKS2 was replaced directionally by the SnaB I / EcoR I-isolated rat P2X3 fragment.  
 
His-hP2X4/rP2X1-pNKS2* 
For construction of a chimeric cDNA encoding a hexahistidyl-tag followed by the first 
45 N-terminal amino acids of the human P2X4 subunit connected with 352 amino 
acids of the C terminus of rat P2X1 polypeptide, a unique SnaB I site was introduced 
by site-directed mutagenesis at the position 
45V of the His-hP2X4-pNKS2* construct 
(oligonucleotides # 513 and # 514). Subsequently, the human P2X4 fragment 
between the SnaB I and Hind III site was excised and the rat P2X2 fragment of the 
construct His-rP2X2/rP2X1-pNKS2 was replaced by the Hind  III  / SnaB I-isolated 
hP2X4 fragment.  
 
 
2.4.1.5. cRNA synthesis 
 
For synthesis of run-off cRNA, plasmids were usually linearized at the unique EcoR I 
cleavage site at the 5’ end of the polyA tail (vector pNKS2). If an additional EcoR I 
site was present in the plasmid (P2X2, and P2X5), Not I was used for linearization. 
Linearized plasmid cDNAs were purified by using the QIAquick Nucleotide Removal 
Kit (Qiagen, Hilden, Germany), and dissolved in 0.5 x TE. Capped cRNAs were 
synthesized from these templates with SP6 RNA polymerase (Pharmacia Biotech, 2. Material and Methods      
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Freiburg, Germany), purified with Sepharose G50 (Stratagene, Heidelberg, 
Germany) chromatography and phenol-chloroform extraction, and dissolved in 5 mM 
Tris/HCl, pH 7.2, using the optical density reading at 260 nm for quantification (OD 
1.0 = 40 µ g/µ l, Hitachi U-2000 spectral photometer). 
 
 
2.4.2. Preparation of ovary and maintenance of Xenopus oocytes 
 
Xenopus leavis females were anaesthetized by 15-30 min immersion in a 0.2% 
solution of 3-aminobenzoic acid ethyl ester (Tricaine, MS 222, Sigma, St.Louis, MO, 
USA) in water (adjusted with HEPES to pH 7.4). The anaesthetized frog was placed 
on a flat surface and an incision of approximately 1 cm was made through skin and 
muscle in the lateral of the abdomen. The desired amount of ovary was carefully 
teased out of the abdomen, excised, and immediately transferred into ORi. The 
incisions in the body wall and in the skin were sutured separately. Frogs were left 
overnight to recover and kept in a separate tank for approximately half a year for 
complete regeneration. 
For isolation of oocytes, the ovary lobes were separated into small pieces and 
incubated for about 15 hours at 19°C with collagenase at a concentration of 1.5 mg 
per ml of ORi (sterile filtered) (Schmalzing et al., 1991). Subsequently, oocytes were 
washed and incubated in Ca
2+ -free ORi for 10 min to remove the adherent follicle 
cells and then placed in ORi. A homogenous group of follicle cell-free oocytes of 
oogenesis stages V and IV (Colman, 1984) was selected soon thereafter and 
injected with 50 nl aliquots of cRNA (0.5 µ g/µ l). Injected oocytes and non-injected 
controls were cultured at 19°C in ORi using petri dishes with modified surface 
(Greiner, Germany). 2. Material and Methods      
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2.4.3. Protein biochemistry 
 
2.4.3.1. Radioactive labeling of proteins 
 
Metabolic labeling with [
35S] methionine 
In general, metabolic labeling was achieved by the overnight incubation of the total 
protein of cRNA-injected Xenopus oocytes and non-injected controls with L-
[
35S]methionine at ~100 MBq/ml with ~0.2 MBq/oocyte. Incubation with 
[
35S]methionine was performed at 19°C in closed sample cups that had been pre-
treated with oocyte homogenate to prevent adhesion of oocytes. Incorporation of 
radioactivity was stopped by an overnight chase period in ORi. During this chase 
interval, oocytes were kept in tissue culture dishes.  
 
Cell surface iodination with 
125I-sulfo-SHPP 
For selective labeling of cell surface proteins, oocytes were cultured for three days 
after cRNA injection. Then 12 to 15 intact oocytes per group were selected, washed 
in chilled oocyte PBS, and placed on ice in 0.5 ml reaction tubes that had been pre-
treated with oocyte homogenate. Sulfosuccinimidyl-3-(4-hydroxyphenyl)-proprionate 
[sulfo-SHPP] was radio-iodinated by a modification of the method described by 
Thompson et al. (Thompson, Lau, & Cunningham, 1986): at ambient temperature the 
reagents were rapidly and subsequently added as described in Table 2.3. All 
solutions were freshly prepared. 15 µ l aliquots were immediately added per 12-15 
oocytes. After 60 min incubation on ice with occasional gentle mixing, oocytes were 
washed in Ca
2+ -free ORi with 5.5 mM lysine-monohydrochloride and the labeled 
protein was purified as described. 2. Material and Methods      
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Table 2.3: Reaction mix for cell surface iodination with 
125I-sulfo-SHPP. 
Reagent 
Concentration of 
stock solution 
Volume 
in reaction mix 
Sulfo-SHPP 
(Pierce, Rockford, USA) 
40 µg/ml 
in DMSO  0.05 µl 
Na
125I  
(Amersham Buchler, Braunschweig)  
4 MBq/µl 
0.25 µl 
Chloramin T 
(Sigma Chemicals, St. Louis, USA) 
5 mg/ml  
in 0.5 M Na-phosphate 
pH 7.4 
1 µl 
D,L-α -hydroxy-Phenyl acetic acid 
(Sigma Chemicals, St. Louis, USA) 
1 mg/ml 
in 0.1 M NaCl 
13 µl 
Sodium meta-bisulfite  
(Sigma Chemicals, St. Louis, USA) 
12 mg/ml 
in 0.05 M Na-phosphate 
pH 7.4 
 
1 µl 
 
 
2.4.3.2. Purification of His-tagged protein 
 
Prior to protein purification, radio-labeled oocytes were washed in Ca
2+ -free ORi to 
avoid activation of Ca
2+-dependent peptidases. If otherwise not noted, all samples 
and buffers were kept on ice during protein purification. Oocytes were homogenized 
in 0.1 M phosphate buffer, pH 8.0 (20 µ l per oocyte), containing 1% digitonin, the 
antipeptidases Pefabloc (1 mM), antipain (100 µ l), and pepstain (100µ l). In addition, 
10 mM iodacetamide was added to avoid artificial disulfide bond formation. The 
homogenate was incubated on ice for 15 min and occasionally vortexed. The extract 
was then cleared by two centrifugation steps, each for 10 min at 15,000 rpm and 
4°C. 200 µl of the clear supernatant was diluted with 300 µl of the 0.1 M phosphate 
buffer and supplemented with 30 µ l of Ni
2+ -NTA agarose beads and 10 mM 
imidazole. After 30 min of incubation under continuous end-over-end mixing at 
ambient temperature, the agarose-bound protein was washed five to six times with 1 
ml phosphate buffer containing 0.2% digitonin, 100 µ M Pefabloc, and imidazole to 
reduce the background of endogenous oocyte proteins. A concentration of 25 mM 
and 15 mM imidazole for metabolically labeled proteins and iodinated proteins, 2. Material and Methods      
 
46 
respectively, was found to be optimal. After washing, the protein was released from 
the agarose beads by a non-denaturing elution buffer containing 1% digitonin with 
200 mM imidazole containing 20 mM Tris/HCl (pH 7.4). Elution was performed under 
continuous shaking at ambient temperature with 2 x 50 µ l elution buffer (each step 
for 10 min). Eluted protein was kept at 0°C until analyzed. 
 
 
2.4.3.3. Glycosylation analysis 
 
For analysis of the glycosylation status, 10 µ l aliquots of purified protein in reducing 
SDS sample buffer were incubated for 2 hours (occasionally over night) at 37°C with 
Endo H or PNGase F. For incubation with PNGase F, the samples were 
supplemented with 1% octylglucoside (added from a 10% stock solution) to prevent 
inactivation of the enzyme by SDS in the sample buffer. 
 
 
2.4.3.4. Cross-linking with glutardialdehyde 
 
Cross-linking was performed after the cell surface iodination with 
125I-sulfo-SHPP on 
intact oocytes. Groups of 12-15 intact radio-iodinated oocytes were washed twice in 
oocyte PBS. Oocytes were then incubated for 30-60 min (as indicated) with 
glutardialdehyde. The glutardialdehyde was freshly prepared from a 10fold 
concentrated stock solution (stock solutions were prepared in oocyte PBS, pH 8.0). 
After incubation time was finished, the cross-linker was quenched with 500 mM 
lysine in oocyte PBS and the cells were washed twice in Ca
2+ -free ORi and the 
labeled protein was purified as described. 
  
 
2.4.3.5. Dissociation of ion channels into lower complexes 
 
Different conditions were needed depending on the stability of the ion channel: for 
dissociation of P2X1 and P2X3 receptors, usually 10 µ l of the protein sample isolated 
under non-denaturing conditions were supplemented with 2.5 µ l of the native sample 
buffer (5x) and 1 µl of DTT (1M) and then incubated for 30-60 min at 37°C. For 2. Material and Methods      
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dissociation of P2X2, P2X5 receptors, and the hetero-multimeric P2X1/P2X2 and 
P2X2/P2X3 receptors addition of 4 M or 8 M urea (added as solid: 2.5 or 5 mg per 10 
µ l sample) was required for effective denaturation. By increasing the incubation time, 
better dissociation efficiency could be achieved. 
 
 
2.4.3.6. Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-
PAGE) 
 
For SDS-PAGE, 10 µ l of the protein samples were supplemented with 2.5 µ l of SDS-
sample buffer (5x) after elution under non-denaturing conditions, If not indicated 
otherwise. DTT was added at a final concentration of 20 mM and samples were 
incubated at 37°C for 15 min to allow for denaturation and reduction of disulfide 
bonds. Samples were subsequently electrophoresed in parallel with [
14C]-labeled 
molecular mass markers on vertical slab SDS-polyacrylamide gels. Homogenous 
gels (0.5 mm) or linear gradient gels (1 mm) were cast as indicated, according to the 
protocol of Biorad, bulletin 1156 (1984). To minimize convective disturbances by 
heat generation during polymerization of 4-10% gradient gels, 75% of the water in 
the 10% acrylamide solutions was replaced by a 40% sucrose solution. 
Electrophoresis was started at 100 V until the buffer front entered the separating gel; 
voltage was then set to 130 V. The running time was about 1.5 hours. 
 
Table 2.4 A: Preparation of the SDS-PAGE separating gel. 
Reagents Final  concentration 
Separating gel buffer  375 mM Tris/ HCl pH 8.8; 
LiDS 0.1% 
40% acrylamide (19 : 1)  8%; 10%; 12% 
APS   0.01% 
TEMED 0.5  µl/ml 
 2. Material and Methods      
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Table 2.4 B: Preparation of the SDS-PAGE stacking gel. 
Reagents Final  concentration 
Separating gel buffer  375 mM Tris/ HCl pH 8.8; 
LiDS 0.1% 
40% acrylamide (19 : 1)  4% 
APS   0.05% 
TEMED  1.2 µl/ml 
 
 
2.4.3.7. Blue native polyacrylamide gel electrophoresis (BN-PAGE) 
 
For BN-PAGE analysis, purified protein was eluted in non-denaturing elution buffer 
supplemented with 1% digitonin. Samples were stored on ice until electrophoresis.  
Blue native PAGE was performed according to the method of Schägger and 
von Jagow (Schägger & von Jagow, 1991) with slight modifications. 10 µ l of the 
protein sample were supplemented with 2.5 µ l of blue native sample buffer (5 X 
concentrated). 1 mm separating gels with linear polyacrylamide gradients (30% 
acrylamide mix 37.5:1, Biorad, München, Germany) were cast by a conventional 
two-chamber gradient mixer and a magnetic stirrer. A 4% polyacrylamide stacking 
gel (30% acrylamide mix 37.5:1, Biorad, München, Germany) was cast to get 
sharper protein bands. Molecular mass markers (a mixture of aldolase, bovine serum 
albumin, ferritin, catalase, and ovalbumin, each 10 µ g per lane) were run at either 
side of the gel. Electrophoresis was performed at 100 V, using the buffers described 
by Schägger (Schägger & von Jagow, 1991) (for description see section 2.1.2.3). 
The running time was about 2.5 hours. To further enhance the staining of the 
molecular weight markers after electrophoresis, the gel was incubated in a staining 
solution containing Coomassie dye. 2. Material and Methods      
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Table 2.5 A: Preparation of the of linear gradient gels (0.1 x 8 x 16 cm) for BN-PAGE 
(separating gel). 
Reagents 4%  10%  13% 
Aqua dest.  3.2 ml  1.03 ml  0.43 
3 x gel buffer  1.9 ml  1.90 ml  1.9 ml 
Acrylamide 30% 
(37.5:1) 
0.8 ml  1.97 ml  2.57 ml 
Glycerol  -  1.0 ml  1.0 ml 
TEMED  4 µ l 4  µ l 4  µ l 
APS (10%)  20 µ l 20  µ l 20  µ l 
 
Table 2.5 B: Preparation of the of stacking gel for BN-PAGE (separating gel). 
Reagents Final  concentration 
3 x gel buffer  1.67 ml 
Acrylamide 30% 
(37.5:1)  0.667 ml 
Aqua dest.  2.64 ml 
APS (10%)  20 µl 
TEMED 4  µl 
 
 
2.4.3.8. Two-dimensional gel electrophoresis 
 
The protein complexes separated in the first dimension by BN-PAGE were further 
resolved into their individual subunits by denaturing SDS-PAGE in the second 
dimension. Two-dimensional gel electrophoresis (2-D gel electrophoresis) was 
performed according to the method of Schägger and von Jagow (Schägger & von 
Jagow, 1994) with slight modifications. BN-PAGE for 4%-10% acryl amide BN-PAGE 
(as described above) was always used in the first dimension of two-dimensional 
PAGE. SDS-PAGE then followed in the second dimension. The transition from first 
to second dimension was performed as follows: one “lane” (0.3-0.5 cm) of BN-PAGE 
was cut out and the gel slice carrying the dissociated proteins separated during the 2. Material and Methods      
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BN-PAGE was soaked with stacking gel buffer (1x) and 1% mercaptoethanol for 2 
hours. Mercaptoethanol was then removed as completely as possible since it inhibits 
polymerization of acrylamide. The gel slice was then placed on a glass plate at the 
usual position for stacking gels. Spacers were positioned (0.1 mm), and the second 
glass plate was put on top. A separating gel mixture for 8% acrylamide SDS-PAGE 
was poured between the glass plates leaving a 1 cm gap to the first-dimensional gel 
strip. After polymerization of the separating gel, the gel strip was embedded in a 4% 
acrylamide stacking SDS gel so that the strip of gel was covered. High APS and 
TEMED concentrations (50 µl of APS (10%) and 10 µl of TEMED per 5 ml) were 
necessary to allow complete polymerization within 60 min despite the presence of 
traces of mercaptoethanol. Electrophoresis was started using the SDS-PAGE 
running buffer at 100 V until the buffer front entered the separating gel; voltage was 
then set to 130 V. The running time was about 1.5 hours. 
 
 
2.4.4. Electrophysiology 
 
Dr. J. Rettinger performed functional analysis of ion channel constructs. Current 
responses were measured by using the two-electrode voltage-clamp technique on 
Xenopus laevis oocytes injected with respective cRNA one to three days earlier. The 
electrodes contained 3 M KCl and had resistances of 0.5 – 2 MΩ . The superfusion 
solution consisted of 90 mM NaCl, 1 mM KCl, 2 mM MgCl2 and 5 mM Hepes/NaOH, 
pH 7.4. Calcium salts were omitted to avoid activation of endogenous Ca
2+-
dependent Cl
- channels. A fast and reproducible solution exchange was achieved by 
using a 10 µl experimental oocyte chamber combined with a fast solution flow (150 
µl/s) fed through a glass capillary mounted close above the oocyte. Current signals 
were low pass filtered at 100 Hz, and sampled at 200 Hz using the Turbo TEC-05 
amplifier (NPI electronics, Germany). All measurements were performed at room 
temperature (20-22°C). 
For analysis of P2X receptor-mediated responses, 1 µM ATP was applied for 5 s at 1 
min intervals. Between measurements at different holding potentials, control 
responses to 1 µM ATP for 5 s at –60 mV were recorded and only oocytes with less 
than 10% change in control responses at –60 mV throughout the experiment were 
included for analysis. 3. Results      
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3. Results 
 
 
3.1. Characterization of P2X receptors in Xenopus laevis oocytes  
 
 
3.1.1. Characterization of His-tagged P2X2 subunits after expression in  
  Xenopus oocytes 
 
The rat P2X2 subunit was N-terminally tagged with a hexahistidyl sequence to allow 
for the purification of the rat P2X2 protein (His-rP2X2) after expression in Xenopus 
oocytes. The isolation of the protein was achieved using Ni
2+-NTA agarose affinity 
chromatography. This purification method has the advantage that proteins can be 
released from the agarose beads under non-denaturing conditions. 
 
 
3.1.1.1. Electrophysiological characterization of rP2X2 constructs after 
expression in Xenopus oocytes 
 
In order to first confirm that the hexahistidyl tag does not disturb the function of the 
rP2X2 receptor, electrophysiological measurements on cRNA-injected oocytes were 
performed to compare the electrophysiological phenotype of the non-tagged and the 
hexahistidyl-tagged P2X2 receptors. Two days after injection, oocytes expressing the 
His-P2X2 subunit were exposed to ATP under two-electrode voltage clamp and the 
rates of desensitization were compared with those of oocytes expressing the wild-
type P2X2 receptor. In oocytes expressing the His-rP2X2  or the wild type rP2X2 
receptor, prolonged application of ATP (30 µM) elicited a large inward current with a 
rapid onset and slow rate of desensitization (Fig. 3.1 A and B). In addition, 
concentration response curves for ATP of the wild type P2X2 and the His-rP2X2 
receptor were recorded (Fig. 3.1 C). Fitting the Hill equation to the data for the wild 
type rP2X2 receptor and the His-rP2X2 receptor yielded EC50 values for ATP of 25.0 
± 1.9 µM (n=12), and 25.9 ± 1.9 µM (n=10), respectively, i.e. an virtually identical 
potency for ATP. This observation indicates that the N-terminal His-tag has no effect 
on the function of the rat P2X2 receptor. 3. Results      
 
52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1: Comparison of electrophysiological responses to activation of the wild type or the 
hexahistidyl-tagged P2X2 receptor. Oocytes were injected with 0.25 ng of cRNA for the wild type 
P2X2 (A) or the His-rP2X2 subunit (B). Two days after injection current responses elicited by 30 µM 
ATP were measured at a holding potential -60 mV. The duration of agonist activation is shown by the 
horizontal bar. (C) ATP dose-response curves for the wild type P2X2 (") and the His-rP2X2 receptor 
(#). Currents were elicited by the respective ATP concentration in 1-min intervals. The experiment 
was performed by Dr. Jürgen Rettinger. 
 
 
3.1.1.2. Biochemical analysis of the glycosylation status of P2X2 constructs  
 
For biochemical analysis, oocytes injected with the cRNA for the His-P2X2 subunit 
were metabolically labeled by overnight incubation with [
35S]methionine. Directly after 
the labeling or after an additional 24h chase interval, digitonin extracts were 
prepared. His-P2X2 was isolated by Ni
2+-NTA agarose affinity chromatography, 
eluted with non-denaturing elution buffer, and then supplemented with SDS sample 
buffer. Samples were incubated in the presence of Endo H or PNGase F and then 
analyzed by SDS-PAGE followed by autoradiography. 
SDS-PAGE analysis of the [
35S]methionine-labeled His-rP2X2 subunit after the 
overnight pulse period yielded two bands with approximate molecular masses of 61 
kD and 50 kD (Fig. 3.2, lane 1), respectively. The smaller band, possibly a proteolytic 
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cleavage product generated within the ER, almost disappeared within the 20h chase 
period (Fig. 3.2, lane 4). Treatment with PNGase F reduced the molecular mass by 
6-8 kD, yielding a 53 kD band (Fig. 3.2, lane 6), close to the mass of the His-tagged 
protein core computed from the cDNA-deduced protein sequence (52.5 kD). Since 6-
8 kD corresponds to the mass of three N-linked oligosaccharide side chains, this 
finding implies that each of the three consensus sequences for N-linked 
glycosylation at positions 
182NFTI, 
239NFTE, and 
298NGTT of the rP2X2 subunit is 
occupied by an N-glycan. 
Glycoproteins carrying fully processed complex-type carbohydrates are 
resistant to Endo H digestion. As shown in Fig. 3.2, lane 5, the His-rP2X2 subunit 
was partially resistant to Endo H after the chase period, indicating that a significant 
portion of the His-rP2X2 receptor is able to leave the ER within 20h, and that possibly 
all of the three N-linked carbohydrate chains become complex glycosylated in the 
Golgi apparatus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2: Glycosylation status of the His-rP2X2 polypeptide after metabolic labeling. Oocytes 
injected with 25 ng of cRNA for His-rP2X2 were metabolically labeled overnight. Cells were either 
directly extracted with 1% digitonin or after a 20 h chase period. His-rP2X2 was purified by Ni
2+-NTA 
affinity chromatography. Samples were eluted in 200 mM imidazole, 20 mM Tris and 1% digitonin (pH 
7.4), and treated with PNGase F (5 IUB, milliunits per 10 µl sample) or Endo H (5 IUB milliunits per 10 
µl sample) and analyzed by SDS-PAGE (8% acrylamide). C, non-injected oocytes. 
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To further explore the glycosylation status of His-rP2X2 at the cell surface, the 
N-glycosylation site at 
239N was eliminated by site-directed mutagenesis. Oocytes 
expressing the parent His-rP2X2 or the mutant His-rP2X2-N
239Q subunit were surface 
radio-iodinated with 
125I-sulfo-SHPP three days after cRNA injection. The radio-
iodinated proteins were then isolated by Ni
2+-NTA chromatography under non-
denaturing conditions from digitonin extracts, denatured with SDS sample buffer, 
then treated with Endo H and PNGase F. SDS-PAGE analysis of 
125I-labeled parent 
His-P2X2 subunit revealed a band with an approximate molecular mass of 61 kD 
(Fig. 3.3, lane 1). Treatment with Endo H did not induce a decrease of the mass of 
the His-rP2X2  subunit (Fig. 3.3, lane 2), indicating that none of the N-glycans is 
sensitive to Endo H. After treatment with PNGase F, the radiolabeled His-rP2X2 
polypeptide migrated at 53 kD (Fig. 3.3, lane 3). Since this reflects a mass difference 
compatible with three Endo H resistant N-glycans compared to the mass of the non-
treated glycoprotein, it can be concluded that the His-rP2X2 subunit acquires three 
complex-type carbohydrates during transit of the Golgi apparatus.  
  Next, the role of N-glycans for surface expression of the His-rP2X2 receptor 
was determined. To this end, the glycan minus mutant His-rP2X2-N
239Q was 
analyzed by SDS-PAGE. The 
125I-labeled His-rP2X2-N
239Q was isolated from the cell 
surface as a glycoprotein that had a 2-3 kD lower mass than the parent P2X2 
glycoprotein (Fig. 3.3, lane 4), indicating that the replaced asparagine is occupied by 
an N-glycan in the wild type P2X2 subunit. Treatment with Endo H failed to alter the 
mobility of the mutant glycoprotein (Fig. 3.3, lane 5), indicating that His-rP2X2-N
239Q 
is only in the complex-glycosylated form. The elimination of the glycan at 
239N 
resulted in a decrease of the expression level. 3. Results      
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Fig. 3.3: Glycosylation status of His-rP2X2 and His-rP2X2N
239Q on the cell surface. Oocytes 
injected with 2.5 ng of cRNA for His-P2X2 or His-P2X2N
239Q were left for 3 days at 19°C and then 
labeled with membrane-impermeant 
125I-sulfo-SHPP. His-rP2X2 and His-rP2X2N
239Q were purified by 
Ni
2+-NTA affinity chromatography from 1% digitonin extracts of each oocyte group, and eluted with 
non-denaturing elution buffer. Aliquots of these samples were supplemented with SDS sample buffer, 
20 mM DTT, and PNGase F in 1% octylglycoside (5 IUB, milliunits per 10 µl sample) or Endo H (5 
IUB milliunits per 10 µl sample). After 2 h incubation at 37°C, proteins were resolved by SDS-PAGE 
(8% acrylamide) followed by autoradiography. C, non-injected control oocytes.  
 
 
3.1.1.3. Investigation of the quaternary structure of the rat P2X2 receptor  
 
3.1.1.3.1. Cross-linking analysis 
 
The cross-linker glutardialdehyde was used to investigate the quaternary structure of 
P2X2 receptors in the plasma membranes of intact Xenopus oocytes. The aldehyde 
groups of glutardialdehyde are able to form a Schiff base with lysine residues. 
Therefore, this cross-linker may be suited to investigate the oligomeric state of 
protein complexes. His-rP2X2 cRNA-injected oocytes were surface-labeled with 
125I-
sulfo-SHPP and then incubated with 100 µM glutardialdehyde for 30 min and 60 min. 
After the cross-linking reaction, His-rP2X2 receptor was purified from a digitonin 
extract of the oocytes by Ni
2+ NTA agarose affinity chromatography and subjected to 
reducing SDS-PAGE analysis. In addition to the rat P2X2 monomer, two bands of 
higher molecular masses were observed in cross-linker treated oocytes (Fig. 3.4, 
lanes 3 and 4). These bands corresponded in size to the calculated molecular 
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masses of the rat P2X2 dimer and trimer. In all experiments, the intensity of the 
bands strongly declined when the incubation time with glutardialdehyde was 
increased. 
  The results of this experiment cannot entirely exclude the generation rP2X2 
complexes higher than the trimer. Such complexes may have remained undetected 
due to the reduced amount of isolated protein after the cross-linking reaction. 
Therefore, the blue native polyacrylamide gel electrophoresis (BN-PAGE) was used 
as an alternative approach to investigate the oligomeric state of rP2X2 receptor 
complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.4: Cross-linking of the His-rP2X2 receptor with glutardialdehyde in intact Xenopus 
oocytes. Oocytes injected with 2.5 ng of cRNA for His-P2X2 were surface iodinated with 
125I-sulfo-
SHPP three days after injection. Immediately after removal of unbound 
125I-sulfo-SHPP by washing, 
the cross-linking reaction was inhibited by adding 100 µM glutardialdehyde to the intact oocytes for 30 
min or 60 min at 4°C. After removing of excess glutardialdehyde by washing with oocyte-PBS, the 
oocytes were homogenized in 1% digitonin. His-P2X2 was purified by Ni
2+-NTA agarose affinity 
chromatography, eluted with non-denaturing elution buffer, and analyzed by reducing SDS-PAGE (4-
10% acrylamide gradient gel). C, non-injected control oocytes.  
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3.1.1.3.2. Blue native PAGE analysis 
 
It was previously reported that the His-tagged rat P2X1 receptor migrates at 240 kD 
when resolved by blue native PAGE (Fig. 3.6, lane 1). The exposure of the natively 
eluted rat P2X1 receptor to DTT and urea in the presence of Coomassie blue and 
sodium 6-amino-n-caproate caused a partial dissociation of the His-rP2X1 receptor 
complex into a monomer and a dimer of apparent masses similar to 80 kD and 170 
kD, respectively (Fig. 3.6, lanes 2-4), indicating that the non-denatured 240 kD 
protein band is a homo-trimer (Nicke et al., 1998). 
To investigate the assembly of rat P2X2 subunits, oocytes injected with the 
cRNA for the His-rP2X2 subunit were metabolically labeled with [
35S]methionine. His-
rP2X2 protein complexes were then isolated under non-denaturing conditions from a 
digitonin extract of the oocytes directly after the metabolic labeling or after a 
subsequent 20 h chase period and analyzed by BN-PAGE. Metabolically
 labeled His-
P2X2 protein isolated after the overnight pulse period migrated at a broad range of 
masses well above the 250 kD band of the rP2X1 homo-trimer when analyzed by 
BN-PAGE (Fig. 3.5, lane 1). Most likely, this large excess of undefined protein 
complexes represents aggregates of His-rP2X2 subunits. Treatment with urea did not 
lead to a marked dissociation of the aggregates into lower order intermediates (Fig. 
3.5, lanes 2 and 3). 
When the digitonin-solubilized His-rP2X2 protein was purified under non-
denaturing conditions from metabolically labeled oocytes after an additional 20 h 
chase period and analyzed by BN-PAGE, not only aggregates in the high molecular 
mass rang, but also two weak protein bands of approximately 220 kD and 380 kD 
were observed (Fig. 3.5, lane 4). Incubation prior to BN-PAGE of the natively eluted 
His-rP2X2 receptor with urea in the presence of the blue native sample buffer 
intensified the visibility of these two bands and induced the appearance of a third 
band of ~120 kD (Fig. 3.5, lanes 5 and 6). In conclusion, these observations 
demonstrate that the majority of metabolically labeled His-rP2X2 subunit did not 
assemble within the first 15h after the cRNA injection. While the trimeric complex of 
His-rP2X2 receptor is weakly visible at 380 kD, also intermediate dimers and a large 
amount of aggregated proteins are observed by BN-PAGE analysis.  3. Results      
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Fig. 3.5: His-rP2X2 receptor complexes resolved on a blue native polyacrylamide gel. Oocytes 
injected with 2.5 ng of cRNA for His-rP2X2 protein were metabolically labeled overnight. Cells were 
either immediately extracted with 1% digitonin (pulse) or first chased for 20 h and then extracted. The 
His-rP2X2 protein was purified by Ni
2+-NTA affinity chromatography under non-denaturing conditions. 
Digitonin solubilized His-rP2X2 receptor was either non-treated or dissociated by incubation with 
increasing concentration of urea in the presence of blue native sample buffer (45 min, 37°C). Samples 
were analyzed by BN-PAGE (4-13% acrylamide gradient gel). C, non-injected control oocytes.  
 
 
Cross-linking analysis of radio-iodinated His-P2X2 subunits in the plasma 
membranes of intact oocytes revealed a trimeric structure for this receptor. However, 
investigation of the glycosylation status of total His-P2X2 protein from the 
[
35S]methionine labeled oocytes revealed that part of the synthesized protein was 
retained in the ER one day after injection (Fig. 3.2, lane 3). This retention of His-
rP2X2 receptor in the ER may reflect ‘quality control’ (Hammond & Helenius, 1995). 
In addition, when resolved by BN-PAGE, the metabolically labeled His-rP2X2 protein 
appeared as two bands representing dimers and trimers and a diffuse smear of 
aggregated protein (Fig. 3.5, lane 4). These results indicate an incomplete folding 
and partial assembly of His-P2X2 receptor. To visualize the plasma membrane form 
of the His-P2X2 receptor with BN-PAGE, oocytes injected with His-rP2X2 cRNA were 
surface radio-iodinated, and the 
125I-labeled His-rP2X2 receptor was isolated by Ni
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-NTA chromatography under non-denaturing conditions. Blue native PAGE analysis 
of the surface expressed His-rP2X2 receptor revealed three bands at 380 kD, 550 kD 
and a band that did not enter the separating gel. The bands at 380 kD and 550 kD 
correspond in size to the trimeric and hexameric form of His-rP2X2 receptor (Fig. 3.6, 
lane 5).  Tetrameric or pentameric complexes between the two bands were not 
detected. The protein band of higher molecular mass, which did not enter the 
acrylamide gel, might correspond to the nanomeric form of His-rP2X2 protein. The 
380 kD protein band corresponded in mass to the metabolically labeled His-rP2X2 
trimer (Fig. 3.5, lane 4). Exposure of the natively eluted His-rP2X2 receptor to urea at 
37°C prior to the blue native PAGE induced the appearance of two additional bands 
beside the non-denatured His-rP2X2 trimeric complex (Fig. 3.6, lane 6). These 
protein bands of apparent masses of 220 kD and 120 kD represent the intermediate 
His-rP2X2 dimer and monomer, respectively.  
To analyze the number of subunits of the rat P2X2 receptor, also the strong 
reductant DTT in the presence of blue native sample buffer was applied. This 
investigation revealed that the radio-iodinated His-P2X2 receptor in contrast to the 
His-rP2X1 complex almost completely resisted dissociation by exposure to DTT 
(Fig.3.6, lane 7). It turned out that DTT intensified the dissociation of the His-rP2X2 
complex when used in combination with urea (Fig. 3.6, lane 8). 3. Results      
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Fig. 3.6: Dissociation of surface-iodinated His-rP2X1 and His-rP2X2 receptors. Oocytes injected 
with 25 ng of cRNA for His-rP2X1 or 2.5 ng of cRNA for His-rP2X2 were left for 3 days at 19°C and 
then surface-labeled with membrane-impermeant 
125I-sulfo-SHPP. His-rP2X1 or His-rP2X2 receptors 
were purified by Ni
2+-NTA agarose affinity chromatography from 1% digitonin extracts of each oocyte 
group, and eluted with non-denaturing elution buffer. His-P2X1 or His-P2X2 receptors were either non-
treated or dissociated by incubation with 8 M urea, dissociated by incubation with 100 mM DTT, 
dissociated by incubation with both 8 M urea and 100 mM DTT in the presence of blue native sample 
buffer (45 min, 37°C). Samples were analyzed by BN-PAGE (4-13% acrylamide gradient gel). C, non-
injected control oocytes.  
 
 
3.1.1.4. Oligomeric state of a His-rP2X2 deletion mutant 
 
All members of the P2X receptor family are produced by the oligomeric assembly of 
two-transmembrane domain subunits with both their N and C termini located 
intracellularly (Chow, 1998). Rat P2X2 subunits have a large intracellular C-terminal 
domain. In an attempt to determine the role of this region in the P2X2 receptor 
oligomerization, a truncated form of the wild-type P2X2 subunit was produced, 
lacking 63 amino acid residues of the C-terminus of His-P2X2 (His-P2X2
1-409). The 
truncation of the P2X2 subunit produced a protein consisting of 409 amino acids that 
had approximately the same size like the wild type P2X1 subunit (399 amino acids). 
It is known that His-rP2X1 migrates at 240 kD when analyzed by BN-PAGE. The 
intention of the investigation was also to compare the migration of the truncated 
P2X2 with the migration of His-P2X1 in the BN-PAGE. A further intention was to 
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reveal the role of the C terminal end of the rat P2X2 subunit in the assembly of the 
His-rP2X2 receptor. 
BN-PAGE analysis of the radio-iodinated His-rP2X2
1-409 mutants revealed that 
the truncated His-P2X2 was detectable on the surface of Xenopus oocytes. Like the 
parent His-rP2X2 receptor, the His-rP2X2
1-409 construct appeared as a distinct protein 
band, but with a lower apparent molecular mass of about 270 kD (Fig. 3.7, lane1). 
This protein band corresponded in mass approximately to the mass of the protein 
band of the His-rP2X1 complex resolved by BN-PAGE and can hence be considered 
to possess a trimeric structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.7: BN-PAGE analysis of a C-terminally truncated His-rP2X2 subunit on the cell surface. 
Oocytes injected with 2.5 ng of cRNA for the His-rP2X2 subunit or His-rP2X2
1-409 mutant were left for 3 
days at 19°C and then surface-labeled with membrane-impermeant 
125I-sulfo-SHPP. Protein was 
isolated under non-denaturing conditions (1% digitonin) and analyzed by BN-PAGE on a 4-10% 
acrylamide gradient gel. C, non-injected control oocytes.  
 
 
When the metabolically labeled His-P2X2
1-409 protein was purified under non-
denaturing conditions and analyzed by BN-PAGE, mainly undefined protein 
complexes in form of aggregates in the high molecular mass rang and a very weak 
protein band of approximately 270 kD were observed (Fig. 3.8, lane 2). Partial 
dissociation with 4 M urea in the presence of blue native sample buffer prior to BN-
PAGE intensified the protein band at 270 kD, but this band was still very poorly 
visible (Fig. 3.8, lane 3). Treatment with 8 M urea reduced the amount of the 
aggregated protein and induced the appearance of two additional bands at 100 kD 
and 190 kD (Fig. 3.8, lane 4). Most of the aggregated protein was dissociated into 
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the monomeric form at 100 kD when treated by 8 M urea. This indicates that like 
parent His-P2X2, the majority of metabolically labeled His-P2X2
1-409 did not assemble 
within the first two days after the cRNA injection. While the trimeric form of the His-
rP2X2
1-409 protein complex could be detected on the cell surface, most of the 
intracellulary located His-P2X2
1-409 subunits existed as aggregated protein as 
visualized by BN-PAGE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.8: C-terminally truncated His-rP2X2  protein complex resolved on a blue native 
polyacrylamide gel. Oocytes injected with 2.5 ng of cRNA for His-rP2X2
1-409 mutant were 
metabolically labeled overnight. Cells were chased for 20 h and then extracted with 1% digitonin. The 
His-rP2X2
1-409 protein was purified by Ni
2+-NTA affinity chromatography under non-denaturing 
conditions. Digitonin solubilized His-rP2X2
1-409 . was either non-treated or dissociated by incubation 
with increasing concentration of urea in the presence of blue native sample buffer (45 min, 37°C). 
Samples were analyzed by BN-PAGE (4-13% acrylamide gradient gel) followed by autoradiography. 
C, non-injected control oocytes.  
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3.1.2. Characterization of His-tagged rat P2X5 receptors after expression in 
Xenopus oocytes 
 
Like the rat P2X2 subunit, also the rat P2X5 subunit was N-terminally tagged with a 
hexahistidyl sequence to allow for affinity chromatography-mediated purification of 
the His-rP2X5 protein after expression in Xenopus oocytes. 
 
 
3.1.2.1. Electrophysiological characterization rat P2X5 receptors after 
expression in Xenopus oocytes 
 
In order to confirm that the hexahistidyl tag does not disturb the function of the rat 
P2X5 receptor, electrophysiological measurements on cRNA-injected oocytes were 
performed to compare the current-carrying properties of the non-tagged and the 
hexahistidyl-tagged rat P2X5 receptors. Two days after injection, oocytes expressing 
the His-rP2X5 subunit were exposed to ATP under two-electrode voltage clamp and 
the current amplitudes as well as the rates of desensitization were compared with 
those of oocytes expressing the wild-type P2X5 receptor. Fig. 3.9 A and B show 
current responses of wild type rP2X5 and His-rP2X5, respectively, elicited at the 
holding potential –60 mV by application of 10 µM ATP. In oocytes expressing the 
His-P2X5 or the wild type rP2X5 receptor, ATP applied for 10 sec evoked a sustained 
nondesensitizing current. Simultaneously, a second non-desensitizing current was 
observed in response to 10 µM ATP from oocytes injected with cRNA for the wild 
type rP2X5 or His-rP2X5 receptors. This non-desensitizing current component results 
possibly from the activation of endogenous ion channels of Xenopus oocytes that 
interact with the heterologously expressed wild type rP2X5 or His-rP2X5 receptors, 
since this current component was not observed when the rP2X5 receptor was 
functionally analyzed in HEK-293 cells (Ruppelt et al., 2001). Taken together, the 
results obtained from the electrophysiological analysis of both constructs suggested 
that N-terminal His-tag has no effect on the function of the rP2X5 receptor. 3. Results      
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Fig. 3.9: Comparison of the ATP-elicited currents responses of the wild type rP2X5 receptor 
and the hexahistidyl-tagged rP2X5 receptor. Oocytes were injected with 25 ng of cRNA for wild 
type P2X5 or His-P2X5. Two days after injection current responses elicited by 10 µM ATP were 
measured at -60 mV. The horizontal bar shows the duration of agonist activation. The experiment was 
performed by Dr. Jürgen Rettinger. 
 
 
 
3.1.2.2. Biochemical characterization of His-rP2X5 polypeptides after 
expression in Xenopus oocytes by SDS-PAGE 
 
His-rP2X5 protein isolated from metabolically labeled oocytes was subjected to SDS-
PAGE analysis. His-rP2X5 subunits yielded one band with approximate molecular 
masses of 60 kD (Fig. 3.10, lane 2). Treatment with PNGase F reduced the 
molecular mass by 6-8 kD to ~52 kD (Fig. 3.10, lane 4), close to the mass of the His-
tagged protein core computed from the cDNA complex (51.5 kD). Since 6-8 kD 
corresponds to the mass of three N-linked oligosaccharide side chains, this finding 
implies that each of the three asparagines for possible N-linked glycosylation 
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(NXT/S) are occupied by an N-glycan in the His-rP2X5 subunit. As shown in Fig. 
3.10, lane 3, a fraction of metabolically labeled His-rP2X5 subunit was partially Endo 
H-resistant, indicating that a significant portion of the His-rP2X5 subunits leaves the 
ER and that at least one N-linked carbohydrate chain becomes complex glycosylated 
in the Golgi apparatus. In addition, the investigation revealed that two days after the 
injection a part of the synthesized protein was entirely Endo H sensitive and thus 
was retained in the ER as shown by the samples (Fig. 3.10, lanes 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.10: Glycosylation status of His-rP2X5. Oocytes injected with 2.5 ng of cRNA for the His-rP2X5 
were metabolically labeled. His-rP2X5 was purified by Ni
2+-NTA affinity chromatography from a 1% 
digitonin extract of the Xenopus oocytes. Samples were eluted under non-denaturing conditions and 
treated with PNGase F or Endo H and analyzed by SDS-PAGE (8% acrylamide). C indicates samples 
from non-injected control oocytes. 
 
 
  To reveal the number of N-linked carbohydrate chains that become complex 
glycosylated en route to the plasma membrane, the surface 
125I-labeled His-rP2X5 
polypeptide was first treated with Endo H to release high mannose-type 
carbohydrates and then subjected to partial deglycosylation with increasing 
concentrations of PNGase F. Upon treatment with Endo H, the mass of fully 
processed His-rP2X5 isolated from surface iodinated oocytes was reduced by 3 kD 
compared to the untreated His-rP2X5 polypeptide (Fig. 3.11, lane 3), indicating that 
only one N-glycan is sensitive to Endo H and hence not complex glycosylated. 
Treatment with PNGase F generated two additional bands (Fig. 3.11, lanes 4 and 5) 
besides the protein band representing the Endo H resistant His-rP2X5 polypeptide. 
Each of these two bands differed in mass by 2-3 kD, i.e. the mass of an N-linked 
oligosaccharide side chain. Since these two bands were generated from an Endo H 
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resistant form of the His-P2X5 polypeptide, it can be inferred that from the total three 
N-linked carbohydrate chains, two N-glycans acquire complex-type carbohydrates 
during transit of the Golgi apparatus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.11: Glycosylation status of surface iodinated His-P2X5 subunit. Oocytes injected with 2.5 
ng of cRNA for the His-rP2X5 subunit were left for 3 days at 19°C and then labeled with membrane-
impermeant 
125I-sulfo-SHPP. The His-rP2X5 protein was purified by Ni
2+-NTA chromatography from 
1% digitonin extracts of oocytes, and eluted with non-denaturing elution buffer. Aliquotes of these 
samples were supplemented with SDS sample buffer, 20 mM DTT, and treated with Endo H or 
PNGase F as indicated. Samples exposed to both enzymes (lanes 4-6) were first treated with Endo H 
for 1 h at 37°C, then supplemented with 1% octylglucoside (final concentration) and incubated with 
PNGase F (1 h at 37°C). After the digestion, proteins were resolved by SDS-PAGE (8% acrylamide), 
followed by autoradiography. C indicates samples from non-injected control oocytes. 
 
 
3.1.2.3. Biochemical characterization of rP2X5 constructs after expression in 
Xenopus oocytes using BN-PAGE 
 
The His-rP2X5 protein that was purified under non-denaturing conditions from 
metabolically labeled oocytes appeared as one single band at about 340 kD when 
analyzed by BN-PAGE. In addition, a large amount of aggregated protein in the 
region of high molecular mass range was observed (Fig. 3.12, lane 1). These 
aggregations may reflect an incomplete folded or only partially assembled His-rP2X5 
subunits that were retained in the ER two days after injection of the oocytes. To 
determine the number of subunits incorporated into the defined 340 kD protein, 
different conditions were elaborated to induce a partial dissociation of the purified 
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His-rP2X5 complex. Incubation prior to blue native PAGE of the natively eluted His-
rP2X5 receptor with the strong reductant DTT in the presence of blue native sample 
buffer had no significant effect (Fig. 3.13, lane 2). When treated with 4 M urea in the 
presence of blue native sample buffer, two additional protein bands besides the 340 
kD His-rP2X5 complex appeared. These bands of the apparent masses of ~ 100 and 
190 kD correspond to the His-rP2X5 monomer and intermediate dimer, indicating 
that the non-denatured 340 kD protein band must be a trimer (Fig. 3.12, lanes 2 and 
3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.12: BN-PAGE analysis of total His-rP2X5 receptor complexes. Oocytes injected with 2.5 ng 
of cRNA for His-rP2X5 subunit were metabolically labeled overnight and then chased for 20 h at 19°C. 
Cells were extracted with 1% digitonin. The His-rP2X5 protein was purified by Ni
2+-NTA affinity 
chromatography under non-denaturing conditions. Digitonin solubilized His-rP2X5 receptor was either 
non-treated (lane 1) or dissociated by incubation at 37°C with 4 M urea in the indicated time (lanes 2 
and 3). Samples were supplemented with blue native sample buffer and analyzed by BN-PAGE (4-
13% acrylamide gradient gel). C indicates samples from non-injected control oocytes. 
 
 
Blue native PAGE analysis of the metabolically labeled His-rP2X5 complex 
revealed a weak dissociation of the natively eluted protein complex upon treatment 
with 4 M urea, suggesting that the His-rP2X5 protein is a rather stable complex. 
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Likewise, treatment of the natively eluted His-rP2X5 receptor from surface labeled 
oocytes with 100 mM DTT in the presence of amino-caproate was not sufficient to 
cause any dissociation of the protein complex (Fig. 3.13, lane 2). However, when the 
His-rP2X5 receptor was treated by both urea and DTT, a partial dissociation 
occurred, leading to a total of three bands, corresponding to the His-rP2X5 monomer 
at ~100 kD, the intermediate dimer at ~190 kD and the non-dissociated, trimeric 
complex at 340 kD (Fig. 3.13, lanes 3 and 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.13: Oligomeric state of the surface-iodinated His-rP2X5 receptor. Oocytes injected with 2.5 
ng of cRNA for His-rP2X5 subunit were left for 3 days at 19°C and then labeled with membrane-
impermeant 
125I-sulfo-SHPP. His-rP2X5 protein was purified by Ni
2+-NTA affinity chromatography from 
1% digitonin extracts of oocytes, and eluted with non-denaturing elution buffer. His-rP2X5 samples 
were supplemented with BN sample buffer and analyzed by BN-PAGE (4-13% acrylamide gradient 
gel) either without incubation or after incubation for 45 min at 37
oC with 4 M urea and/or 100 mM DTT 
as indicated. C indicates samples from non-injected control oocytes. 
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3.1.3. Characterization of His-tagged rP2X6 subunits after expression in 
Xenopus oocytes 
 
For the investigation of heterologously expressed rat P2X6 subunits in Xenopus 
oocytes, the cDNA for rP2X6 was N-terminally labeled with a hexahistidyl sequence 
(His-rP2X6) to allow for purification by affinity chromatography.  
 
 
3.1.3.1. Electrophysiological analysis of oocytes expressing the rat P2X6 
subunit  
 
In an initial experiment, the function of His-rP2X6 expressed in Xenopus oocytes was 
tested. Under two-electrode voltage clamp at a holding potential of –60 mV, oocytes 
injected with His-rP2X6 cRNA two days earlier showed no response to ATP. This 
observation was also made by other groups, suggesting that rP2X6 fails to form a 
functional ion channel in oocytes and that rP2X6 subunits may require a partner 
subunit for functional expression (Collo et al., 1996). Currently, there is evidence for 
the hetero-polymerization of P2X6 and P2X4 subunits, since oocytes expressing both 
P2X6 and P2X4 subunits exhibit larger currents than those expressing homomeric 
P2X4 receptors alone (Le et al., 1998). 
 
 
3.1.3.2. Biochemical characterization of the rP2X6 subunit after expression in 
Xenopus oocytes using SDS-PAGE 
 
Oocytes injected with the cRNA encoding His-rP2X6 subunits were metabolically 
labeled by overnight incubation with [
35S]methionine. Directly after the pulse or after 
an additional 24 h chase interval, digitonin extracts were prepared. His-rP2X6 protein 
was isolated by Ni
2+-NTA affinity chromatography, eluted with non-denaturing elution 
buffer, denatured with SDS-sample buffer, and analyzed by reducing SDS-PAGE. 
Fig. 3.14 A (lane 1) and B (lane 5) show that His-rP2X6 polypeptides are synthesized 
in Xenopus oocytes. SDS-PAGE characterization of the metabolically
 labeled His-
rP2X6 subunits after the overnight pulse period yielded a band with an approximate 
molecular mass of ~52 kD (Fig. 3.14 A, lane 1). Treatment with PNGase F reduced 3. Results      
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the molecular mass by 8 kD to ~44 kD (Fig. 3.14 A, lane 3), close to the mass of the 
His-tagged protein core computed from the cDNA complex (43.5 kD). Since 8 kD 
corresponds to the mass of three N-linked oligosaccharide side chains, this finding 
implies that each of the three asparagines for possible N-linked glycosylation 
(NXT/S) of the His-rP2X6 subunit is occupied by an N-glycan. 
Deglycosylation of the His-rP2X6 subunit after the pulse and the chase interval 
with Endo H released all N-linked glycans, indicating that the protein does not 
acquire complex type carbohydrates and therefore, most likely resides entirely in the 
ER (Fig. 3.14 A, lane 2, and B, lane 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.14: Glycosylation status of the His-rP2X6 subunit after metabolic labeling. Oocytes 
injected with the cRNA for the His-rP2X6 subunit were metabolically labeled overnight. Cells were 
either directly extracted with 1% digitonin (A) or first chased for 20 h and then extracted (B). His-
rP2X6 protein was purified by Ni
2+-NTA affinity chromatography. Samples were eluted under non-
denaturing conditions and treated with PNGase F or Endo H and finally analyzed by SDS-PAGE (8% 
acrylamide). Lanes 1 and 5 indicate non-injected controls. C indicates samples from non-injected 
control oocytes. 
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3.1.3.3. Biochemical characterization of the His-rP2X6 protein after 
expression in Xenopus oocytes by BN-PAGE 
 
To investigate the assembly of His-rP2X6 subunits, oocytes injected with the cRNA 
for His-P2X6 were metabolically labeled. His-P2X6 protein was then isolated under 
non-denaturing conditions from a digitonin extract of the oocytes and analyzed by 
BN-PAGE. The bulk amount of His-rP2X6 protein migrated at a broad range of high 
molecular masses indicative of non-defined aggregates (Fig. 3.15. lane 2). 
Treatment with 0.1 M DTT and 8M Urea (Fig. 3.15, lanes 3 and 4) visualized some 
intermediate bands that were possibly due to aggregation. These results suggested 
that His-rP2X6 subunits alone do not reach a defined assembly status and as 
suggested by other groups needs the hetero-assembly with other P2X subunits to 
assemble properly for export to the plasma membrane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.15: Oligomeric state of metabolically labeled His-rP2X6 subunits. Oocytes injected with 
cRNA for His-rP2X6 were metabolically labeled overnight following a 20 h chase period at 19°C. Cells 
were extracted with 1% digitonin. His-rP2X6 protein was purified by Ni
2+-NTA affinity chromatography 
under non-denaturing conditions. Digitonin solubilized His-rP2X6 protein was analyzed by BN-PAGE 
(4-13% acrylamide gradient gel) either without further treatment (lane 2) or after 45 min of incubation 
at 37°C and 100 mM DTT (lane 3) or 100 mM DTT and 8 M urea (lane 4). C indicates samples from 
non-injected control oocytes. 
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3.1.4. Characterization of rat P2X1 and P2X2 subunits after co-expression in 
Xenopus oocytes 
 
3.1.4.1. Biochemical characterization of the rat P2X1 and P2X2  polypeptides 
after co-expression in Xenopus oocytes by SDS-PAGE 
 
To examine whether rP2X1 and rP2X2 subunits are able to form a heteromultimeric 
complex, a co-purification assay was exploited, in which the hexahistidyl-tagged rat 
P2X2 was co-expressed with non-tagged rP2X1 and vice versa in Xenopus oocytes. 
After digitonin extraction of the cells, the interaction of these subunits was judged 
from the co-precipitation of the hexahistidyl-tagged subunits with the non-tagged 
subunits using Ni
2+-NTA agarose affinity chromatography. The isolated polypeptides 
were analyzed by SDS-PAGE. To validate this assay, the formation of rP2X2/rP2X3 
complexes as a positive control was examined. Co-expression of rP2X3 subunit with 
rP2X2 subunit is known to result in the formation of a hetero-polymerized P2X 
receptor in Xenopus oocytes (Lewis  et al., 1995). The rP2X2 subunit exhibits a 
higher mass than the P2X1 or P2X3 subunits due to its much longer C terminal tail 
(total length of 472 amino acids vs. 399 amino acids of P2X1 and 397 amino acids of 
rP2X3 polypeptides), and hence exhibits a slower migration in the SDS-
polyacrylamide gel. As shown in Fig. 3.16, lanes 3 and 4, co-expression of His-rP2X2 
subunit with non-tagged rP2X1 or His-rP2X1 subunit with non-tagged rP2X2 subunit 
did not result in a detectable co-isolation of any of the two subunits. In contrast, the 
non-tagged rP2X3 subunit was co-purified with the His-rP2X2 subunit, confirming that 
this assay is able to correctly display the known physical interaction between rP2X2 
and rP2X3 subunits (Fig. 3.16, lane 6). 3. Results      
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Fig. 3.16: Co-isolation assay of rP2X1 with rP2X2 or rP2X3 with rP2X2 subunits after metabolic 
labeling. Oocytes were injected with cRNAs for His-rP2X1 (25 ng), non-tagged rP2X1 (25 ng), His-
rP2X3  (25 ng), non-tagged rP2X3 (25 ng), His-rP2X2 (2.5 ng), or non-tagged rP2X2  (2.5 ng). The 
cRNAs were injected either individually or together as indicated. The injected cells were metabolically 
labeled overnight. Cells were extracted with 1% digitonin after a 20 h chase period. Co-isolation was 
achieved by Ni
2+-NTA affinity chromatography. Samples were eluted under non-denaturing 
conditions, denatured with SDS sample buffer in the presence of 100 mM DTT (10 min at 37
oC), and 
then analyzed by SDS-PAGE (8% acrylamide). 
 
 
To further investigate a possible co-assembly of the P2X1 and P2X2 subunits 
expressed on the cell surface, oocytes injected with cRNA for His-P2X2 and non-
tagged rP2X1 and vice versa were surface radio-iodinated with 
125I-sulfo-SHPP three 
days after cRNA injection. The radio-iodinated proteins were then isolated by Ni
2+-
NTA chromatography under non-denaturing conditions from digitonin extracts, 
denatured with SDS sample buffer, and resolved by SDS-PAGE. Purification of His-
P2X1 protein by Ni
2+
-NTA agarose under non-denaturing conditions resulted in co-
purification of non-tagged rP2X2 subunit from oocytes injected with both cRNAs (Fig. 
3.17, lane 5). Likewise, non-tagged rP2X1 subunits could be co-isolated with His-
rP2X2 protein (Fig. 3.17, lane 4). Proteins isolated from oocytes that were injected 
with cRNAs for His-rP2X1 or His-rP2X2 alone are also shown (Fig. 3.17, lanes 2 and 
3). As shown in Fig. 3.17, lane 8, the non-tagged rP2X3 subunit was co-purified with 
the His-rP2X2 subunit, consistent with the presence of rP2X2/rP2X3 heterooligomers. 
Altogether, these data indicate that rP2X1 and rP2X2 subunits can co-assemble into 
hetero-oligomers like rP2X2 and rP2X3 subunits. However, in contrast to rP2X2/rP2X3 
heteromultimers, which occur in significant amounts also in the cell interior, the 
rP2X1/rP2X2 heteromultimers can only be detected at the plasma membrane. 
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Fig. 3.17: Plasma membrane-bound rP2X1 and rP2X2 can be co-purified after co-expression.  
Oocytes were injected with cRNAs for His-rP2X1 (25 ng), non-tagged rP2X1 (25 ng), His-rP2X3 (25 ng), 
non-tagged rP2X3 (25 ng), His-rP2X2 (2.5 ng), or non-tagged rP2X2  (2.5 ng). The cRNAs were 
injected either individually or together as indicated. Cells were kept for 3 days at 19°C and then 
labeled with membrane-impermeant 
125
I-sulfo-SHPP. Proteins were (co-) purified by Ni
2+
-NTA 
chromatography from 1% digitonin extracts of each oocyte group, eluted with non-denaturing elution 
buffer and resolved by reducing SDS-PAGE (8% acrylamide) followed by autoradiography. 
 
 
Next, the glycosylation status of the hetero-oligomerized His-rP2X2/rP2X1 
complex from radio-iodinated oocytes was compared with homomultimeric His-rP2X1 
and His-rP2X2 complexes. SDS-PAGE analysis revealed that the PNGase F-treated 
rP2X2 subunit from the hetero-assembled complex migrated at 53 kD like the rP2X2 
subunit from the homomultimeric complex (Fig. 3.18, lanes 6 and 9). Since 53 kD 
reflects a mass difference in three N-glycans (8 kD) compared to the mass of the 
non-treated His-rP2X2 subunit (61 kD), it can be inferred that the number of the 
acquired N-glycans is not changed by hetero-polymerization of the rP2X2 subunits. 
Treatment with Endo H failed to alter the mobility of the homomultimeric His-rP2X2 
subunit and the His-rP2X2 polypeptide from the heteromultimeric complex, indicating 
that all three N-glycans are exclusively in the complex-glycosylated form (Fig. 3.18, 
lane 5 and 8).  
Endo H treatment diminished the molecular mass of homomultimeric His-rP2X1 
subunit by 8 kD, but was unable to release all N-glycans, indicating that at least one 
N-linked oligosaccharide side chain of the subunit must have been complex 
glycosylated in the Golgi and thus acquired Endo H resistance (Fig. 3.18, lane 2). 
The same result was obtained for the co-isolated rP2X1 subunit. Endo H clearly 
reduced the molecular mass of hetero-assembled rP2X1 subunit, but in contrast to 
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PNGase F, was unable to release all N-glycans, indicating that the rP2X1 subunit is 
also complex-glycosylated in one site (Fig. 3.18, lane 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.18: Glycosylation status of homomultimeric and heteromultimeric rP2X1 and rP2X2 
subunits on the cell surface. Oocytes were injected with cRNAs for His-rP2X1 (25 ng), non-tagged 
rP2X1 (25 ng), or non-tagged rP2X2 (2.5 ng). The cRNAs were injected either individually or together 
as indicated. Cells were kept for 3 days at 19°C and then labeled with membrane-impermeant 
125I-
sulfo-SHPP. Proteins were purified by Ni
2+-NTA chromatography from 1% digitonin extracts of each 
oocyte group and eluted with non-denaturing elution buffer. Aliquots of these samples were 
supplemented with SDS sample buffer and DTT and then incubated in the absence or presence of 
PNGase F or Endo H as indicated. Samples were resolved by SDS-PAGE (8% acrylamide) followed 
by autoradiography. C indicates samples from non-injected control oocytes. 
 
 
3.1.4.2. Investigation of the quaternary structure of the rP2X2/rP2X1 complex 
 
3.1.4.2.1. Cross-linking analysis 
 
Analogous to the investigation of the quaternary structure of the homotrimeric His-
rP2X2 receptor (chapter 3.1.1.3), the cross-linker glutardialdehyde was used to 
investigate the quaternary structure of the hetero-assembled rP2X2/rP2X1 complex in 
the plasma membrane of intact Xenopus oocytes. The injected oocytes were 
surface-labeled with 
125I-sulfo-SHPP and incubated with glutardialdehyde for up to 
60 min before digitonin extraction and affinity purification was performed. SDS-PAGE 
analysis of the chemically cross-linked His-rP2X2/rP2X1 complex revealed two 
additional bands of ~117 kD and ~175 kD, corresponding to the dimers and trimers 
of the 57 kD and 61 kD polypeptides of rP2X1 and rP2X2, respectively (Fig. 3.19, 
-
-
-
+ - + -
+
- - - +
-
-
+
-
- +
-
-
Endo H
PNGase F
10
C
6 7 8 5 2 3 4 1 9
His-P2X2 His-P2X1 
His-P2X2 +
wt-P2X1
66
kD
46
-
-
-
+ - + -
+
- - - +
-
-
+
-
- +
-
-
Endo H
PNGase F
-
-
-
+ - + -
+
- - - +
-
-
+
-
- +
-
-
Endo H
PNGase F
10
C
6 7 8 5 2 3 4 1 9
His-P2X2 His-P2X1 
His-P2X2 +
wt-P2X1
10
C
6 7 8 5 2 3 4 1 9
His-P2X2 His-P2X1 
His-P2X2 +
wt-P2X1
66
kD
463. Results      
 
76 
lane 6). Interestingly, these bands of the higher molecular mass migrated in between 
the dimeric and trimeric protein bands obtained by cross-linking of homomultimeric 
His-rP2X1 and His-rP2X2 subunits (Fig. 3.19, lanes 5 and 7), indicating the chemical 
cross-linking of rP2X1 with rP2X2. Increasing the incubation time with 
glutardialdehyde did not increase the number of bands, but resulted in a decrease of 
their intensity (Fig. 3.19, lanes 8-10). These observations suggested that hetero-
assembled rP2X1 and rP2X2 exist as trimers in the plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.19: Cross-linking of rP2X1/rP2X2 complexes by glutardialdehyde in intact Xenopus 
oocytes. Oocytes were injected with cRNAs for His-rP2X1 (25 ng), non-tagged rP2X1 (25 ng), or His-
rP2X2 (2.5 ng). The cRNAs were injected either individually or together as indicated. Cells were kept 
for 3 days at 19°C and then labeled with 
125I-sulfo-SHPP. Cross-linking was performed on intact 
oocytes with 10 mM glutardialdehyde for 30 min or 60 min at 4°C. After removing the excess of 
glutardialdehyde by washing with oocyte-PBS, the oocytes were homogenized in 1% digitonin. 
Proteins were purified by Ni
2+-NTA agarose affinity chromatography and eluted with non-denaturing 
elution buffer and analyzed by reducing SDS-PAGE (4-10% acrylamide gradient gel). 
 
 
3.1.4.2.2. BN-PAGE analysis of the rP2X2/rP2X1 complex 
 
In addition, the oligomeric state of the rP2X2/rP2X1 complex was analyzed by BN-
PAGE. To this end, oocytes injected with cRNAs for non-tagged P2X1 and 
hexahistidyl-tagged P2X2 were surface-labeled with 
125I-sulfo-SHPP and then 
extracted with 1% digitonin and chromatographically purified on Ni
2+-NTA agarose 
beads. In parallel, heteromultimeric His-rP2X2/rP2X3 and homomultimeric His-rP2X1, 
His-rP2X2, and His-rP2X3 receptor complexes were surface radio-iodinated and 
purified under the same conditions. The purified proteins were then analyzed by BN-
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PAGE. Proteins isolated from oocytes co-synthesizing rP2X1 and rP2X2 subunits 
migrated as a single protein band at about 320 kD, when resolved by BN-PAGE (Fig. 
3.20, lane 3). Homomultimeric His-rP2X1 and His-rP2X2 receptors exhibited lower 
and higher mobility and migrated at 240 kD and 380 kD, respectively (Fig. 3.20, 
lanes 1 and 2). Likewise, the heteromultimeric rP2X2/rP2X3 receptor appeared as a 
single band at ~260 kD, slightly larger than the homomultimeric His-rP2X3 protein at 
~240 kD (Fig. 3.20, lanes 4 and 5).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.20: Rat P2X1 and P2X2 subunits co-purified under non-denaturing conditions migrate as 
one distinct band when resolved by BN-PAGE. Oocytes were injected with cRNAs for His-rP2X1 
(25 ng), non-tagged rP2X1 (25 ng), His-rP2X3 (25 ng), non-tagged rP2X3 (25 ng), or His-rP2X2 (2.5 
ng). The cRNAs were injected either individually or together as indicated. Cells were kept for 3 days 
at 19°C and then labeled with membrane-impermeant 
125
I-sulfo-SHPP. Proteins were purified by Ni
2+
-
NTA chromatography from 1% digitonin extracts of each oocyte group, eluted with non-denaturing 
elution buffer and resolved by blue native PAGE (4-10% acrylamide) followed by autoradiography. 
 
  To determine the number of subunits per complex, the natively eluted 
rP2X2/rP2X1 complex was incubated with increasing concentration of urea, inducing 
a partial dissociation of the protein complex prior to the BN-PAGE. Upon denaturing 
of the rP2X1/rP2X2 complex, blue native PAGE analysis revealed four bands, 
representing the rP2X1/rP2X2 trimer at ~320 kD, the dimer at ~200 kD, the rP2X2 
monomer at ~120 kD, and the rP2X1 monomer at ~80 kD (Fig. 3.21, lanes 5 and 6). 
These results indicate that the hetero-oligomeric rP2X2/rP2X1 complex possesses a 
trimeric structure like the homomultimeric His-rP2X1 complex (Fig. 3.21, lanes 1-3) 
and His-rP2X2 receptors (Fig. 3.21, lanes 7-9).  
When the His-rP2X2/rP2X3 complex was treated with urea in the presence of 
blue native sample buffer, three protein bands appeared in addition to the non-
dissociated 260 kD protein. The bands of the apparent masses of ~80 kD and ~120 
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kD correspond to the rP2X3 and rP2X2 monomers, respectively. The intermediate 
dimer appeared as a ~170 kD protein band (Fig. 3.21, lanes 11 and 12). Thus, 
apparently the heteromultimeric His-rP2X2/rP2X3 complex is a trimer like the 
homomultimeric His-rP2X2 (Fig. 3.21, lanes 7-9) and His-rP2X3 (Fig. 3.21, lanes 13-
15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.21: Partial dissociation of rP2X1/rP2X2 and rP2X2/rP2X3 complexes. Oocytes were injected 
with cRNAs for His-rP2X1 (25 ng), non-tagged rP2X1 (25 ng), His-rP2X3 (25 ng), non-tagged rP2X3 (25 
ng), or His-rP2X2 (2.5 ng). The cRNAs were injected either individually or together as indicated. Cells 
were kept for 3 days at 19°C and then labeled with 
125
I-sulfo-SHPP. Proteins were purified by Ni
2+
-
NTA chromatography from 1% digitonin extracts of each oocyte group and eluted with non-denaturing 
elution buffer. Samples were supplemented with 4 M or 8 M urea in the presence of blue native 
sample buffer and incubated for 45 min 37°C prior to blue native PAGE (4-13% acrylamide gradient 
gel). C indicates samples from non-injected control oocytes. 
 
The two-dimensional PAGE analysis was used to confirm that the distinct 
bands observed by BN-PAGE analysis and ascribed to trimeric and dimeric protein 
complexes of rP2X2/P2X1 and rP2X2/P2X3 consisted of both P2X isoforms. For this 
purpose, the partially dissociated protein complexes were excised from the blue 
native gel (Fig. 3.21, lanes 6 and 12) and reanalyzed in the second dimension by 
SDS-PAGE. As shown in Fig. 3.22, the higher molecular mass complexes 
corresponding to the trimeric and dimeric forms of P2X2/P2X1 dissociated into P2X1 
monomers of 57 kD and P2X2 monomers of 61 kD, when treated with SDS and 
resolved by SDS-PAGE. Using two-dimensional PAGE, the trimeric and dimeric 
bands observed for the P2X2/P2X3 complex could also be dissociated into defined 
P2X2 and P2X3 monomers, confirming a hetero-assembly of these subunits in 
oocytes. 
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Fig. 3.22: 2D-PAGE analysis of partially dissociated rP2X1/rP2X2 and rP2X2/rP2X3 complexes. 
Surface radio-iodinated oocytes injected either with the cRNA encoding His-rP2X2 and non-tagged 
rP2X1 or His-rP2X2 and non-tagged rP2X3 were extracted with 1% digitonin. Proteins were purified by 
Ni
2+
-NTA chromatography from extracts of each oocyte group and eluted with non-denaturing elution 
buffer. Proteins were partially dissociated with 8 M urea in the presence of blue native sample buffer 
at 37°C for 45 min and resolved on a 4-13% blue native polyacrylamide gradient gel. After BN-PAGE, 
the lanes carrying the separated proteins were excised and polymerized into the stacking gel of a 8% 
SDS-polyacrylamide gel. Polypeptides were then resolved in the 2
nd dimension by SDS-PAGE. 
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3.1.5. Characterization of P2X1 subunits tagged with green fluorescent protein 
after expression in Xenopus oocytes 
 
To examine the subcellular localization and membrane targeting of rat P2X1 receptor 
by fluorescence microscopy, the His-rP2X1 receptor subunit was tagged N-terminally 
(GFP-His-rP2X1) or C-terminally (His-rP2X1-GFP) with the green fluorescent protein 
(GFP). These fusion proteins were then expressed in Xenopus oocytes. 
 
 
3.1.5.1. Electrophysiological characterization GFP-tagged His-rP2X1 constructs 
after expression in Xenopus oocytes 
 
To test whether both the N- and C- terminally GFP-tagged His-rP2X1 subunits could 
assemble into a functional homomultimeric receptors, oocytes expressing one of the 
two constructs were tested with a two-electrode voltage clamp. Fig. 3.23 shows 
current responses of parent His-rP2X1 and C-terminally GFP-tagged His-rP2X1 
receptors, elicited at -60 mV by application of 10 µM ATP. Two days after cRNA 
injection, His-P2X1-GFP produced ATP-elicited currents comparable to that of His-
P2X1 (about 17 µA). Furthermore, the results demonstrate the virtually identical time 
course of desensitization of both receptors, implying that the electrophysiological 
properties were not affected by the C-terminal GFP tag. In contrast, only faint signals 
were detected for the fusion protein consisting of His-P2X1, N-terminally tagged with 
GFP (< 50 nA, results not shown).  3. Results      
 
81 
5
 
µ
A
5 s
His-P2X
1 gfp-His-P2X
1
5
 
µ
A
5 s
Fig. 3.23: Comparison of electrophysiological responses to activation of the parent and GFP-
tagged His-P2X1 receptor. Oocytes were injected with 25 ng of cRNA for His-rP2X1, or C-terminally 
GFP-tagged His-rP2X1 (His-rP2X1-GFP). Two days after injection current responses elicited by 10 µM 
ATP (applied for 5 s) were measured at holding potential -60 mV. The experiment was performed by 
Dr. Jürgen Rettinger. 
 
 
 
3.1.5.2. Visualization of GFP-tagged His-rP2X1 protein in Xenopus oocytes by 
confocal fluorescence microscopy 
The confocal fluorescence microscopy was done by Dr. Bodo Laube (Max-Planck-
Institute for Neurology, Frankfurt, Germany).To determine the subcellular distribution 
of GFP-tagged His-rP2X1, oocytes were injected with the cRNA for His-rP2X1-GFP 
and GFP-His-rP2X1. Two to three days after injection, the oocytes were examined by 
confocal fluorescence microscopy for the detection of green fluorescence. Non-
injected oocytes showed very low levels of autofluorescence and defined back-
ground fluorescence. GFP fluorescence was found throughout the plasma 
membrane in oocytes that had been injected with His-rP2X1-GFP (Fig. 3.24, B). The 
oocytes also accumulated His-rP2X1-GFP in internal membranous structures. These 
clusters varied in size between 3 µm and 6 µm and formed a continuous web 
throughout the cytoplasm as shown in oocytes (Fig. 3.24, A). The GFP fluorescence 
was not observed at the plasma membrane of oocytes injected with GFP-His-rP2X1. 
His-P2X1-GFP 3. Results      
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Fig. 3.24: Visualization of His-rP2X1 receptor distribution in Xenopus oocytes using the GFP-
tagged rP2X1 fusion protein. Confocal image of oocytes membranes after injection of 25 ng of 
cRNA encoding His-rP2X1-GFP. 
 
 
3.1.5.3. Biochemical characterization of GFP-tagged His-rP2X1 constructs after 
expression in Xenopus oocytes by SDS-PAGE 
 
For biochemical analysis, oocytes injected with the cRNA for the parent His-P2X1 
subunit or the N- and C- terminally GFP-tagged His-rP2X1 subunits were 
metabolically labeled by overnight incubation with [
35S]methionine. After an additional 
20 h chase interval, digitonin extracts were prepared. The fusion proteins were 
isolated by Ni
2+-NTA agarose affinity chromatography, and eluted with non-
denaturing elution buffer. Samples were incubated in the presence of Endo H or 
PNGase F and then analyzed by SDS-PAGE. Like the parent His-rP2X1 subunit, a 
fraction of the His-rP2X1-GFP polypeptide was partially Endo H resistant, indicating 
that C-terminally GFP-tagged His-rP2X1 polypeptide is able to leave the ER and that 
at least one N-linked carbohydrate chain becomes complex glycosylated in the Golgi 
apparatus (Fig. 3.25, lane 5). In contrast, deglycosylation of N-terminally GFP-
tagged His-rP2X1 polypeptide with Endo H released all N-linked glycans (Fig. 3.25, 
lane 10), suggesting that this protein does not acquire complex type carbohydrates 
and, therefore, most likely resides entirely in the ER. Treatment with PNGase F 
reduced the molecular masses by 10 kD, yielding a ~75 kD band (Fig. 3.25, lanes 6 
an 11), close to the 77 kD of the fusion protein computed from the translated cDNA 
sequence (47 kD for rP2X1 and 29.4 kD for GFP). His-rP2X1 C- or N-terminally 
tagged with GFP both migrated with approximate molecular masses of 87 kD (Fig. 
3.25, lanes 4 and 9). As shown in Fig. 3.25, the N-terminally GFP-tagged His-rP2X1 
polypeptide exhibited a decreased expression level as compared with the parent His-
100 µm
50 µm
100 µm
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rP2X1 protein. This observation may be explained by the impaired folding resulting 
from the N-terminal GFP tag, which may lead to increased degradation through the 
quality control machinery of the oocytes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.25: Glycosylation status of the GFP-tagged His-rP2X1 polypeptide after metabolic 
labeling. Oocytes injected with 25 ng of cRNA for His-rP2X1, His-rP2X1-GFP or GFP-His-rP2X1 were 
metabolically labeled overnight. After a 20 h chase period, cells were extracted with 1% digitonin. 
Proteins were purified by Ni
2+-NTA affinity chromatography, eluted under non-denaturing conditions 
and treated with PNGase F or Endo H and finally analyzed by SDS-PAGE (8% acrylamide). C 
indicates samples from non-injected control oocytes. 
 
 
Next, the glycosylation status of the surface-expressed His-P2X1-GFP protein 
was compared with that of the parent His-rP2X1 protein. Endo H treatment reduced 
the molecular mass of both the parent His-rP2X1 subunit and the C-terminally GFP-
tagged His-rP2X1 subunit by 8 kD, but was unable to remove all N-glycans (Fig. 
3.26, lane 5). In contrast, PNGase F treatment released all N-glycans of the His-
rP2X1-GFP polypeptide (Fig. 3.26, lane 6). These results suggest that the His-rP2X1-
GFP fusion protein like the parent His-rP2X1  subunit carries four N-linked 
oligosaccharide side chains, one of which becomes complex glycosylated in the 
Golgi. 
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Fig. 3.26: Glycosylation status of surface His-rP2X1-GFP. Oocytes injected with 25 ng of cRNA for 
His-rP2X1 or His-rP2X1-GFP were left for 3 days at 19°C and then labeled with membrane-
impermeant 
125I-sulfo-SHPP. Proteins were purified by Ni
2+-NTA chromatography from 1% digitonin 
extracts of oocytes, and eluted with non-denaturing elution buffer. Aliquots of these samples were 
supplemented with SDS sample buffer and treated with Endo H or PNGase F as indicated. After the 
digestion, proteins were resolved by SDS-PAGE (8% acrylamide) followed by autoradiography. C, 
non-injected control oocytes. 
 
 
3.1.5.4. Investigation of the quaternary structure of the GFP-tagged rP2X1 
fusion proteins 
 
3.1.5.4.1. Cross-linking analysis of the GFP-tagged rP2X1 fusion proteins 
 
 
Oocytes injected with the cRNA for His-rP2X1-GFP fusion protein were surface-
labeled with 
125I-sulfo-SHPP and then incubated with glutardialdehyde for 60 min. 
After the cross-linking reaction, the fusion proteins were purified from a digitonin 
extract of the oocytes by Ni
2+-NTA agarose affinity chromatography and subjected to 
reducing SDS-PAGE analysis. In addition to the His-rP2X1-GFP monomer, two 
bands of higher molecular masses were observed (Fig. 3.27, lane 4). These bands 
corresponded in size to the calculated molecular masses of the His-rP2X1-GFP 
dimer of ~175 kD and trimer of ~260 kD. Incubation of the injected oocytes with 
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increasing concentrations of glutardialdehyde did not yield bands with higher 
molecular masses than for a trimer (Fig. 3.27, lanes 5). These results suggest that 
the His-rP2X1-GFP protein, like the parent His-P2X1 receptor, exists as a trimer in 
the plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.27: Cross-linking of the His-rP2X1-GFP fusion protein on intact Xenopus oocytes. 
Oocytes injected with 25 ng of cRNA for His-rP2X1-GFP were surface iodinated with 
125I-sulfo-SHPP 
three days after injection. Cross-linking was performed on intact oocytes with the indicated 
concentrations of glutardialdehyde for 60 min at 4°C. After removing the excess of glutardialdehyde 
by washing with oocyte PBS, the oocytes were homogenized in 1% digitonin. His-rP2X1-GFP was 
purified by Ni
2+-NTA agarose affinity chromatography and eluted with non-denaturing elution buffer 
and finally analyzed by reducing SDS-PAGE (4-10% acrylamide gradient gel). C indicates samples 
from non-injected control oocytes. 
 
 
3.1.5.4.2. BN-PAGE analysis of the GFP-tagged rP2X1 fusion proteins 
 
The N- or C-terminally GFP-tagged His-rP2X1 fusion proteins that were purified 
under non-denaturing conditions from metabolically labeled oocytes migrated as 
single bands at about 350 kD when analyzed by BN-PAGE (Fig. 3.28, lanes 7 and 
10). In addition, a large amount of aggregated protein in the region of high molecular 
mass range was observed for His-P2X1-GFP (Fig. 3.28, lane 7). These aggregations 
may reflect incompletely folded or only partially assembled fusion protein that was 
retained in the ER. Due to the mass addition by the GFP tag, the fusion proteins 
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86 
exhibited a lower mobility in the BN-PAGE system than the parent His-P2X1 receptor 
that migrated at 240 kD (Fig. 3.28, lane 4). To determine the number of subunits 
incorporated into the defined 350 kD fusion protein, a partial dissociation was 
induced by treatment of the complexes with urea. This treatment led to the 
appearance of two additional bands besides the non-dissociated complex at 350 kD, 
corresponding to the monomer at ~120 kD, and the intermediate dimer at ~250 kD 
(Fig. 28, lanes 9 and 12). These results indicated that the N- or C-terminally GFP-
tagged His-rP2X1 polypeptides adopt a trimeric structure like the parent His-rP2X1 
polypeptide (Fig. 3.28, lanes 4-6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.28: BN-PAGE analysis of N- or C-terminally GFP-tagged His-rP2X1 protein after metabolic 
labeling. Oocytes injected with 25 ng of cRNA for His-P2X1, His-rP2X1-GFP or GFP-His-rP2X1 were 
metabolically labeled overnight and then chased for 20 h at 19°C. Cells were extracted with 1% 
digitonin. Parent His-P2X1 or the fusion proteins were purified by Ni
2+-NTA affinity chromatography 
under non-denaturing conditions. Digitonin solubilized proteins were supplemented with blue native 
sample buffer and either directly applied on the gel or first incubated at  at 37°C with 4 M or 8 M urea 
in the presence of blue native sample buffer and than applied on the gel (4-13% acrylamide gradient 
gel). 
 
Blue native PAGE analysis revealed a strong dissociation of the metabolically 
labeled His-rP2X1 receptor and the fusion proteins upon treatment with 4 M or 8 M 
urea, as shown by appearance of the strong monomeric bands (Fig 3.28, lanes 6, 9, 
and 12). A similar dissociation of the protein complexes could also be produced by 
treatment with 100 mM DTT in the presence of aminocaproate for the natively eluted 
His-rP2X1 or His-rP2X1-GFP receptors from surface labeled oocytes (Fig 3.29, lanes 
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2 and 5). The DTT treatment induced a partial dissociation of the fusion protein and 
led to the appearance of two additional bands besides the non-dissociated complex 
at 350 kD, corresponding to the monomer at ~120 kD, and the intermediate dimer at 
~250 kD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.29: Partial dissociation of surface-iodinated His-rP2X1-GFP complex. Oocytes injected with 
25 ng of cRNA for His-rP2X1 or His-rP2X1-GFP were left for 3 days at 19°C and then labeled with 
membrane-impermeant 
125I-sulfo-SHPP. Proteins were purified by Ni
2+-NTA affinity chromatography 
from 1% digitonin extracts of oocytes, and eluted with non-denaturing elution buffer. Samples were 
supplemented with BN sample buffer and analyzed by BN-PAGE (4-13% acrylamide gradient gel) 
either without incubation or after incubation for 45 min at 37
oC with 4 M urea and/or 100 mM DTT as 
indicated. C indicates samples from non-injected control oocytes. 
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3.1.6. Characterization of P2X subunit chimeras after expression in Xenopus 
oocytes 
 
Currents evoked by ATP at P2X1 and P2X3 receptors undergo marked 
desensitization within a few hundred milliseconds. In contrast, currents evoked at 
P2X2 receptors, similarly expressed, undergo little or no desensitization on this time 
scale (Valera et al., 1994). The 399 amino acids of P2X1 subunit are 37% identical 
with the corresponding portion of the P2X2 receptor, which has 472 amino acids due 
to a longer C-terminus. The aim of these studies was to prove or disprove whether 
P2X receptors with non-desensitizing phenotype have a propensity to assemble to 
hexamers rather than to trimers. Therefore, the rP2X2 N-terminal domain was 
substituted for the corresponding portion of the rP2X1 and rP2X3 receptor, which 
results in a non-desensitizing phenotype in both cases (Werner  et al., 1996). 
Furthermore, the N-terminal domain of human P2X4 subunit was inserted into the 
rP2X1 receptor subunit and the first transmembrane segment of the rP2X1 receptor 
subunit was substituted by the first transmembrane region of rP2X2 receptor subunit 
(Fig. 3.30). Prior to the electrophysiological characterization of the constructs, the 
chimeras were analyzed by SDS- and BN-PAGE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.30: Schematic representation of the chimeras. Checkered rectangles indicate positions of 
putative membrane-spanning regions M1 and M2. White letters in gray rectangles indicate the 
substituted sequence of segments into the respective P2X subunits. Light gray rectangles show N-
terminal hexahistidyl tag. 
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3.1.6.1. Biochemical characterization of P2X subunit chimeras by SDS-PAGE 
 
For biochemical analysis, oocytes injected with the cRNA for the His-rP2X1 subunit 
or the N-terminally hexahistidyl-tagged P2X chimeras were metabolically labeled by 
an overnight incubation with [
35S]methionine. After the metabolic labeling of the 
oocytes, digitonin extracts were prepared. The proteins were isolated by Ni
2+-NTA 
agarose chromatography, and eluted with non-denaturing elution buffer. Samples 
were incubated in the presence of Endo H or PNGase F and then analyzed by SDS-
PAGE. Fig. 3.31 A shows that like the parent His-P2X1  subunit, the chimeras 
consisting of the first 53 amino acids of the rat P2X2 subunit (His-rP2X2/rP2X1) or the 
first 51 amino acids of the human P2X4 subunit (His-rP2X4/rP2X1) connected with 
352 amino acids of the C terminus of the rat P2X1 polypeptide could be isolated as 
57 kD proteins (lanes 1, 4 and 7). A His-P2X1 mutant with the amino acid residues 
for the first transmembrane region substituted with those of the rat P2X2 subunit 
(His-rP2X1[TM(1)P2X2]) migrated as a single polypeptide of an apparent molecular 
masses of 57 kD (Fig. 3.31 B, lane 4). These manipulations appeared to influence 
the glycosylation status of the proteins. While the parent His-P2X1 subunit and the 
His-hP2X4/rP2X1 chimera were partially Endo H resistant, indicating that at least one 
N-linked carbohydrate chain becomes complex glycosylated (Fig. 3.31 A, lanes 2 
and 8), deglycosylation of the His-rP2X2/rP2X1 and His-rP2X1[TM(1)P2X2] chimeras 
with Endo H released all N-linked glycans (Fig. 3.31 A and B, lanes 5), indicating that 
the rP2X2/rP2X1 chimeras do not acquire complex type carbohydrates.  
The His-rP2X2/rP2X3 chimera consisting of the hexahistidyl-tag and the first 47 
N-terminal amino acids of rP2X2 subunit with the C-terminal 356 amino acids of the 
P2X3 polypeptide was isolated from Xenopus oocytes as a 57 kD protein (Fig. 3.31 
B, lane 1). The molecular mass of the metabolically
 labeled chimera was reduced by 
10 kD to 47 kD when this glycoprotein was incubated with PNGase F (Fig. 3.31 B, 
lane 3). This suggests that His-rP2X2/rP2X3  chimera  carries four N-linked 
oligosaccharide side chains. Upon treatment with Endo H, all N-linked glycans were 
released, indicating that this chimera does not acquire complex type carbohydrates 
(Fig. 3.31 B, lane 2).  3. Results      
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Fig. 3.31: SDS-PAGE analysis of P2X subunit chimeras after metabolic labeling. Oocytes 
injected with 25 ng of cRNA for His-rP2X1 or the respective P2X chimeras were metabolically labeled 
overnight. After the metabolic labeling, cells were extracted with 1% digitonin. Proteins were purified 
by Ni
2+-NTA affinity chromatography, eluted under non-denaturing conditions and treated with 
PNGase F or Endo H and analyzed by SDS-PAGE (8% acrylamide) followed by autoradiography. C 
indicates samples from non-injected control oocytes. 
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3.1.6.2. Blue native PAGE analysis of P2X subunit chimeras 
 
In addition, the oligomeric state of the parent His-rP2X1 receptor and the respective 
chimeras was analyzed by BN-PAGE. The parent His-P2X1 receptor isolated from 
cRNA injected and [
35S]methionine-labeled oocytes migrated as a single protein 
band at about 240 kD, when resolved by BN-PAGE (Fig. 3.32 A, lane 1). His-
rP2X2/rP2X1  (Fig. 3.32 A, lane 5), His-hP2X4/rP2X1 (Fig. 3.32 A, lane 9) and 
rP2X1[TM(1)P2X2] chimeras (Fig. 3.32 B, lane 7) exhibited a similar mobility and 
migrated at ~250 kD. For the His-rP2X2/rP2X1 and His-hP2X4/rP2X1 chimeras, an 
additional band with a high molecular mass of about 450 kD was observed. This 
band might corresponded in mass to the hexameric form of the chimeras.  
To determine the number of subunits per receptor complex, the natively 
eluted rP2X1 receptor or the respective chimeras were incubated prior to the BN-
PAGE with DTT or urea in the presence of blue native sample buffer to induce a 
partial dissociation of the protein complexes. As reported already above, blue native 
PAGE analysis revealed three bands after partial denaturing of the His-rP2X1 
receptor, representing the P2X1 trimer at ~240 kD, the dimer at ~180 kD, and the 
P2X1 monomer at ~80 kD (Fig. 3.32 A, lanes 3 and 4). Treatment with urea in the 
presence of DTT induced a very strong dissociation, such that almost only His-rP2X1 
monomers of 80 kD are observed (lane 4). When treated with DTT alone in the 
presence of blue native sample buffer, three protein bands appeared also with His-
rP2X2/rP2X1  (lane 7), His-hP2X4/rP2X1 (lane 11) and rP2X1[TM(1)P2X2] chimeras 
(Fig. 3.32 B, lane 8). The bands of the apparent masses of ~80 and ~200 kD 
correspond to the monomers and dimers, respectively. From these results, it is 
deduced that the chimeras constructed by the connection of complementary regions 
of the P2X2 with the P2X1 polypeptide also assemble to a trimeric complex like the 
parent His-P2X1 subunit. 
The His-rP2X2/rP2X3  chimera migrated as a single band at ~250 kD when 
resolved by the blue native PAGE (Fig. 3.32 B, lane 2). Incubation prior to BN-PAGE 
of the natively eluted His-rP2X2/rP2X3 receptor with DTT and urea in the presence of 
the blue native sample buffer caused a partial dissociation of the complex into the 
monomer and dimer of apparent masses of 90 kD and 190 kD, respectively (Fig 3.32 
B, lane 5). This observation implies that the non-denatured protein band must be a 
trimer.  3. Results      
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Fig. 3.32: BN-PAGE analysis of partially dissociated chimeric P2X receptors. Oocytes injected 
with 25 ng of cRNA for His-P2X1 or one of the respective P2X chimeras were metabolically labeled 
overnight. After the metabolic labeling, digitonin extracts were prepared. Proteins were isolated by 
Ni
2+-NTA chromatography and eluted under non-denatured conditions. Samples were analyzed by 
blue native PAGE (4 –13% acrylamide gradient gel) either without further treatment or after incubation 
with blue native sample buffer in the presence or absence of 100 mM DTT and/or 8 M urea at 37°C 
for 60 min. C indicates samples from non-injected control oocytes. 
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3.1.6.3. Electrophysiological characterization of P2X subunit chimeras after 
expression in Xenopus oocytes 
 
P2X1 and P2X2 receptors are distinguished by their different rates of desensitization 
(Fig. 3.23 and Fig. 3.1 A). In oocytes expressing P2X1 or P2X3 receptors, the current 
evoked by 10 µM ATP desensitized by around 100% during a 10 s application of 
ATP. In oocytes expressing the His-rP2X2 receptor, prolonged application of ATP (30 
µM) elicited a large inward current with a rapid onset and slow rate of 
desensitization. Substitution of the P2X1 or the P2X3 subunits with corresponding 
parts of the intracellular N-terminus and first transmembrane region of P2X2 receptor 
segments removes desensitization (Werner et al., 1996) (Fig. 3.33 A and C). At 
these constructs, ATP (10 µM) evoked a current that declined by only few percents 
in 10 s. These experiments indicate that exchange of the first 53 amino acid residues 
fully eliminates desensitization from the P2X1 or P2X3 receptors. 
Substitution of the corresponding P2X2 segment into position 43–65 of the 
P2X1 receptor provided a channel at which a current was evoked that declined by 
only few percents during a 10-s application of ATP (10 µM). Thus, Substitution of the 
residues 43–65 (approximately equivalent to the first transmembrane domain of 
P2X2) into the P2X1 receptor was effective to remove desensitization from the 
chimera (Fig. 3.33 B), indicating that a portion of the P2X1 receptor that is 
responsible for desensitization is located in this region (Werner et al., 1996).  
The analysis of the designed chimeric constructs revealed that two subunits 
with widely different biophysical and pharmacological properties as P2X2 and P2X1 
could yield chimeric receptors with unique functional properties as already was 
reported by others (Werner et al., 1996). Next, instead of P2X2, the P2X4 subunit 
was chosen. The P2X4 receptor is known to desensitize partially and it behaves 
functionally in between P2X1  and P2X2 receptors. A chimeric construct was 
engineered, in which the N-domain including the first transmembrane domain was 
from P2X4 and the rest of the flanking protein from P2X1. As revealed by the two-
voltage clamp measurements, the P2X1 receptor with the P2X4 N-domain also 
exhibits a rapid activation in response to 10 µM ATP followed by a strong 
desensitization, as also observed for the wild type P2X1 receptor (Fig. 3.33 D). 3. Results      
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Fig. 3.33: Comparison of electrophysiological responses to activation of the P2X receptor 
chimeras.  Oocytes were injected with 23 ng of cRNA for P2X2/P2X1chimera (A), P2X1[TM-P2X2] 
chimera  (B),  P2X2/P2X3  chimera (C), or P2X4/P2X1 chimera  (D). One day after injection current 
responses elicited by 10 µM ATP were measured at a holding potential -60 mV from oocytes 
expressing P2X2/P2X1 chimera. Two days after injection current responses elicited by 10 µM ATP 
were measured at a holding potential -60 mV from oocytes expressing P2X1[TM-P2X2] chimera, or 
P2X2/P2X3  chimera. Three days after injection current responses elicited by 10 µM ATP were 
measured at a holding potential -60 mV from oocytes expressing P2X4/P2X1 chimera. The duration of 
agonist activation is shown by the horizontal bar. The experiments were performed by Dr. Jürgen 
Rettinger. 
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3.2. Studies on the role of N-linked glycosylation in the rat P2X1 receptor 
function and expression  
 
 
3.2.1. Identification of the sites of N-linked glycosylation of rat P2X1 receptor 
  after expression in Xenopus oocytes 
 
The His-P2X1 subunit was isolated from cRNA-injected and [
35S]methionine-labeled 
oocytes as a 57 kD glycoprotein (Fig. 3.34 A, lane 1) that carries four N-glycans 
making up ∼ 18% by mass of the protein (Nicke et al., 1998). The deduced amino 
acid sequence of the P2X1 subunit shows five asparagines for possible N-linked 
glycosylation (NXT/S): 
153NGT, 
184NFT, 
210NGT, 
284NLS, and 
300NGT. Replacement 
of 
153N, 
184N, 
210N and 
300N by Q, one at a time, resulted in the synthesis of 
glycoproteins that had a 2-3 kD lower mass than the wild type P2X1 glycoprotein 
(Fig. 3.34 A, lanes 2-4, 7). Since 2-3 kD corresponds to the mass of one N-linked 
oligosaccharide side chain, this finding implies that each of the replaced asparagines 
is occupied by an N-glycan in the wild type P2X1 subunit. In contrast, replacement of 
284N by Q had no effect on the mass (Fig. 3.34 A, lane 5), indicating that 
284N of the 
wild type P2X1 subunit is the asparagine that is not used as a glycosyl acceptor site. 
The inability to glycosylate 
284N of the 
284NLS sequon may be attributed to the 
leucine residue in the X position, which has been found to impair core glycosylation 
(Shakin-Eshleman et al., 1996). Alternatively, 
287P immediately following the 
284NLS 
sequon might be responsible, since proline inhibits core glycosylation not only at the 
X, but also at the +4 position (Gavel et al., 1990). Indeed, 
284N was efficiently used 
as a glycosyl acceptor site when alanine was substituted for 
287P, as inferred from 
the reduced mobility of the His-A
287-P2X1 polypeptide, indicating the presence of an 
additional (fifth) N-glycan (Fig. 3.34 A, lane 6). The occupancy of 
284N by a glycan 
had no apparent effect on P2X1 receptor function, as deduced from the magnitude 
and concentration dependence of ATP-gated currents. The efficient glycosylation at 
284N after elimination of 
287P argues against a significant role of 
285L for the inability to 
glycosylate 
284N
 of the parent P2X1 polypeptide. 3. Results      
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Fig. 3.34: N-glycosylation of His-P2X1 mutants each lacking one out of five N-glycosylation 
sites. Oocytes injected with 25 ng of the indicated cRNAs were metabolically labeled by overnight 
incubation with [
35S]methionine. After an additional 24 h chase interval, digitonin extracts were 
prepared. Parent His-P2X1 and the various glycan minus mutants were isolated by Ni
2+-NTA 
chromatography, eluted with non-denaturing elution buffer, and then supplemented with SDS sample 
buffer, 20 mM DTT (final concentration). Samples were incubated for 15 min at 37°C in the absence 
(A) or for 2 h at 37°C in the presence of Endo H (B) or PNGase F, 1% octylglucoside (C) and then 
analyzed by SDS-PAGE (10% acrylamide) followed by autoradiography. C indicates samples from 
non-injected control oocytes. 
 
 
From the four N-glycans per P2X1 receptor subunit, only one acquired Endo H 
resistance during transport to the plasma membrane of Xenopus oocytes (Nicke et 
al., 1998). This suggests that processing by Golgi enzymes of three of the N-glycans 
is sterically hindered, most likely because of folding and oligomerization of the P2X1 
chains. Fig. 3.34 B shows that like the parent His-P2X1 receptor (lane 1) all the P2X1 
receptor mutants (lanes 2-6) except ∆ N5 (lane 7) acquired Endo H-resistant 
carbohydrates. Since the P2X1 receptor mutant ∆ N5 appears at the plasma 
membrane (cf. Figs. 3.35 – 3.37), the absence of Endo H-resistant carbohydrates 
can be directly conferred to the lack of the sole N-glycan that can acquire complex-
type carbohydrates during transit of the Golgi apparatus. This indicates that the 
glycan at 
300N of the parent His-P2X1 receptor subunit is the one accessible for 
complex-glycosylation. 
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3.2.2. Importance of N-glycans for P2X1 receptor function and assembly 
 
 
3.2.2.1. BN-PAGE analysis of P2X1 mutants lacking one or several consensus 
sequences for N-glycosylation 
 
An additional aim of the study was to examine the influence of carbohydrates on 
P2X1 receptor assembly as assessed by blue native PAGE analysis. Parent His-
P2X1 subunits combine rapidly to stable homotrimers that exit the ER, transit the 
Golgi where complex-glycosylation of ∆ N5 occurs (Fig. 3.34) and finally appear at 
the plasma membrane. To visualize the plasma membrane form of the His-P2X1 
glycan minus receptor mutants, oocytes surface proteins were radio-iodinated with 
membrane impermeant 
125I-sulfo-SHPP and then isolated the His-tagged proteins by 
Ni
2+-NTA chromatography. When resolved by blue native PAGE, the parent His-
P2X1 receptor migrated at 250-290 kD (Fig. 3.35, lane 1). Overall, elimination of N-
glycans resulted in a slight increase in electrophoretic mobility, corresponding 
maximally to 20 kD when two N-glycans per subunit were lacking. Within the 
technical limits of receptor quantification by surface radio-iodination, all the receptor 
mutants lacking one N-glycan (Fig. 3.35, lanes 2-5) and most of the mutants lacking 
two N-glycans (lanes 12-14) were present at approximately the same density at the 
plasma membrane as the parent His-P2X1 receptor.  3. Results      
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Fig. 3.35: Glycan minus mutants migrate as trimers like parent 2X1 when analyzed by blue 
native PAGE. Oocytes injected with 25 ng of the indicated cRNA 3 days earlier were surface-labeled 
with membrane impermeant 
125I-sulfo-SHPP and extracted with digitonin. His-P2X1  and the His-
tagged mutant proteins were then purified by Ni
2+-NTA chromatography under non-denaturing 
conditions and after native elution resolved by blue native PAGE (4 –10% acrylamide gradient gel), 
followed by autoradiography. Shown are samples from two independent experiments. #, 
contaminating protein not observed in other experiments (cf. lane 3). C indicates samples from non-
injected control oocytes. 
 
 
  To display the oligomeric state of these receptor complexes, the natively eluted 
His-P2X1 mutant receptors were exposed to DTT in the presence of Coomassie blue 
and sodium 6-amino-n-caproate. This treatment caused a partial dissociation of the 
parent His-P2X1 receptor to the monomer and dimer of apparent masses similar to 
80 kD and 170 kD, respectively, indicating that the non-denatured 240 kD protein 
band must be a His-P2X1 homotrimer (Fig 3.36 A, lanes 1-5). Likewise, also the His-
P2X1 glycan minus receptor mutants lacking one or two N-glycans per subunit 
dissociated into dimers and monomers when exposed to DTT (Fig. 3.36 A-C). 
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Fig. 3.36: Partial dissociation of glycan minus mutants. Oocytes injected with 25 ng of the 
indicated cRNA were metabolically labeled by overnight incubation with [
35S]methionine (C), or 
alternatively, oocytes injected with 25 ng of the indicated cRNA were kept for 3 days at 19°C and then 
labeled with 
125
I-sulfo-SHPP(A and B). Proteins were purified by Ni
2+
-NTA chromatography from 1% 
digitonin extracts of each oocyte group and eluted with non-denaturing elution buffer. Digitonin 
solubilized proteins were non-treated or alternatively dissociated by incubation with blue native 
sample buffer in the presence of indicated amounts of DTT (37°C, 45 min) (A and B), or dissociated 
by incubation with 100 mM DTT in the presence of blue native sample buffer for the indicated time at 
37°C (C) and finally analyzed by BN-PAGE (4-13% acrylamide gradient gel). C indicates samples 
from non-injected control oocytes. 
 
 
3.2.3. Electrophysiological analysis of oocyte-expressed P2X1 mutants lacking 
one or several consensus sequences for N-glycosylation 
 
To examine whether the elimination of a particular N-glycan affects the expression 
level of functional P2X1 receptors, current responses to 30 µM ATP at -40 mV were 
recorded. This ATP concentration elicited different yet maximum responses at the 
parent P2X1 receptor and all receptor mutants, since activation with 100 µM ATP did 
not result in a further increase of currents. Like the parent P2X1 receptor, also all 
receptor mutants lacking one N-glycan per subunit exhibited large ATP-gated 
currents, indicating that no particular N-glycan is essential for receptor function (Fig. 
3.37). There are, however, marked positional effects of the N-glycans. While the 
glycans at ∆ N2 or ∆ N5 were without significant effect on the expression level of 
functional receptors, elimination of the glycan at ∆ N1 or ∆ N3 resulted in a 30% 
decrease or 70% increase, respectively, of the current response (Fig. 3.37). 
Likewise, reduced currents were recorded from double mutants that lacked ∆ N1 
together with ∆ N2 or ∆ N5, whereas elimination of ∆ N3 consistently resulted in 
increased currents even when ∆ N1 was simultaneously eliminated (Fig. 3.37). These 
findings suggest that the glycans at ∆ N1 and ∆ N3 play opposing roles for the 
expression level of functional P2X1 receptors. 
Elimination of any three N-glycans did also not prevent P2X1 receptor formation, 
but the functional expression level decreased markedly to < 10% of that of the parent 
P2X1 receptor. The currents were particularly low when the three acceptor sites that 
were eliminated included ∆ N1 (Fig. 3.37). No ATP-induced currents could be 
recorded from oocytes after removal of all canonical N-glycosylation sites. Taken 
together, these results implicate that despite their marked positional effects, only one 
N-glycan at any locus is required for the formation of functional P2X1 receptors and 
two such sites are sufficient for robust functional expression. 3. Results      
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Fig. 3.37: Comparison of maximum inward current responses generated by parent P2X1 and 
glycan minus mutants. Oocytes were injected with 25 ng of the indicated cRNAs. After three days at 
19
oC, currents were activated at a holding potential of –40 mV by 30 µM ATP, which elicits maximum 
responses at parent His-P2X1 and each mutants. Currents were normalized to the response of the 
parent His-P2X1 receptor. Data are given as means ±  SEM from 20-48 oocytes per column of 2-6. 
The experiment was performed by Dr. Jürgen Rettinger. 
 
 
Since N-glycans are bulky and can shield a large section of the protein surface, 
the effects on ATP potency by the elimination of N-glycans was investigated. To this 
end, receptor currents elicited by 0.3 µM and 30 µM ATP were recorded and the 
ratio of the current responses at these two ATP concentrations were determined. As 
apparent from Fig. 3.38 C, all the receptor mutants lacking ∆ N3 (
210N) showed a 
current ratio of 5-7% independent of simultaneous elimination of additional N-
glycosylation sites. In contrast, all glycan minus receptor mutants that contained N-
glycan ∆ N3 showed a ratio of 26-37% similar to the 32% for the parent His-P2X1 
receptor. Since ∆ N3 turned out to be crucial for the reduced potency, concentration 
response curves for ATP of ∆ N3 and parent His-P2X1 were recorded. Fitting the Hill 
equation to the data for the parent His-P2X1 receptor yielded an EC50 value for ATP 
of 0.7 µM (Fig. 3.38 D). In contrast, the glycan minus receptor mutant ∆ N3 exhibited 
an EC50 value of 2.1 µM, i.e. a threefold-reduced potency for ATP. The Hill 
coefficients (1.1 vs. 1.3) were not significantly different. 
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Fig. 3.38: Comparison of ATP potency of the parent His-P2X1 receptor and the glycan minus 
mutants. Inward current traces were recorded at the indicated ATP concentrations and a holding 
potential -40 mV from oocytes injected three days earlier with 25 ng of cRNA for parent His-P2X1 (A) 
or the glycan minus mutant ∆ N3 (B).  C, ATP dose-response curve for parent P2X1-His (!) and 
mutant  ∆ N3 ("). Currents were elicited by the respective ATP-concentration in 1 min intervals. 
Continuous lines represent least squares fits of the Hill-equation to the data points, yielding EC50 
values of 0.7 ± 0.1 µM (Hill-coefficient of 1.1 ± 0.1) and 2.1 ± 0.2 µM (Hill-coefficient of 1.3 ± 0.1) for 
the parent His-P2X1 receptor and mutant ∆ N3, respectively (n = 6-7, mean ± SEM); D, The ratio 
between currents activated at –40 mV by 0.3 µM and 30 µM ATP was calculated as a measure of the 
ATP potency at the various glycan minus mutants (n  =  5-6, mean  ± SEM). Note that all mutants 
lacking N-glycosylation site N3 exhibit a markedly decreased current ratio indicative of a reduced ATP 
potency. The experiment was performed by Dr. Jürgen Rettinger. 
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3.3. Role of conserved cysteine residues for the function and expression of rat 
P2X1 receptor 
 
3.3.1. P2X1 receptor expression, subunit folding, and intracellular transport: 
effects of DTT in Xenopus oocytes.  
 
The P2X1 receptors are membrane glycoproteins with large ectodomains that fold 
inside the ER lumen. The ectodomain contains ten conserved cysteine residues that 
may contribute to the generation of five intrachain disulfide bonds. From other 
membrane proteins it is known that the formation of disulfide bonds begins co-
tranlationally in the ER and is a prerequisite for correct folding of the entire 
polypeptide (Green & Wanamaker, 1997). 
The reducing agent DTT can permeate across cellular membranes and 
prevent the formation of disulfide bonds of nascent proteins in the ER of living cells 
(Braakman et al., 1992). Here, this approach was used to study the contribution of 
the ER redox environment to the posttranslational processing and intracellular 
transport of oocyte-expressed P2X1 receptors. Oocytes injected with the cRNA for 
the His-P2X1 subunit were pulse-labeled overnight with [
35S]methionine in the 
absence or presence of DTT.  
  As shown in Fig. 3.39, His-P2X1 subunits were synthesized in the presence of 
DTT as 57 kD polypeptides (lane 5) like the His-P2X1 subunits that were synthesized 
under non-reducing conditions (lane 2). Incubation with PNGase F reduced the 
molecular masses of the polypeptides to 47 kD (lanes 4 and 7), implying that His-
P2X1 subunits carried four N-glycans irrespective of whether DTT was present 
during synthesis or not. In contrast, the single Endo H resistant N-glycan was only 
observed on His-P2X1 subunits from oocytes that were pulse-labeled in the absence 
of the reducing agent (Fig. 3.39, lane 6). This indicates that the His-P2X1 protein 
does not acquire a complex type carbohydrate in the presence of DTT and, 
therefore, most likely resides entirely in the ER. If DTT was present only during pulse 
labeling and was omitted from the chase medium, then His-P2X1 receptors acquired 
Endo H resistance (lane 9), implying that the effect exerted by the presence of DTT 
was reversible. Apparently, His-P2X1 that was synthesized in the presence of DTT 
was able to commence proper folding and assembly and eventually to reach the 
Golgi upon removal of the reducing agent. 3. Results      
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Fig. 3.39: His-P2X1 subunits synthesized in the presence of DTT do not acquire complex-type 
carbohydrates. Oocytes injected with 25 ng of cRNA for His-P2X1 were metabolically labeled 
overnight in the presence or absence of 5 mM DTT as indicated. Cells were either directly extracted 
with 1% digitonin or first chased for 24 h and then extracted. His-P2X1 was purified by Ni
2+-NTA 
affinity chromatography. Samples were eluted under non-denaturing conditions and treated with 
PNGase or Endo H and analyzed by SDS-PAGE (8% acrylamide). C indicates samples from non-
injected control oocytes. 
 
To determine whether the assembly of His-P2X1 subunits is affected by DTT 
treatment, metabolically labeled and natively purified His-P2X1 protein was subjected 
to BN-PAGE. His-P2X1  receptors that were synthesized under reducing or non-
reducing conditions migrated like a trimer at 240 kD when resolved by BN-PAGE 
(Fig 3.40, lanes 2 and 5). Incubation prior to BN-PAGE of the natively eluted His-
P2X1 receptor with DTT in the presence of the blue native sample buffer caused a 
partial dissociation of the His-P2X1 receptor into the monomer and dimer of apparent 
masses of 80 and 170 kD, respectively (Fig 3.40, lanes 7). This observation implies 
that the formation of His-P2X1 to a homotrimer is not hindered by the presence of 
DTT during the synthesis. 
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Fig. 3.40: Effect of DTT on P2X1 subunit assembly. Oocytes injected with 25 ng of cRNA for His-
P2X1 were metabolically labeled overnight in the presence or absence of 5 mM DTT. Cells were 
either directly extracted with 1% digitonin or first chased for 24 h and then extracted. His-P2X1 protein 
was purified by Ni
2+-NTA affinity chromatography. Samples were eluted under non-denaturing 
conditions and directly analyzed by BN-PAGE (4-13% acrylamide) or incubated at 37°C with 100 mM 
DTT in the presence of blue native sample buffer for 30 or 60 min prior to BN-PAGE. C indicates 
samples from non-injected control oocytes. 
 
 
3.3.2. Mutational analysis of the importance of conserved cysteine residues for 
the generation of P2X1 receptors in Xenopus oocytes 
 
 
3.3.2.1. Effects of single cysteine substitutions on P2X1 receptor expression 
and processing 
 
Rat P2X1  receptor subunit possesses 11 cysteine residues, from which 10 are 
located on the extracellular region of the subunit and one (
353C) is located on the 
second transmembrane segment. To determine the relative importance of each 
native cysteine residue in the rat P2X1 receptor, each of these residues was 
individually mutated to serine. The cysteine to serine conversion results in a 
relatively small change in the size of the amino acid side chain, but changes the 
residue to a more hydrophilic one without the ability to form covalent cross-links. 
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Oocytes injected with the cRNA for the parent or the mutated His-P2X1 subunits 
were pulse-labeled overnight with [
35S]methionine. After an additional 24 h chase 
interval, digitonin extracts were prepared. Proteins were isolated by Ni
2+-NTA 
agarose affinity chromatography, eluted with non-denaturing elution buffer, then 
supplemented with SDS sample buffer. Samples were incubated in the presence of 
Endo H or PNGase F and then analyzed by SDS-PAGE. As shown in Fig 3.31 A, the 
parent His-P2X1 subunit and the respective cysteine minus mutants were isolated 
from the oocytes as 57 kD polypeptides. Apparently, the substitution of an individual 
cysteine residue by serine did not hinder the synthesis of the respective mutant 
polypeptide, but influenced the amount of protein synthesized. While serine 
substitutions at the positions 
117C (∆ C1), 
165C (∆ C6) and 
353C (∆ C11) did not reduce 
the amount of the protein made, the mutations at the positions 
126C (∆ C2), 
132C 
(∆ C3), 
149C (∆ C4), 
159C (∆ C5), 
217C (∆ C7), 
227C (∆ C8), 
261C (∆ C9), and 
270C (∆ C10) 
markedly reduced the amount of the synthesized protein.  
Fig. 3.41 B shows that like the parent His-P2X1 subunit (lane 2), the receptor 
mutants  ∆ C1 - ∆ C6 and ∆ C11 (lanes 3-8, and 13) acquired Endo H-resistant 
carbohydrates. This finding implies that these mutants like the parent His-P2X1 
receptor can leave the ER and acquire complex-type carbohydrates during transit of 
the Golgi apparatus. In contrast, Endo H deglycosylation of the cysteine minus 
mutants  ∆ C7 - ∆ C10 (Fig. 3.41 B, lanes 9-12) released all N-linked glycans, 
indicating that these mutants do not acquire complex type carbohydrates and most 
likely reside entirely in the ER. 
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Fig. 3.41: Carbohydrate status of His-P2X1 mutants each lacking one out of 11 cysteine 
residues. Oocytes injected with 25 ng of the indicated cRNAs were metabolically labeled by overnight 
incubation with [
35S]methionine. After an additional 24 h chase interval, digitonin extracts were 
prepared. Parent His-P2X1 and the various cysteine minus mutants were isolated by Ni
2+-NTA 
chromatography, eluted with non-denaturing elution buffer, and then supplemented with SDS sample 
buffer. Samples were incubated for 15 min at 37°C in the absence (A) or for 2 h at 37°C in the 
presence of Endo H (B) or PNGase F (C), and then analyzed by reducing SDS-PAGE (10% 
acrylamide) followed by autoradiography. C indicates samples from non-injected control oocytes. 
 
Next, the appearance of the various mutants at the cell surface was 
investigated. To this end, surface protein of intact oocytes injected with the cRNAs 
for the different cysteine minus mutants was radio-iodinated and subsequently 
purified by Ni
2+-NTA chromatography. On oocytes injected with the cRNA for the 
cysteine minus mutants ∆ C7 - ∆ C10, no P2X1 subunit-specific protein band could be 
detected by SDS-PAGE. Apparently, these receptor mutants were retained in the 
ER. This observation is in agreement with the glycan status of the metabolically 
labeled cysteine minus mutants, showing that the receptor mutants ∆ C7 - ∆ C10 do 
not acquire complex type carbohydrates. In contrast to mutants ∆ C7 - ∆ C10, mutants 
∆ C1 - ∆ C6 could be detected at the cell surface (Fig. 3.42 A and B). Treatment of the 
cysteine minus mutants ∆ C1 - ∆ C6 with Endo H diminished the molecular mass of 
these glycoproteins by 8 kD, indicating that three minus mutants also acquired three 
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high mannose type carbohydrates (Fig. 3.42 A, lanes 2, 5, 8, 11 and Fig. 3.42 B, 
lanes 2, 5) like the parent His-P2X1. Endo H was unable to release all N-glycans of 
these mutant receptors, indicating that the asparagine 
300N of the respective cysteine 
minus mutants has acquired complex type carbohydrates in the Golgi and thus 
exhibits Endo H resistance (Fig. 3.42 A, lanes 3, 6, 9, 12 and Fig. 3.42 B, lanes 3, 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.42: Glycosylation status of surface iodinated cysteine minus mutants. Oocytes injected 
with 25 ng of cRNA for His-P2X1 or the indicated cysteine minus mutants were left for 3 days at 19°C 
and then labeled with membrane-impermeant 
125I-sulfo-SHPP. The proteins were purified by Ni
2+-NTA 
chromatography from 1% digitonin extracts of oocytes, and eluted with non-denaturing elution buffer. 
Aliquotes of these samples were supplemented with SDS sample buffer, 20 mM DTT, and treated 
with Endo H or PNGase F as indicated. After the digestion, proteins were resolved by SDS-PAGE 
(8% acrylamide) followed by autoradiography. C indicates samples from non-injected control oocytes. 
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3.3.2.2. BN-PAGE analysis of P2X1 mutants lacking one cysteine residue 
 
To examine the influence of single cysteine residues on P2X1 receptor assembly, the 
natively eluted parent P2X1 receptor and the respective cysteine single mutants were 
analyzed by BN-PAGE. Like the metabolically labeled parent His-P2X1 receptor, the 
cysteine minus mutants ∆ C1 - ∆ C6 and ∆ C11 migrated as one distinct band at 240 
kD (Fig. 3.43 A, lanes 2-8, and 13). Thus, elimination of one cysteine residue at a 
time did not influence the assembly of the respective minus mutants. In contrast to 
the [
35S]methionine-labeled ∆ C1 - ∆ C6 and ∆ C11 mutants, the appearance of the 
mutants ∆ C7 - ∆ C10 differed markedly when these cysteine minus mutants were 
resolved by BN-PAGE analysis. Besides a smear of aggregated protein, a total of 
five to six bands were resolved when these mutants were subjected to the BN-PAGE 
(Fig.3.43 B, lanes 2-5). The ladder of bands that appeared corresponded in size to 
multiples of the monomer, which by itself migrates at 80 kD, up to the pentamer and 
hexamer. Taken together, these results suggest that single exchange of C7, C8, C9, 
or C10 against S hindered the proper assembly and ER exit of the respective mutant 
His-P2X1 receptors. In contrast, the substitution of one of the proximal six cysteine 
residues of the ectodomain, C1 - C6, or C11 in the second transmembrane segment 
did not affect assembly and processing of the respective minus mutants. 
To display the oligomeric state of the cysteine minus mutants ∆ C1 - ∆ C6 and 
∆ C11, the natively eluted His-P2X1 mutant receptors were exposed to Coomassie 
blue and sodium 6-amino-n-caproate in the presence or absence of DTT. This 
treatment caused a partial dissociation of the parent His-P2X1 receptor and the 
respective cysteine minus mutants into the monomer and dimer of apparent masses 
similar to 80 kD and 180 kD, respectively, indicating that the non-denatured 240 kD 
protein bands observed must be homotrimers (Fig 3.44 A and B). 
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Fig. 3.43: BN-PAGE analysis of cysteine minus mutants. Oocytes injected with 25 ng of the 
indicated cRNAs were metabolically labeled by overnight incubation with [
35S]methionine. After an 
additional 24 h chase interval, digitonin extracts were prepared. The parent His-P2X1 receptor and the 
various cysteine mutants were isolated by Ni
2+-NTA chromatography, and after native elution resolved 
by blue native PAGE (4 –10% acrylamide gradient gel) followed by autoradiography. (B) Shown are 
samples from a second independent experiment, in which a BN-polyacrylamide gel (4 –10% 
acrylamide gradient gel) was autoradiographed for 10 days to make the cysteine minus mutants ∆ C7 
– ∆ C10 visible. C in lane 1 indicates samples from non-injected control oocytes. 
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Fig. 3.44: Oligomeric state of the cysteine minus mutants ∆∆∆∆ C1 - ∆∆∆∆ C6, and ∆∆∆∆ C11. Oocytes injected 
with 25 ng of the indicated cRNAs were metabolically labeled by overnight incubation with 
[
35S]methionine. After an additional 24 h chase interval, digitonin extracts were prepared. The parent 
His-P2X1 receptor and the cysteine mutants were isolated by Ni
2+-NTA chromatography and eluted 
under non-denatured conditions. Proteins were analyzed by blue native PAGE (4 –13% acrylamide 
gradient gel) either without further treatment or after incubation with blue native sample buffer in the 
presence or absence of 100 mM DTT at 37°C for 60 min. C in lane 1 indicates samples from non-
injected control oocytes. 
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3.3.2.3. Analysis of cell surface expressed P2X1 receptor mutants lacking two 
or three cysteine residues 
 
In view of the strong conservation of all cysteine residues, the apparently unimpaired 
surface-appearance of homotrimeric P2X1 receptors lacking individual cysteine 
residues was unexpected. Therefore, additional mutants were generated lacking two 
or three of the proximal 6 cysteine residues in various combinations to examine 
whether these mutations affected cell surface appearance and function. Remarkably, 
also these mutants appeared at the cell surface, as revealed by surface radio-
iodination combined with Ni
2+-NTA agarose chromatography and SDS-PAGE. 
Mutants lacking two or three cysteine residues migrated with apparent masses of 57 
kD. Endo H treatment reduced the molecular mass of the cysteine double mutants 
∆ C1+6, ∆ C2+5, ∆ C3+5, and ∆ C2+4 by 8 kD (Fig. 3.45. A-C), consistent with the 
removal of three high mannose type carbohydrate side chains. An 8 kD shift was 
also observed for the parent His-P2X1 subunit and all the cysteine single mutants 
(Fig. 3.42 A and B). A 3 kD larger shift to 47 kD was produced by PNGase F 
treatment, indicating that these cysteines minus mutants acquire a single complex-
type carbohydrate side chain during transit of the Golgi apparatus. 
The molecular masses of the 
125I-labeled cysteine double mutants ∆ C2+3, 
∆ C3+4, ∆ C4+5, ∆ C5+6 and all the cysteine triple mutants (∆ C1+2+6, ∆ C2+3+4 and 
∆ C2+4+5) were reduced by 6 kD only upon Endo H treatment, whereas PNGase F 
treatment induced a 10 kD shift to 47 kD. This observation suggests that these 
cysteine minus mutants carry four N-linked oligosaccharide side chains like the 
parent His-P2X1, yet that the mutants acquired two instead of one complex type 
carbohydrates in the Golgi. This result can best be reconciled with a change of 
structural conformation induced by the removal of the respective cysteine residues, 
leading to access of one additional N-glycan for the Golgi enzymes responsible for 
attachment of complex type carbohydrates (Fig. 3.45 A-C). 
 
 
 
 
 
 
 3. Results      
 
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.45: Glycosylation status of surface iodinated cysteine double and triple mutants. 
Oocytes injected with 25 ng of cRNA for His-P2X1 or the indicated cysteine minus mutants were left 
for 3 days at 19°C and then labeled with membrane-impermeant 
125I-sulfo-SHPP. The proteins were 
purified by Ni
2+-NTA chromatography from 1% digitonin extracts of oocytes, and eluted with non-
denaturing elution buffer. Aliquots of these samples were supplemented with SDS sample buffer, 20 
mM DTT, and treated with Endo H or PNGase F as indicated. After treatment, proteins were resolved 
by SDS-PAGE (8% acrylamide) followed by autoradiography. C in lane 13 indicates samples from 
non-injected control oocytes. 
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3.3.2.4. BN-PAGE analysis of P2X1 mutants lacking two or three cysteine   
   residues 
 
Upon surface labeling, all cysteine minus mutants lacking two cysteine residues 
appeared as one single band at about 240 kD when analyzed by BN-PAGE 
(Fig.3.46, lanes 1-9). The mutants were present at the plasma membrane and 
exhibited a mobility that corresponded to the migration observed for the parent His-
P2X1 receptor (lane 10). Apparently, elimination of two cysteine residues from the 
first cysteine rich domain of the extracellular region of the rat P2X1 receptor does not 
influence the assembly of the respective minus mutants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.46: BN-PAGE analysis of cysteine mutants lacking two cysteine residues. Oocytes 
injected with 25 ng of the indicated cRNAs were left for 3 days at 19°C and then labeled with 
125I-
sulfo-SHPP. Parent His-P2X1 and the various cysteine mutants were isolated by Ni
2+-NTA 
chromatography, and after native elution resolved by blue native PAGE (4–10% acrylamide gradient 
gel) followed by autoradiography. C in lane 11 indicates samples from non-injected control oocytes. 
Shown are samples from independent experiments, in which the digitally scanned autoradiograms of 
respective protein bands were joined together using the software Paint Shop Pro 5. Samples from the 
lanes 1, 2, 6, and 7, and lanes 8 through 11, and lanes 3 and 4 were from identical experiments, 
respectively.  
 
 
To determine the number of subunits incorporated into the defined 240 kD 
proteins detected by BN-PAGE, the various surface-expressed mutants lacking two 
cysteine residues were treated with DTT to induce a partial dissociation of the 
protein complex. Fig. 3.47 A shows that this treatment of the cysteine minus mutants 
∆ C2+4 (lanes 3 and 4), ∆ C3+4 (lanes 6 and 7), ∆ C4+5 (lanes 9 and 10), and ∆ C2+3 
(lanes 12 and 13) led in each case to the appearance of two additional bands, 
corresponding to the monomer at ~80 kD, and the intermediate dimer at ~170 kD 
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besides the non-dissociated 240 kD complex. These results indicated that these 
cysteines minus mutants are inserted into the plasma membrane as trimeric 
complexes like the parent His-P2X1 receptor. Identical results were obtained for the 
cysteine minus mutants lacking three cysteine residues (∆ C1+2+6, ∆ C2+3+4, and 
∆ C2+4+5). When a partial dissociation was induced by DTT, the non-dissociated 240 
kD complexes were also dissociated into the monomer and dimer of apparent 
masses similar to 80 kD and 180 kD, indicating that the non-denatured 240 kD 
protein bands of the mutants ∆ C1+2+6 (Fig. 3.47 B, lanes 3 and 4), ∆ C2+3+4 (lanes 
6 and 7) and ∆ 2+4+5 (lanes 9 and 10) must be homotrimers. 
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Fig. 3.47: Oligomeric state of the cysteine minus mutants lacking two or three cysteine 
residues. Oocytes injected with 25 ng of cRNA for His-P2X1 or the indicated cysteine minus mutants 
were left for 3 days at 19°C and then labeled with 
125I-sulfo-SHPP. The parent His-P2X1 receptor and 
the cysteine mutants were isolated by Ni
2+-NTA chromatography and eluted under non-denatured 
conditions. Proteins were analyzed by blue native PAGE (4 –13% acrylamide gradient gel) either 
without further treatment or after incubation with 100 mM DTT in the presence of blue native sample 
buffer at 37°C for 30 or 60 min. #, contaminating protein not observed in other experiments (cf. A, 
lane 2; B, lanes 5 and 8). C in lane 1 indicates samples from non-injected control oocytes. Shown are 
samples from independent experiments, in which the digitally scanned autoradiograms of respective 
protein bands were joined together using the software Paint Shop Pro 5. 
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3.3.2.4. Functional analysis of P2X1 receptor mutants lacking one, two, or three 
cysteine residues 
 
The conservation of the extracellular cysteines among all the members of P2X 
receptor family suggests the potential importance of the corresponding cysteine 
residues in the function of P2X subunits. To verify this hypothesis, the cysteine 
minus mutants were expressed in Xenopus oocytes. Subsequently, current 
responses to 30 mM ATP at -40 mV were recorded to examine whether the 
elimination of particular cysteine residues affect the expression level of functional 
P2X1 receptors. Like the parent P2X1 receptor, the cysteine minus mutants ∆ C1-∆ C6 
exhibited large ATP-gated currents, indicating that no particular cysteine residue 
from this domain is essential for receptor function (Fig. 3.46). There are, however, 
marked positional effects of the cysteine substitution from this region. While the 
cysteines at C1, C2, and C6 were without significant effect on the expression level of 
functional receptors, elimination of the cysteines at C3, C4, and C5 resulted in a 30-
60% decrease of the current response (Fig. 3.48). In contrast, currents recorded 
were markedly decreased to near undetectable levels for oocytes expressing the 
cysteine minus mutants ∆ C7-∆ C10 (Fig. 3.48). The possible mechanisms which 
could explain the decreased cell surface expression of the these cysteine mutants 
are a complete blockade of routing to the cell surface by misfolding during 
translation, as also revealed by the SDS-PAGE analysis after Endo H treatment of 
the minus mutants, implying a crucial role of this cysteine (C6-C10) containing 
domain for protein assembly and stability. 
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Fig. 3.46: Comparison of maximum inward current responses generated by parent P2X1 and 
cysteine minus mutants. Oocytes were injected with 23 ng of the indicated cRNAs. After 3 days at 
19°C, currents were activated at a holding potential of -40 mV by 30 mM ATP, which elicits maximum 
responses at parent His-P2X1 and each mutants. Currents were normalized to the response of the 
parent His-P2X1 receptor. Data are given as means ±  S.E. from 20–48 oocytes per column of two to 
six experiments with 6–10 oocytes per experimental condition. The experiment was performed by Dr. 
Jürgen Rettinger. 
 
 
3.3.2.4.1. Effects of cysteine substitution on ATP concentration response of 
P2X1 Receptors 
ATP evoked concentration-dependent P2X1 receptor-mediated currents from parent 
receptors with an EC50 value of 0.8 µM (Rettinger et al., 2000) (Fig. 3.49). The ability 
of ATP to evoke functional responses, its potency, is the result of two steps: 1) the 
binding of ATP to the receptor (affinity) and 2) the ability of bound ATP to open the 
ion channel (efficacy) (Ennion et al., 2000). Therefore, in the present study, it is 
referred to the potency of ATP and can only make inferences about the effects of the 
mutations on the affinity of ATP for the receptor. Point mutants at conserved cysteine 
C1, C2, C4, C6 had only a small (2-3-fold) decrease in ATP potency. However, when 
the cysteine residue C3 was removed, the potency was decreased by 5-fold, and 
even a 10-fold decrease was observed for the Mutations at C5.  
  Additionally, various double and triple mutants originated from cysteines C1 – 
C6 were measured after expression in oocytes to verify their effect on the EC50 for 
ATP (Fig 3.49). While no EC50 value could be assessed for the cysteine mutants 
∆ C12, ∆ C13, ∆ C14, ∆ C15, ∆ C36, ∆ C46, ∆ C126, due to a substantial decrease in cell 
surface expression, double and triple mutations of the most other cysteine residues 
wt C1 C2 C3 C4 C5 C6 C7 C8 C9 C10
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
single_mut_expr-all.OPJ
no response
N
o
r
m
a
l
i
z
e
d
 
c
u
r
r
e
n
t3. Results      
 
120 
led to an 15–50-fold decrease in ATP potency at the P2X1 receptor. For most double 
cysteine mutants, so far measurable, the ATP potency was markedly decreased in 
comparison to their respective cysteine single mutants. This observation was not 
made for three cysteine double mutants only. The minus mutants ∆ C16, ∆ C24, ∆ C35 
showed a small (2-3-fold) decrease in ATP potency like that observed for the single 
minus mutants. These data indicate that the C1 and C6 in on the one hand and the 
C2 and C4 in on the other hand as well as C3 and C5 participate in the formation of 
three different disulfide bridge of this domain of P2X1 subunit. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.49: Comparison of ATP potency between parent His-P2X1 and cysteine minus mutants. 
ATP dose-response curves were elicited at holding potential -40 mV from oocytes injected 3 days 
earlier with 23 ng of cRNA for parent His-P2X1 or the indicated cysteine minus mutants. Currents 
were elicited by the respective ATP concentration in 1-min intervals. Continuous lines represent least 
squares fits of he Hill equation to the data points, yielding EC50 values for parent His-P2X1 and 
cysteine minus mutants. The experiment was performed by Dr. Jürgen Rettinger. 
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4. Discussion 
 
 
4.1. Investigation of P2X receptors after expression in Xenopus oocytes 
 
 
4.1.1. Homomultimeric assembly of P2X receptors after expression in Xenopus 
oocytes 
 
The most common methods used to assess the expression of fully assembled ion 
channels are either the electrophysiological assay or flux measurements (for reviews 
see Sheng & Deutsch, 1998). In the present study, P2X receptor assembly was 
assayed by BN-PAGE analysis after metabolic labeling of Xenopus oocytes injected 
with the respective cRNA for the P2X constructs. By first pulse-labeling the subunits, 
and then chasing the labeled subunits, folding and oligomerization of P2X subunits 
was assayed by subjecting the purified proteins to blue native PAGE (Schägger & 
von Jagow, 1991). Alternatively, Xenopus oocytes injected with the respective cRNA 
for the P2X subunits were surface-labeled using 
125I-sulfo-SHPP prior to the BN-
PAGE. The radio-iodination method has the advantage that only completely 
assembled proteins are labeled that are at the cell surface, i.e. the same proteins 
that are amenable to electrophysiological analysis. These investigations provide 
strong evidence for a trimeric architecture of the homomultimeric His-P2X2, and His-
P2X5 receptors. The results obtained by BN-PAGE analysis could be corroborated 
by chemical cross-linking using glutardialdehyde. The observations made are in 
agreement with the results obtained by Nicke et al. (1998), who were the first to 
describe a trimeric architecture for His-P2X1 and His-P2X3 receptors. By 
investigating single channel properties of the P2X2 receptor, Ding & Sachs (1999) 
found that the channel proceeds through three ATP binding steps before opening 
and that the three ATP binding sites are not independent, but positively cooperative, 
supporting the view for a trimeric structure for this receptor. In contrast, Kim and 
coworkers (1997) suggested a tetrameric structure for the extracellular domain of 
P2X2, which was purified from bacteria. However, a proper folding of the extracellular 
domain of the P2X2 subunit appears to be rather unlikely, since Torres (Torres et al., 
1999) showed that the transmembrane domains in addition to the extracellular 
domain are critical for productive P2X subunit assembly. 4. Discussion      
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The P2X receptors that were investigated by BN-PAGE migrated 
quantitatively as trimers when extracted with digitonin and purified by Ni
2+-NTA 
agarose chromatography. Nevertheless, beside trimers also protein bands of higher 
molecular masses were observed that corresponded in size to hexamers (P2X1 and 
P2X2) or even nanomers (P2X2), when resolved by BN-PAGE. These observations 
may be interpreted to show that P2X receptors are complexes of six identical 
subunits. Recently, Surprenant and coworkers identified by using BN-PAGE and 
Western blotting that native P2X7 receptors from peritoneal macrophage and bone 
marrow cells exist as hexa- or nanomeric complexes (Kim  et al., 2001). Under 
physiological conditions, the assembly of P2X receptors into larger complexes might 
be a possible mechanism for the formation of large pores observed upon repeated 
stimulation of P2X7 or P2X2 with ATP (for P2X7 see Klapperstück et al., 2000; for 
P2X2 see Virginio et al., 1999), as initially suggested by Nicke et al. (1998). 
Dissociation of hexameric complexes into trimeric complexes could be a possible 
mechanism for the known long lasting desensitization of some P2X subtypes. In 
addition, it may be considered that digitonin which was used to solubilize 
membranes is unable to preserve weak protein-protein interactions, such that an 
actually hexameric P2X2 receptor dissociates into two trimeric complexes, which by 
themselves are rather stable. However, from the observation that hexamers became 
more abundant when P2X receptors were extracted with octylglucoside or 
dodecylmaltoside, it was concluded that the hexamers represent aggregates of two 
trimers rather than authentic hexamers of P2X trimers (Nicke et al., 1998).  
 
 
4.1.2. Role of carboxyl-terminal domain for the assembly of the P2X2 receptor 
 
In an additional study, the role of cytoplasmic domains of P2X2 in subunit assembly 
was investigated. Since a previous study had already ruled out the amino-terminal 
domain as being critical for assembly (Torres et al., 1999), this investigation was 
restricted to the carboxyl terminus. To biochemically investigate the role of this 
region in P2X2 receptor assembly, a deletion mutant of the His-P2X2 receptor 
subunit was constructed, designated His-P2X2
1-409 lacking the uttermost 63 C-
terminal amino acids by introducing a stop codon behind 
409G. The investigation of 
the metabolically labeled deletion mutant after expression in oocytes revealed that, 
like full length His-P2X2 subunit, the C-terminally truncated mutant failed to fully 4. Discussion      
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assemble and that part of this protein was located intracellularly as aggregates. 
However, surface radio-iodination of oocytes expressing this His-P2X2 deletion 
mutant revealed that the deletion mutant, like the parent P2X2 receptor, was 
detectable on the surface of Xenopus oocytes. His-P2X2
1-409 migrated as a distinct 
protein band like the parent P2X2 receptor when resolved by BN-PAGE, but with a 
lower apparent molecular mass of about 270 kD (Fig 3.7). This protein band 
corresponded in size approximately to the size of the protein band detected for the 
His-P2X1 complex on the BN-PAGE. Since both proteins consist of approximately 
the same number of amino acids, this observation indirectly suggests that the P2X2
1-
409 mutant receptor exists also as a trimer. The fact that this carboxyl-terminal mutant 
was detected on the cell surface indicate that it retained the ability to form 
homomultimers. This result therefore provides direct evidence that the intracellular 
carboxyl-terminal tail of P2X2 is not absolutely required for subunit assembly. The 
P2X2 deletion mutant was not studied by electrophysiological techniques, yet it was 
reported by other laboratories that removal of the entire intracellular carboxyl-
terminal domain did not result in loss of channel function (Torres et al., 1999). The 
P2X2 C terminal tail consists of a proline-rich site with similarity to a consensus SH3 
binding domain. This may provide a functional role for the P2X2 such as directing 
subcellular localization, as has been shown for a similar region of the epithelial 
sodium channel (Rotin  et al., 1994). Association of P2X receptors with cellular 
proteins has been suggested in a study that examined an effect of the state of the 
actin cytoskeleton on P2X1 receptor function (Parker, 1998). Phosphorylation of the 
P2X2 receptor C terminal tail has also been implicated in the control of its function 
(Chow & Wang, 1998).  
 
 
4.1.3. Heteropolymerization of P2X1 and P2X2 subunits in Xenopus oocytes 
 
A novel and interesting finding of this study is that the P2X1 and P2X2 subunits can 
exist as heteromultimeric protein complexes in the plasma membrane of Xenopus 
oocytes. In all of the surface-labeling experiments employing 
125I-sulfo-SHPP, 
hetero-oligomeric P2X1 and P2X2 receptors were detected, directly demonstrating a 
physical interaction between P2X1 and P2X2 subunits. Purification of surface-
expressed His-P2X2 on nickel-binding agarose beads under non-denaturing 
conditions allowed the co-purification of co-expressed non-tagged P2X1 subunits. 4. Discussion      
 
124 
Likewise, His-P2X1 showed detergent-stable association with P2X2 subunits. These 
protein-protein interactions were sufficiently strong, and were detected only when 
cells were surface labeled. When lysates from radio-iodinated cells expressing either 
subunit were mixed, no interaction was detected, suggesting that the interaction on 
the cell surface was the result of specific co- or posttranslational processing 
mechanisms and not the result of random interactions within the plasma membrane. 
Surprisingly, when co-assembly was assayed in metabolically labeled oocytes, no 
interaction was detected. One possible reason for this finding can be that the 
interaction of the two subunit isoforms is stable only when the subunits are in the 
plasma membrane of the cells and thus only detectable when the receptors have 
reached the surface of the cell. 
Incubation with the bifunctional reagent glutardialdehyde led to the cross-
linking of P2X2 and P2X1 subunits to dimers and trimers. Interestingly, the cross-
linked heteromultimeric complexes migrated in between the dimeric and trimeric 
protein bands observed for the respective homomultimeric complexes, as expected 
for chemically cross-linked P2X1 and P2X2 subunits. Analysis of P2X2/P2X1 receptor 
complexes by blue native PAGE yielded results that are consistent with the cross-
linking experiments. BN-PAGE analysis of the P2X2/P2X1 complex isolated under 
non-denaturing conditions from surface-labeled oocytes yielded one distinct band 
corresponding to a trimeric complex, as also observed for homomultimeric P2X2 and 
P2X1 receptors. The band for the heteromultimeric complex migrated in between the 
trimeric protein bands obtained for homomultimeric His-P2X1 or His-P2X2 receptors, 
as expected for a heterotrimer consisting of 56 kD P2X1 subunits and the 66 kD 
larger P2X2 subunits. Treatment with urea prior to BN-PAGE induced the partial 
dissociation of the complex, yielding bands corresponding to dimers and monomers 
of P2X1 and P2X2 subunits. Physical interactions of the subunits were further 
investigated by SDS-PAGE analysis of the partially dissociated His-P2X2/P2X1 
complex in the second dimension, leading to a complete dissociation of the protein 
complexes observed in the BN-PAGE. The partial dissociation of heteromultimeric 
complex induced by urea treatment and the complete dissociation observed by 
denaturing SDS in the second dimension indicated that the association of both 
subunits is in a non-covalent manner as also observed for homomultimeric His-P2X1 
and His-P2X2 receptors.  
Although the investigations showed the interaction of both subunits, the 
analysis failed to reveal the ratio of the subunits in the assembly of the observed 4. Discussion      
 
125 
phenotype. By mixing different concentrations of P2X1 and P2X2 cRNAs prior to 
injection, it was intended to vary the subunit stoichiometry of the two subunits that 
form the heteromultimeric complex. Unfortunately, this investigation failed to give an 
appropriate result. Even when the cRNA coding for His-P2X2 was injected with a 
concentration hundred times less than the concentration for cRNA coding for His-
P2X1, a significant higher amount of His-P2X2 protein than of His-P2X1 protein was 
detected on the surface of radio-iodinated oocytes when analyzed by BN-PAGE.  
The results suggested that P2X1 and P2X2 receptor subunits could form 
hetero-oligomeric assemblies that exist as trimeric complexes, properties that might 
have important influences on the characteristics of ATP signaling. Thus, extension of 
the biochemical experiments to functional studies is needed in order to determine the 
physiological significance of P2X1/P2X2 subunit co-assembly. In situ hybridization 
studies suggested that different P2X1 and P2X2 receptor subunits are co-expressed 
in the same tissues and may be co-localized to the same cells (Lewis et al., 1995, 
Nori  et al., 1998). In a paper by Lewis et al. (1995), it was reported that co-
transfection of HEK 293 cells with of rat P2X1 and P2X2 cDNA did not lead to the 
formation of receptors with novel phenotypes, suggesting that the subunits did not 
co-assemble. Although in the present investigation no evidence for distinct function 
can be provided, the results indicate co-assembly of the subunit pair P2X1 and P2X2. 
The lack of a novel phenotype does not necessarily mean that two subunits do not 
interact to form a hetero-oligomeric channel complex. When two receptor subunits 
participate to form a complex, one subunit type can dominate the phenotype of the 
resulting channel, and thus only a single phenotype is observed. This phenomenon 
is observed in the ionotropic glutamate receptor family, where the presence of the 
GluR-β  subunit dominates hetero-oligomeric receptor assemblies with regard to both 
rectification and calcium permeability properties (Seeburg, 1993). Even if there is no 
significant effect on the biophysical phenotype of a receptor, heteromultimeric 
assembly could still have important impact on receptor function; e.g., by altering the 
responsiveness of a complex to intracellular regulation. 
The first study examining P2X co-assembly was for P2X2 and P2X3 subunits, 
which were shown to form a hetero-oligomeric channel with a novel phenotype when 
co-expressed in HEK 293 cells (Lewis  et al., 1995). The phenotype for the 
heteromultimeric receptor correlated well with the receptors described in some 
sensory neurons, where the two proteins are co-expressed, suggesting that this 
subunit interaction occurred in the native cells as well. Additional evidence for 4. Discussion      
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hetero-oligomeric assembly of P2X subunits was shown by Le  et al.  (1998), 
providing functional evidence for a channel formed between P2X4 and P2X6 
subunits, and furthermore, it was reported that the co-expression of P2X1 and P2X5 
subunits also resulted in a channel with a novel phenotype (Torres et al., 1998). 
Hetero-polymerization of channel subunits has been suggested as a means of 
generating functional and molecular diversity (Green & Millar, 1995). Indeed, the 
formation of heteromultimeric channels has been demonstrated for many members 
of the transmitter-gated ion channel family such as nicotinic receptors (Ragozzino et 
al., 1997; Yu & Role, 1998) and ionotropic glutamate receptors (Boulter et al., 1990). 
 
 
4.1.4. Investigation of P2X6 after expression in Xenopus oocytes  
 
In the present study, the homomultimeric (P2X1, P2X2, P2X5) and heteromultimeric 
assembly (P2X1 with P2X2) of various P2X receptor subunits after expression in 
Xenopus oocytes was investigated. A lack of functional expression was observed for 
the P2X6 receptors that were synthesized in oocytes. This result can be explained by 
the inability of the P2X6 subunits to form a homomultimeric receptor complex. As 
demonstrated by BN-PAGE analysis of His-P2X6 after metabolic labeling with 
[
35S]methionine, the His-P2X6 protein migrated as an amorphous aggregate rather 
than a protein complex of well-defined stoichiometry and failed to exit the ER. The 
results reported in the present work are in agreement with findings from two other 
laboratories that have examined expression of the P2X6 subunit using Xenopus 
oocytes (Le et al., 1998; Soto et al., 1996). These findings are in contrast to the 
report describing that the homomultimeric P2X6 receptor desensitizes only slowly 
and does not respond to αβ -met-ATP when heterologously expressed in HEK 293 
cells (Collo et al., 1996). The observed lack of assembly and function suggests that 
differences in the source of cells can influence some cellular features that are crucial 
for the homomultimeric assembly of these subunits. Such factors may play an 
important role for the regulation of functional P2X receptor formation in different cell 
types and/or tissues. 
For the P2X subunits abundunt in the CNS (namely P2X2, P2X4, and P2X6), 
epitope-tagged P2X2 and P2X6 subunits or P2X4 and P2X6 subunits have been 
shown to form heteromultimeric receptors (Collo et al., 1996). In addition, the 
functional properties of the P2X4/6 heteromers (Le  et al., 1998) and P2X2/6 4. Discussion      
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heteromers (King et al., 2000) have been examined, and their phenotype has been 
characterized. The finding that P2X6 subunits can co-assemble into heteromultimeric 
complexes with other P2X subunit isoforms but not with itself, suggests that P2X6 
subunits play a regulatory role within heteromultimeric assembly, similar to the role 
played by the ß and γ  subunits of the epithelial sodium channel (Canessa et al., 
1994; Cheng et al., 1998), or the ß subunit of the inhibitory glycine receptors (Kuhse 
et al., 1995) 
 
 
4.1.5. Factors that regulate assembly and folding of P2X receptors 
 
The assembly of P2X receptors shares many features with other proteins produced 
in the secretory pathway. A large variety of membrane proteins have been studied 
including viral envelope proteins (Hammond & Helenius, 1995). It has been shown 
that particular mechanisms exist, which support the folding and assembly of proteins 
formed in the secretory pathway. To begin with, mRNA is linked to the ER 
membrane where assembly starts. The early assembly events occur 
cotranslationally. When the polypeptide chains are inserted into the membrane, the 
core N-linked glycans are attached to them, and the initial rapid folding takes place. 
These cotranslational events are followed by slower folding reactions where different 
domains interact and the disulfide bonds are arranged. This posttranslational folding 
and processing takes place in the ER and is a requirement for subunit 
oligomerization, which provides “quality control” by identifying and degrading any 
misassembled proteins (Hurtley & Helenius, 1989; Helenius et al., 1992; Kopito, 
1997). Most likely, the same mechanisms apply also to P2X receptors. In the present 
study it was shown that the posttranslational modification of P2X receptor subunits, 
namely  
attachment of N-linked glycans and disulfide bond formations are crucial for proper 
oligomerization of P2X receptors. 
For intracellular degradation of membrane proteins currently two systems are 
known, a vacuolar system including lysosomes (Mortimore et al. 1983; Urade & Kito 
1992; Dunn 1994), and a cytoplasmic system involving ubiquitin and proteasomes 
(Hershko & Ciechanover, 1992; Bonifacino & Weissman, 1998). It has been 
described that cells degrade various materials such as internalized ion channels 
(Silverstein  et al., 1977) by the vacuolar system. In addition, in the cytoplasmic 4. Discussion      
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system, secretory and membrane proteins (Ellgaard et al., 1999) are degraded by 
proteasomes, by which differential turnover of the proteins is controlled (Rechsteiner 
1987; Hershko & Ciechanover 1992; Rivera et al., 2000). Many proteins that are not 
correctly folded or misassembled in the ER are polyubiquitinated and degraded in 
this pathway by a process known as ER-associated degradation (Haas & Siepmann 
1997; Kopito 1997; Sommer & Wolf 1997; Ellgaard et al., 1999). These mechanisms 
of degradation are likely to be used by Xenopus oocytes expressing N-glycan or 
cysteine minus mutants of P2X1 receptor. As was shown in this study, many of these 
mutants failed to fully assemble into functional receptors and the amount of the 
isolated protein was markedly decreased compared with the wild type receptor. 
Some nicotinic receptors are correctly assembled only in cells of neuronal 
origin containing additional factors (Cooper & Millar, 1997; Rangwala et al., 1997). 
Chaperone proteins are likely to be some of the cellular factors required for 
assembly. The ER chaperone proteins BiP (Blount & Merlie, 1991; Paulson et al., 
1991; Forsayeth et al., 1992) and calnexin (Gelman et al., 1995; Keller et al., 1996, 
1998) associate with unassembled AChR subunits and may directly aid the 
assembly process. Furthermore, NSF and SNAPS associate with AMPA receptors in 
the dendrites of hippocampal pyramidal cells (Osten et al., 1998) and appear to 
function as “chaperones” that are required for channel function or recycling 
(Nishimune et al., 1998). 
 
 
4.1.6. Methods used to investigate the quaternary structure of P2X receptors  
 
4.1.6.1. Cross-linking of P2X receptors  
 
Using the potent cross-linker glutardialdehyde, purified His-P2X1, His-P2X1-GFP, 
His-P2X2 receptors, and the P2X2/P2X1 complexes of surface-labeled, intact oocytes 
could be cross-linked to dimers and trimers. It is assumed that glutardialdehyde via 
its aldehyde groups forms Schiff bases with lysine residues leading to the cross-
linking of the subunits. However, cross-linking could not exclude the existence of 
complexes higher than a trimer, because the cross-linking reaction was not very 
efficient. Increasing the concentration of glutardialdehyde or the incubation time led 
to a decrease of the amount of isolated protein. A possible explanation is the 4. Discussion      
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formation of non-specific aggregates at high concentrations of the cross-linker, which 
inhibited the accessibility of respective hexa-histidyl tag to the Ni
2+- agarose beads. 
 
 
4.1.6.2. Biochemical analysis of the P2X receptor complexes by BN-PAGE  
 
Using polyacrylamide gel electrophoresis, proteins can be separated depending on 
their net charge and their size as well as on the density of the acrylamide gel. In the 
present study, two electrophoresis methods, SDS-PAGE and BN-PAGE were 
applied to biochemically explore the proteins isolated from Xenopus oocytes. Both 
methods are “charge shift methods”, in which the individual proteins receive 
additional negative charges by binding of SDS or Coomassie blue G in case of SDS-
PAGE or BN-PAGE, respectively.  
  In the SDS-PAGE system, the detergent SDS unfolds proteins and forms 
SDS/protein micelles. Thereby the intrinsic charges of the proteins are masked by 
SDS and an excess of negative charges is conferred to them, such that the 
charge/mass ratio becomes roughly constant for most proteins. Therefore, SDS-
PAGE allows for the determination of the molecular mass of migrating proteins, 
because the charge density is almost equal for all proteins, thus separation of the 
proteins depends only on the effective molecular radius, which approximates the 
relative molecular mass. In the BN-PAGE system, Coomassie dye binds to 
hydrophilic segment of the protein exterior and is believed to have no dissociating 
effects to bound proteins (Schägger & von Jagow, 1991). The capability of binding 
Coomassie dye and therefore the charge densities vary between different proteins 
(Schägger, Cramer & von Jagow, 1994). In the BN-PAGE system, the separating 
principle is the molecular sieving effect of a polyacrylamide gel within a relatively 
steep acrylamide gradient. The molecular masses of proteins are determined at their 
individual end points of migration corresponding to the acrylamide concentration, 
where they reach their pore edge. Schägger demonstrated that a calibration curve 
can be established from migration distances in BN-PAGE and known molecular 
masses of various soluble and membrane proteins (Schägger, Cramer & von Jagow, 
1994). Since appropriate membrane proteins of known molecular mass were not 
available, a set of water-soluble proteins (ferritin, catalase, aldolase, bovine serum 
albumin and ovalbumin) was utilized in the present study as molecular weight 
standards for BN-PAGE. Using these proteins as references, BN-PAGE analysis of 4. Discussion      
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all P2X complexes revealed apparent masses of approximately 250-450 kD, far 
higher than the calculated molecular masses of trimers, which should be in the range 
of 170-230 kD. This discrepancy might be due to one or more of the following 
reasons. Generally, the following conditions must be fulfilled to allow for 
determination of molecular masses by BN-PAGE: the protein must either have an 
isoelectric point (IP) at or below 5.4 or it must be able to bind Coomassie blue G and 
have an IP below 8.6 (Schägger, Cramer & von Jagow, 1994). Since most P2X 
complexes are rather basic (IP of the rat P2X1 polypeptide: 8.54), the charge shift 
introduced by Coomassie dye could be insufficient, thus leading to a particularly low 
electrophoretic mobility and a comparably long electrophoresis time until the end 
point of migration is reached. The same effect would occur if the P2X proteins were 
unable to bind enough Coomassie dye to induce an adequate charge shift.  
The apparent molecular masses of the BN-PAGE separated P2X complexes 
might not be those of the pure glycoproteins, but of complexes including detergent. 
Moreover, since protein complexes are considered to remain in their native state 
during BN-PAGE, the shape of the P2X receptors could influence its hydrodynamic 
properties: for example a tightly folded globular protein would exhibit a greater 
electrophoretic mobility than a funnel shaped ion channel. In addition, the N-glycans 
exert a small effect on the mobility of the P2X receptors as shown by the slightly 
faster migration of glycan minus mutants of the His-P2X1 receptor. 
 
 
4.1.7. Identification of regions that regulate desensitization of P2X receptors 
 
Desensitization can be removed from the P2X1 or P2X3 receptor by replacing the 
cytoplasmic N-terminal domain including parts of the first transmembrane domain 
with corresponding parts of the domain from P2X2 receptor (Werner et al., 1996). 
The domains play a role in P2X receptor desensitization include the most 
hydrophobic segments of the molecules, which are known to be membrane-spanning 
segments. However, they additionally include segments of 11–15 amino acids that 
are located at the immediate cytoplasmic side of the membrane; these segments 
have an abundance of positively charged residues, as is commonly found in such a 
location (von Heijne, 1992). Although these regions were not systematically 
shortened or mutated, it appears from the results that the first charged region (pre-
M1) of P2X2 is needed for desensitization of P2X1 or P2X3. The amino acid 4. Discussion      
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sequences of the first transmembrane domains of the three receptors P2X1, P2X2 
and P2X3  are compared in Fig. 4.1; they are 26–48% pairwise identical and the 
positions of all positively charged amino acids are highly conserved. This aligment 
does not imply that single amino acid substitutions might not have effects on 
desensitization, but it makes it unlikely that a difference in one or a few amino acids 
could account for the large differences between P2X1 and P2X2. In homomultimeric 
α 7 nicotinic AchR and 5-HT3 receptors, mutationally induced changes at a single 
position in the amphipathic M2 (pore-lining) domain can considerably alter the rate of 
desensitization (Revahet al., 1991; Yakelet al., 1993), while glutamate receptors can 
fine-tune their kinetic properties with the help of alternative splicing (Mosbacher et 
al., 1994).  
 
 
 
 
P2X2 
P2X1 
P2X3 
WDYETPKVIVVRNRRLGFVHRMVQLLILLYFVWY 
FEYDTPRMVLVRNKKVGVIFRLIQLVVLVYVIGW 
FTYETTKSVVVKSWTIGIINRAVQLLIISYFVGW 
 
 
 
Fig. 4.1: The domains required for desensitization are the same in P2X3 and P2X1 receptors. 
Domains required to transfer desensitization include the hydrophobic, presumed first membrane-
spanning domain (M1) and 11–15 residues of the cytoplasmic region. Identical amino acids are 
indicated by shaded boxes. 
 
  
The alteration of the desensitization of the wild-type P2X1 receptor by 
replacing the cytoplasmic N-terminal domain including parts of the first 
transmembrane domain suggests that it may result from intrinsic conformational 
changes of the receptor protein. The portions of the molecule that are directly 
involved in this conformational change appear not to include the large extracellular 
loop (Werner et al., 1996).  
BN-PAGE analysis of the chimeras revealed a trimeric complex for all 
chimeras, although differences between the acquired types of carbohydrate residue 
have been observed. Like the parent P2X receptors, the chimeras migrated as one 
distinct band that could be partially dissociated into dimers and monomers by 
M1 
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treatment with DTT and/or urea. Thus, a change of desensitization does not have an 
impact to the oligomeric states of the respective chimeras. 
 
 
4.2. Investigation of P2X1-GFP fusion proteins  
 
Expression of a C-terminally GFP-tagged His-P2X1 subunit in oocytes results in 
proteins that migrated quantitatively as trimers when purified in digitonin and 
analyzed by BN-PAGE. In addition, cross-linking of His-P2X1-GFP on intact oocytes 
indicated that the fusion protein exists as a trimer on the cell surface consistent with 
the quaternary structure analysis of the parent His-P2X1 receptor. Moreover, 
electrophysiological measurements showed that the C-terminally GFP-tagged His-
P2X1 receptor exhibits a phenotype similar to the parent His-P2X1 receptor in 
Xenopus oocytes. These results indicated that the GFP tag is functionally silent even 
though it is much larger than most other protein tags and, with 238 amino acid 
residues, has approximately half the size of a P2X1 receptor subunit. Despite this, 
the addition of this relatively large protein to the C-terminus of the His-P2X1 subunit 
does not appear to interfere or alter subunit folding, oligomeric assembly, membrane 
targeting, or the physiological properties of the receptor.  
An N-terminally GFP-tagged His-P2X1 (designated GFP-His-P2X1) subunit 
was also capable of assembling into trimers, as shown by BN-PAGE. However, most 
of the protein was retained in the core-glycosylated form in the ER. Likewise, no 
GFP-His-P2X1 protein could be detected by surface labeling of oocytes injected with 
the cRNA for N-terminally GFP tagged His-P2X1 and no response to ATP was 
measured when these oocytes were analyzed electrophysiologically. This result 
indicates the importance of an uncapped N terminal domain for routing of the P2X1 
receptor to the plasma membrane. However, elongation of the N terminal domain 
does not seem to have an impact on assembly, as shown by BN-PAGE analysis, but 
rather on routing of the protein complex to the cell surface. 
 
 
4.2.1. Clustering of His-P2X1-GFP receptors 
 
Confocal fluorescence microscopy of oocytes injected with the cRNA for His-P2X1-
GFP revealed small clusters of the fusion protein, approximately 4–6 µm in diameter 4. Discussion      
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in intracellular membranes of Xenopus oocytes. During development of striated 
muscle fibers, small acetylcholine receptor clusters less than 2 µm in diameter 
appear in the membrane independently of the arrival of motor nerves (Phillips et al., 
1985). It seems that there is an intrinsic tendency for receptors to induce the 
formation of clusters and that these clusters are in a size class of 1–6 µm. However, 
once the nerve terminal arrives, such large receptor clusters become confined to 
sites immediately beneath the terminal (Phillips & Bennett, 1987 & 1989). A similar 
restriction of large P2X1 receptor clusters to varicosities has been observed during 
formation of the autonomic neuromuscular junction (Dutton et al., 1999). It is likely 
that a decrease in extra-junctional receptor insertion occurs at the developing 
autonomic junction similar to that observed at the somatic neuromuscular junction. 
 
 
4.2.2. Anchoring of P2X receptors in the membrane 
 
Acetylcholine receptor clustering in striated muscle cells is determined by a 43 kD 
cytoplasmic protein called rapsyn. Rapsyn interacts with each of the α , β , γ , and δ  
subunits to precisely localize them to the postsynaptic membrane of the motor nerve 
terminal (Maimone & Merlie, 1993; Glass & Yancopoulos, 1997; Feng et al., 1998). 
Such a process has been followed in detail by fusing rapsyn to GFP (Ramarao & 
Cohen, 1998). Injection of cRNA encoding AchR subunits together with the RNA for 
rapsyn leads to the formation of receptor clusters of 0.5–1.5 µm in diameter 
(Froehner et al., 1990), i.e. at the lower end of the size range of the P2X1–GFP 
clusters observed in the present study. Another anchoring protein for receptors that 
has been isolated to date is the 93 kD protein gephyrin that clusters glycine 
receptors (Kirsch & Betz, 1998). Whether rapsyn or gephyrin can anchor P2X 
receptors is not yet known. In addition, it is not known whether the clustering of His-
P2X1–GFP observed in oocytes involves an anchoring mechanism. It seems 
possible that this anchor system may involve a clustering agent that is not cell 
specific. This observation is strengthened by data that demonstrate a role for the 
actin cytoskeleton in the control of the turnover of P2X1 receptors following agonist 
exposure (Parker, 1998).  
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4.3. Role of N-glycans for the functional expression and assembly of the rat 
P2X1 receptor 
 
The P2X1 receptor influences its own N-glycosylation at two levels, (i) at the level of 
its primary sequence and (ii) the level of its three-dimensional structure. First, the 
284NLS tripeptide (N4) is not used as a site for N-glycosylation because of a proline 
residue in the +4 position. Replacement by alanine resulted in unimpaired N-
glycosylation at this site. This observation agrees well with previous reports that the 
presence of proline immediately following a sequon can inhibit core glycosylation 
(Gavel et al., 1990; Bause, 1983). A sequon with a proline in +4 position is also 
present on the P2X4 polypeptide, but not on the other P2X isoforms. Second, from 
the four N-glycans that are cotranslationally attached per P2X1 subunit, only the one 
at 
300N (N5) acquires complex-type carbohydrates during passage of the Golgi 
apparatus, whereas the others remain in an Endo H-sensitive form. This observation 
can best be reconciled with constraints imposed by the three-dimensional structure 
of the P2X1 receptor, which apparently restricts the access of individual N-glycans to 
processing by Golgi enzymes. We considered that the restricted accessibility of the 
N-glycans results from a lectin-like subunit interaction. However, present findings 
exclude this possibility, since a P2X1 triple mutant devoid of the three inaccessible N-
glycans (∆ N123) acquired the same homotrimeric configuration like the correctly 
glycosylated parent P2X1 receptor and formed a functional P2X1 receptor at the 
plasma membrane though with low efficiency. 4. Discussion      
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4.3.1. N-glycans and membrane folding of P2X1  
 
The two-dimensional orientation of P2X subunits in the plasma membrane has been 
predicted from hydropathy plots, usage of natural N-glycosylation sites and N-glycan 
scanning mutagenesis studies (Newbolt et al., 1998, Torres et al., 1998). The five 
putative N-glycosylation sites of the P2X1 polypeptide are all located in the predicted 
ectodomain. As noted previously, the demonstration that four of the five natural sites 
are occupied by sugars confirms the membrane topology deduced from hydropathy 
analysis, since N-glycosylation sites occur always on the extracellular portion of a 
protein. Additional important information about membrane folding can be deduced 
from the observation that 
300N (N5) is not only used, but also fully accessible to Golgi 
enzymes to acquire complex type carbohydrates. N5 is located only eight residues 
upstream of the conserved lipophilic domain, which has been postulated to constitute 
a reentry loop immediately before M2 like the H5 domain of K
+ channels and hence 
to contribute to the pore (Brake, 1994). Using a cell-free translation system, it has 
been demonstrated that oligosaccharide transfer occurs only when 12-14 amino 
acids downstream to a sequon have been translocated (Nilsson & Von Heijne, 
1993). The efficient N-glycosylation of N5 and its ready accessibility for Golgi 
enzymes, i.e. within the fully assembled P2X1 receptor argues against a significant 
membrane embedding of this lipophilic domain. The glycan may serve to shield a 
hydrophobic surface at this locus. 
 
 
4.3.2. Positional effects of N-glycans on surface expression of P2X1 receptor  
 
The most proximal glycan (N1) appears to be especially important for high surface 
expression levels of functional P2X1 receptors, whereas N2 and N5 are dispensable 
in this respect. The surprising observation that the expression level of functional 
receptors increased upon elimination of N3 may be correlated with an increased 
number of P2X1 receptors at the plasma membrane, as evident from most though 
not all surface radio-iodination experiments (results not shown), rather than by 
altered receptor function. The mechanism of this increase is not clear yet. The 
peculiar role of the glycan at N3 for ATP potency is discussed below.  
If the modulatory roles of individual N-glycans are neglected, it becomes 
obvious that the elimination of two of the four canonical N-glycosylation sites per 4. Discussion      
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subunit is quite well tolerated. This suggests that the number of N-glycans per P2X1 
subunit is redundant, at least for robust expression. A large decline of the expression 
level occurs only after elimination of three sites per subunit both in terms of 
maximum current amplitudes and receptor protein at the cell surface. Taking the 
trimeric architecture of P2X receptors into account, this means that a total of six N-
glycans are required per receptor complex for robust functional expression. A 
reduction of surface appearance has been observed for the non-glycosylated forms 
of a large variety of glycoproteins, but the mechanisms that account for this 
phenomenon appear to be different. Many non-glycosylated forms of glycoproteins 
accumulate in the ER, aggregate, and do not exit (Helenius, 1994). Others exit the 
ER, but are retained in the Golgi apparatus, apparently because N-linked 
oligosaccharides are required for efficient transport from the Golgi apparatus to the 
cell surface (Gut, 1998). Since non-glycosylated His-P2X1 receptor subunits or 
complexes accumulate neither in the ER nor in the Golgi apparatus, rapid 
degradation soon after synthesis is likely to account for the low functional expression 
levels and low amounts of receptor protein at the cell surface of mutants carrying 
solely one N-glycan. Elimination of all four glycosyl acceptor sites abolished the 
appearance of His-P2X1 at the cell surface. An essential role of N-glycans has been 
also described for the formation of functional P2X2 receptors in HEK293 cells 
(Torres, 1998). This raises the possibility that interaction with lectin-like chaperones 
such as calnexin and/or calreticulin (Trombetta & Helenius, 1998) is crucial at certain 
stages of the folding process and for oligomerization of P2X subunits, for instance by 
providing additional time to allow for productive collisions between P2X monomers. 
Incompletely folded monomers that lack N-glycans as functional tags may no longer 
be retained in the ER and eventually get degraded (Hebert et al., 1996). 
 
 
4.3.3. Conservation of N-glycosylation sites among P2X isoforms  
The four N-glycans of P2X1 are distributed over two thirds of the ectodomain like the 
ten cysteine residues that are assumed to be involved in disulfide formation. In 
contrast to the cysteines, however, which are totally conserved among all P2X 
isoforms, only P2X3 exhibits a N-glycan distribution that overlaps exactly with that of 
the P2X1 subunit. Sequons corresponding to N1 and N2 of P2X1 are present on 4. Discussion      
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almost all isoforms, whereas the sequon corresponding to N5 (N300) is found on 
P2X1-P2X3 only. The number of N-glycosylation sites likely to be used amount to 
three (P2X2, P2X5, P2X6), four (P2X1, P2X3), six (P2X7), and seven (P2X4), i.e. all 
isoforms carry at least three N-glycans. Since only two such sites are actually 
required for robust receptor formation and no particular N-glycan is absolutely 
important, variation in acceptable positions of glycans can occur. Hence, the 
redundancy in the number of N-glycans provides at least a partial explanation for the 
imperfect conservation of the number and positions of N-glycans among the P2X 
isoforms.  
 
 
4.3.4. N-glycans and ligand recognition  
 
Elimination of N-glycans has only occasionally been observed to be associated with 
altered ligand recognition. Lack of N-glycosylation of the glucose transporter GLUT1 
decreased its apparent affinity for glucose (Asano et al., 1993). In contrast, the non-
glycosylated transporter for serotonin (Tate & Blakely, 1994) or norepinephrine 
(Melikian  et al., 1996) like the Na
+/glucose symporter SGLT1 (Wu et al., 1994) 
exhibited no alteration of substrate recognition. Elimination of the four N-
glycosylation sites of the insulin receptor ß subunit did also not affect the affinity for 
insulin, but blocked signal transduction (Leconte et al., 1992). The single N-glycan of 
the human T-cell surface glycoprotein CD2 was first suggested by cell adhesion 
assays to be required for binding of the counter receptor CD58. However, structure 
resolution by NMR revealed that this N-glycan is not directly involved in ligand 
binding, but crucial for the stabilization of the folded protein structure (Wyss et al., 
1995). Presence of a glycan in the vicinity of the α -bungarotoxin binding surface has 
been demonstrated to confer α -bungarotoxin resistance to the nicotinic acetylcholine 
receptor (Kreienkamp et al., 1994). Most likely, the bulky glycan moiety imposes 
steric hindrance for toxin binding. Referred to the present work, one would expect a 
gain of function, i.e. an increase in ATP potency, once a bulky N-glycan is removed 
in the vicinity of the ligand-binding site. The observation of a decrease in the potency 
for ATP, i.e. a loss of function, makes it more likely that the glycan at N210 imposes 
structural alterations, which may act to stabilize a folded domain essential for ATP 
binding. A contribution of this region to the ATP binding site can be inferred from the 
recent observation that neutralization of the conserved residues K190 and K215 by 4. Discussion      
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alanine substitution produced also a slight (2-5fold) decrease of ATP potency 
(Ennion et al., 2000).  
 
 
4.4. Role of individual cysteine residues for the functional expression and 
assembly of the rat P2X1 receptor 
 
 
4.4.1. Effects of the reducing agent DTT on His-P2X1 expression and assembly 
In this study, the effects of the reducing agent DTT on synthesized His-P2X1 were 
investigated. The results demonstrate that DTT treatment blocked the appearance of 
newly synthesized His-P2X1 receptors at the plasma membranes of Xenopus 
oocytes. In addition, a marked reduction in the amount of isolated protein was 
observed. The pulse-labeling experiments in the presence of DTT suggest that 
disulfide bond formation is fundamental for the transport and maturation of the His-
P2X1 receptor. By blocking the disulfide bonds formation, the reducing agent most 
likely prevented oxidative folding and affected the protein maturation process. As a 
consequence, His-P2X1 subunits synthesized in the presence of DTT does not reach 
the trans-Golgi compartment and therefore does not acquire complex 
oligosaccharides. Apparently, the amount of isolated His-P2X1 protein is markedly 
affected under reducing conditions. In addition, immaturely folded His-P2X1 subunit 
in its fully reduced conformation cannot escape the ER quality control system and is 
probably eliminated by the mechanisms adopted for misfolded proteins. The present 
study revealed that the described effects of DTT on His-P2X1 receptor biogenesis 
are fully reversible. Removal of the reducing agent leads to the resumption of 
disulfide bond formation of the arrested subunits, with subsequent folding and 
assembly into trimeric His-P2X1 receptor complexes, followed by transport to the cell 
surface as deduced from the capability of the protein to acquire complex-type 
carbohydrates. These results indicate that DTT treatment does not cause irreversible 
misfolding or aggregation of the subunits. It appears that subunit conformational 
maturation is suspended until the oxidizing environment in the ER is restored. It is 
possible that the prevention of irreversible misfolding of proteins reduced by DTT is 
mediated by one or more ER-resident molecular chaperones such as calnexin 
(Gelman & Prives, 1996), which facilitates correct folding of nascent polypeptides. 4. Discussion      
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4.4.2. Investigation of P2X1 receptor mutants lacking cysteine residues 
 
One of the peculiar features of the P2X receptor family is its membrane topology, 
which predicts that more than 70% of the
 protein mass is exposed to the extracellular 
space. Since the natural ligand ATP is a highly polar and strongly charged molecule, 
it is self-evident  that the extracellular loop has a potential role in ligand-receptor
 
interaction. The extracellular loop of P2X receptor family proteins has been proposed 
to possess two cysteine-rich
 domains (CRDs) (Hanson et al., 1997). It has been 
demonstrated that during protein folding
  and maturation, extracellular cysteine 
residues are rapidly oxidized,
  and that enzyme-catalyzed disulfide exchange 
continues until the
  thermodynamically most stable conformation is achieved. For 
membrane proteins, the formation of disulfide bonds in the extracellular
 loop of the 
protein is critical for
 proper co-translational folding of the protein and subsequent
 
assembly and oligomerization in the ER compartment (Firsov et al., 1999). 
The dissociation of the P2X1 receptor complex into monomers by DTT 
treatment may suggest that the subunits are covalently linked by disulfide bridges. 
However, the intersubunit bonding of these proteins
  can be excluded for the 
following reason: although dissociation of P2X1 complexes into monomers was 
caused by DTT in the presence of sodium aminocaproate, there are a variety of 
denaturing treatments, which by themselves will not affect disulfide bonds, such as 
addition of urea or SDS as was visualized by BN-PAGE analysis. Moreover, and 
even more importantly, there is no evidence from reducing SDS-PAGE for disulfide 
intersubunit cross-linking of P2X polypeptides. From these results it is concluded that 
the most probable structural feature of the conserved
 cysteines is the formation of 
intrasubunit disulfide bonds. Thus, native P2X receptor complexes are maintained by 
non-covalent interactions and not by interchain disulfide linkages.  
Several approaches are usually used in order to determine the exact pattern 
of disulfide bond formation for membrane proteins.
 A possible biochemical approach 
uses the differential electrophoretic
 mobility by SDS-PAGE of the wild type and the 
mutant proteins
 in their non-reduced forms. However, for the P2X1 receptor, the shift 
in the
  electrophoretic mobility between the parent subunit in its
  reduced and 
nonreduced state was not large enough in the present experiments
 to identify a total 
of up to five possible disulfide bonds
 (data not shown). The approach used in the 
present study is based on the assumption that the effect of Cysteine
   Serine 
mutations is limited to the elimination of
 disulfide bonds, which involved the mutated 4. Discussion      
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C residue. Therefore, mutation
 of either one or both cysteine residues involved in a 
given disulfide bond may be expected to result
 in channel mutants with the same 
phenotype. To this end, a series of
 cysteine double mutants was generated, which 
included mutations of C1 – C6 of the His-P2X1 subunit. From the similarity of the 
decrease in sensitivity to ATP, it is deduced that C1 and C6, C2 and C4 and C3 and 
C5 are cysteine residues, which might be covalently linked by each other in each 
P2X1
 subunit.  
Interestingly, despite of the absolute conservation of C1 through C6 among all 
P2X subunits, the substitution of one or more cysteine residues of the CRD1 region 
with serine did not substantially decrease channel function, as judged from 
electrophysiological measurements in Xenopus oocytes. BN-PAGE characterization 
of cysteine minus mutants from this domain indicates that the cysteine substitutions 
do not have a major effect on assembly of the mutant subunits, or on subunit 
stoichiometry with regard to the trimerization. It seems likely that the modest 
changes of ATP potency observed by substituting individual cysteines result from 
small conformational changes rather than from disruption of any specific function of 
the involved cysteine. The absence of marked functional effects by cysteine 
substitution could signify that they do not participate in formation of protein structures
 
necessary for intrinsic channel activity. However, from the effect of the cysteine 
substitutions on ATP potency, an important role of these cysteines in stabilization of 
the three-dimensional structure of the ligand-binding site can be deduced. Like the 
number of N-glycans per P2X1 subunit, also the number of cysteine bonds in the 
CRD1 region appears to be redundant, since elimination of more than one cysteine 
was necessary to significantly reduce channel function. Interestingly, North and 
coworker identified a region distal  to the first transmembrane domain, which 
contained two lysine residues (
69Lys and 
71Lys) that were critical for the action of 
ATP. These residues are located close to the domain, in which the first cysteine rich 
domain is located (Jiang et al., 2000). In conclusion, present results suggest that 
replacement of the cysteine residues located in the first CRD introduces structural 
changes, which affect ion channel characteristics, but that these cysteines (C1-C6) 
are not absolutely needed for the assembly of the receptor.  
The mutational investigation of the four cysteine residues (C7 – C10) of CRD2 
demonstrated their critical importance in functional surface expression of the P2X1 
receptor. Biochemical analysis revealed that all the cysteine minus mutants of CRD2 
were entirely retained in the ER. Moreover, these mutants existed solely as 4. Discussion      
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aggregates as judged by BN-PAGE analysis. This result suggests that P2X1 subunits 
lacking one of the cysteines of CRD2 are incorrectly folded or mis-assembled. 
Likewise, mutations of one or two cysteines involved in the formation of a
 disulfide 
bond in the N-terminus of either the α  or β  subunit of
 the AchR abolished subunit 
assembly and
  ligand binding (Green & Wanamaker, 1997). The possible 
mechanisms which could explain the abolished cell surface expression of these 
cysteine mutants are the following: (i) misfolding during translation, (ii) lack of proper 
oligomerization due to abnormal conformations of assembled complexes, (iii) 
disruption of the normal transport of the mutant proteins from ER to Golgi and/or 
from Golgi to the cell surface, or (iv) increased rate of degradation of the mutant 
proteins leading to a decrease of the total channel protein pool.  
 5. Summary      
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5. Summary 
 
P2X receptor subunits assemble in the ER of Xenopus oocytes to homomultimeric or 
heteromultimeric complexes that appear as ATP-gated cation channels at the cell 
surface. In this work it was intended to investigate the posttranslational modifications 
such as N-linked glycosylation and disulfide bond formation that is undergone by 
P2X1 receptors. In addition, the aim of this study was to examine the expression and 
the quaternary structure of selected P2X receptor isoforms in Xenopus oocytes. 
The investigation of the quaternary structure of the metabolically or surface 
labeled His-P2X2 receptor by BN-PAGE revealed that, while the protein complex is 
only partially assembling in oocytes, the plasma membrane form of the His-P2X2 
receptor assembled into trimeric and even hexameric complex as was shown by the 
BN-PAGE analysis. Besides this finding, it is shown that the His-P2X5 protein that 
was purified from metabolically or surface labeled oocytes appeared as one single 
band corresponding to a trimer when analyzed by BN-PAGE. The present study 
signified that His-P2X6 alone does not reach a defined assembly status and possibly 
needs the hetero-polymerisation with other P2X subunits to assemble properly for 
insertion into the plasma membrane. Another finding of this study is that the P2X1 
and P2X2 subunits could exist as heteromultimeric protein complexes in the plasma 
membrane of cells. Purification of surface expressed His-P2X2 subunit allowed the 
detection of co-injected P2X1 subunit and vice versa in Xenopus oocytes. Incubation 
with glutardialdehyde led to the cross-linking of P2X2 and P2X1 subunits to dimers 
and trimers. BN-PAGE analysis of the P2X2/P2X1 complex isolated under non-
denaturing conditions from surface-labeled oocytes yielded one distinct band 
corresponding to a trimeric complex. 
The analysis of a C-terminally GFP tagged His-P2X1 fusion protein by 
confocal fluorescence microscopy revealed small clusters of the protein complexes, 
approximately 4–6 µm in diameter from a diffuse distribution of the protein in the 
plasma membranes of Xenopus oocytes. The cross-linking or BN-PAGE analysis of 
the fusion protein resulted in proteins that migrated quantitatively as trimers when 
purified in digitonin.  
The analysis of some chimeric constructs confirmed the results of others, which 
showed that desensitization can be removed from the P2X1 or P2X3 receptor by 
providing the N-domain from the P2X2 receptor (Werner et al., 1996) The exchange 5. Summary      
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of this domain did not alter the quaternary structure of the chimeras, which showed 
to be present as trimers when expressed in oocytes.  
In addition, glycan minus mutants of His-P2X1 receptor were analyzed to 
examine whether carbohydrate side chains are important for P2X1 subunit assembly, 
surface expression, or ligand recognition. SDS-PAGE analysis of glycan minus 
mutants carrying Q instead of N at five individual NXT/S sequons reveals that 
284N 
remains unused because of a proline in the +4 position. The four other sites (
153Asn, 
184N, 
210N, and 
300N) carry N-glycans, but solely 
300N acquires complex-type 
carbohydrates. Like parent P2X1 receptor, glycan minus mutants migrate as 
homotrimers when resolved by blue native PAGE. Recording of ATP-gated currents 
revealed that elimination of 
153N or 
210N diminishes or increases functional 
expression levels, respectively. In addition, elimination of 
210N causes a 3-fold 
reduction of the potency for ATP. If three or all four N-glycosylation sites are 
simultaneously eliminated, formation of P2X1 receptors is severely impaired or 
abolished, respectively. It is concluded that at least one N-glycan per subunit of 
either position is absolutely required for the formation of P2X1 receptors. 
The SDS-PAGE analysis of surface-labeled His-P2X2 and His-P2X5 receptors 
revealed that, while the His-P2X2 subunit acquires three complex-type 
carbohydrates, in case of His-P2X5 polypeptide, only two of the three N-glycans 
could obtain complex-type carbohydrates during transit of the Golgi apparatus. 
Furthermore, it was shown that DTT treatment blocked the appearance of 
newly made His-P2X1 at the plasma membranes of Xenopus oocytes. Also, it was 
revealed that the effects of DTT on His-P2X1 biogenesis are fully reversible. 
Removal of the reducing agent leads to subsequent folding and assembly into His-
P2X1 receptor complex, followed by transport to the cell surface.  
  The characterization of cysteine minus mutants by SDS PAGE and BN-PAGE 
demonstrated that, the cysteine substitution in the first cysteine rich domain (C1 - 
C6) does not have a major effect on assembly for the mutant receptors. In contrast, 
the replacement of the four cysteine residues (C7 – C10) from the second cysteine 
rich domain demonstrate a critical importance of this domain for the functional 
surface expression of P2X1 receptor. The investigations of several double cysteine 
mutants revealed that according to a similarity in the sensitivity to ATP, the C1 and 
C6, as well as C2 and C4 and finally C3 and C5 are pairs forming two disulfide 
bonds in each P2X1
 subunit.  6. Zusammenfassung      
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6. Zusammenfassung 
 
P2X-Rezeptoren stellen ligandengesteuerte Ionenkanäle dar, die nach ATP-Bindung 
innerhalb weniger Millisekunden eine intrinsische Pore öffnen, die nicht-selektiv 
permeabel für kleine Kationen ist. Ziel meiner Arbeit war es, Tertiär- und 
Quartärstruktur der P2X-Rezeptoren mit molekularbiologischen Methoden zu 
charakterisieren. Hierbei wurde der Einfluss von Kohlenhydrat-Seitenketten und die 
Rolle der Disulfidbrücken auf die Expression und Assemblierung des P2X1-
Rezeptors untersucht.  
Die Analyse der Quartärstruktur von metabolisch markierten His-P2X2-
Rezeptoren ergab, dass die Proteinkomplexe nach der Expression in Oozyten 
hauptsächlich  als Dimere und Trimere vorliegen. Zusätzlich wies ein Teil der 
isolierten Proteine keinen definierten Oligomerisierungszustand auf, was darauf 
hindeutet, dass His-P2X2 in intrazellulären Kompartimenten der Oozyten nicht 
vollständig assembliert. Die Untersuchung von plasmamembranständigen His-P2X2-
Rezeptorkomplexen mittels BN-PAGE zeigte neben Proteinbanden für eine trimere 
Struktur auch Banden, die einer hexameren und einer nanomeren Strukturen 
entsprechen könnten. Die BN-PAGE-Analyse von P2X5-Rezeptoren, die heterolog in 
Ooyzten exprimiert wurden, ergab, dass die Rezeptoren sowohl intrazellulär als auch 
an der Zelloberfläche hauptsächlich als Trimere vorliegen. Ferner wurde in den 
Untersuchungen gezeigt, dass die His-P2X6-Rezeptoren hauptsächlich als 
hochmolekulare Komplexe erscheinen und somit keinen definierten Oligomerzustand 
aufweisen. Diese Resultate deuten daraufhin, dass die P2X6-Rezeptoruntereinheit 
nicht imstande ist, einen homo-oligomeren Ionenkanal zu bilden, und auf die 
Assemblierung mit anderen P2X- Rezeptoruntereinheiten angewiesen ist. 
Ein weiteres Ziel meiner Arbeit war der proteinchemische Nachweis der 
Bildung von P2X1 und P2X2 Heteromultimeren durch Koisolierung. Die cRNA für 
diese zwei P2X-Isoformen mit oder ohne der jeweiligen Hexahistidiylsequenz 
wurden in Xenopus-Oozyten injiziert und die Proteine nach entsprechender 
radioaktiver Markierung mittels Ni
2+-Chelat-Chromatographie koisoliert. Die 
Untersuchung ergab, dass die binäre Kombination von P2X1 und P2X2 zur Bildung 
von stabilen Heteromultimeren führt. Des weiteren wurde mit Hilfe von Cross-linking-
Experimenten und BN-PAGE-Analyse gezeigt, dass diese Proteinkomplexe eine 
trimere Struktur aufweisen. 6. Zusammenfassung      
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Um die zelluläre Lokalisation des P2X1-Rezeptors zu bestimmen, wurden die 
Xenopus-Oozyten mit der cRNA eines gentechnisch hergestellten Fusionsproteins, 
bestehend aus dem P2X1-Rezeptor und dem grünfluoreszierenden Protein (GFP), 
injiziert. An intakten Oozyten erkennt man in den fluoreszenzmikroskopischen 
Aufnahmen eine Fluoreszenz an der Plasmamembran, sowie kleine, etwa 4-6 µm 
große Vesikel unterhalb der Plasmamembran. Die Quartärstrukturanalyse dieses 
Proteins mittels Cross-linking-Experimenten und BN-PAGE ergab, dass dieses 
Fusionsprotein wie der Wildtyp-P2X1-Rezeptor eine trimere Struktur besitzt.  
Proteinchemische Analysen der durch gerichtete Mutagenese hergestellten 
Glycan-Minus-Mutanten des His-P2X1 Rezeptors zeigten, dass (1) 
284N keine 
Kohlenhydrat-Seitenkette trägt, weil ein Prolin (
287P) auf das Glykosylierungsmotiv N-
L-S folgt; (2) dass nur die Oligosaccharid-Seitenkette an 
300N auf dem Weg des 
trimeren Rezeptors an die Plasmamembran im Golgi-Apparat komplex-glykosyliert 
wird; (3) dass die Deletion von zwei Glykosylierungsstellen gut toleriert wird, dass 
aber bei der Deletion von drei Stellen die Expression drastisch abnimmt, und (4) 
dass bei der Deletion aller vier Stellen weder intrazellulär noch an der 
Plasmamembran P2X1-Rezeptoren nachweisbar sind. Elektrophysiologisch zeigte 
sich, dass die Mutation N
210Q eine Abnahme der scheinbaren ATP-Affinität um den 
Faktor drei gegenüber dem Wildtyp-P2X1 bewirkt, die vermutlich auf dem Ausbleiben 
der N-Glykosylierung in dieser Position beruht.  
Ferner zeigte die proteinchemische Analyse des His-P2X2-Rezeptors durch 
SDS-PAGE, dass alle drei Kohlenhydrat-Seitenketten des P2X2-Rezeptors auf dem 
Weg zur Plasmamembran in die komplex-glykosylierte Form überführt werden, 
unterdessen aber nur zwei der drei Kohlenhydrat-Seitenketten der P2X5-
Rezeptoruntereinheit auf dem Weg zur Plasmamembran in die komplex-glykosylierte 
Form überführt werden. 
Untersuchungen zur Rolle der Disulfidbrücken bei der Expression und 
Assemblierung von P2X-Rezeptoren ergaben, dass die P2X1-Rezeptoruntereinheit 
offenbar über zwei Cysteinfaltungsdomänen, CRD1 und CRD2, verfügt. CRD1 
umfasst die N-terminal gesehen ersten sechs Cysteine, CRD2 die letzten vier 
Cysteine der Ektodomäne. Die Disulfidbrücken in CRD1 scheinen redundant 
angelegt zu sein, da hier der Austausch eines einzelnen Cysteins gegen Serin 
keinen nennenswerten Einfluss auf die Expression und Assemblierung hat. Bei 
Mutationen von Cysteinen im CRD2-Bereich kommt es dagegen zu massiven 
Störungen der Assemblierung. 6. Zusammenfassung      
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Aufgund der Ähnlichkeit der ATP-Emfindlichkeit bei den untersuchten 
Cysteindoppelmutanten lässt sich schlussfolgern, dass zwischen den Cyteinresten 
C1 und C6, C2 und C4 sowie zwischen C3 und C5 Disulfidbrücken gebildet werden. 7. Reference List      
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8. Appendix 
 
 
8.1. Oligodeoxynucleotides 
 
8.1.1. Oligodeoxynucleotide primers used for site-directed mutagenesis 
(mutated codons are indicated by shaded boxes) 
Mutated 
construct  Primer  Sequence (5’→→→→ 3’) 
492  CTGTGTGCCCTTCCAGGGCACTGTGAAG (sense)  His-P2X1.N153Q 
(∆ N1)  493  CTTCACAGTGCCCTGGAAGGGCACACAG (antisense) 
494  CTTCGTGAGGCTGAGCAGTTCACCCTCTTC (sense)  His-P2X1.N184Q 
(∆ N2)  495  GAAGAGGGTGAACTGCTCAGCCTCACGAAG (antisense) 
506  GTAGAGGAGGTGCAGGGCACCTACATGAAG (sense)  His-P2X1.N210Q 
(∆ N3)  507  CTTCATGTAGGTGCCCTGCACCTCCTCTAC (antisense) 
508  CTGTATGGGGAGAAGCAGCTGTCTCCAGGC (sense)  His-P2X1.N284Q 
(∆ N4)  509  GCCTGGAGACAGCTGCTTCTCCCCATACAG (antisense) 
519  GCCAGGCATTTCGTGCAGCAGGGGACAAACCGTCG (sense)  His-P2X1.N300Q 
(∆ N5)  520  CGACGGTTTGTCCCCTGCTGCACGAAATGCCTGGC (antisense) 
642  GACTCAAGGCCATTCTGCAGAGAACCCAG (sense)  His-rP2X1.C117S 
(∆ C1)  643  CTGGGTTCTCTGCAGAATGGCCTTGAGTC (antisense) 
652  CAGAAGGTGGCATATCCCAGGATGACAGTG (sense)  His-rP2X1.C126S 
(∆ C2)  653  CACTGTCATCCTGGGATATGCCACCTTCTG (antisense) 
654  GGATGACAGTGGCTCCACTCCAGGAAAAG (sense)  His-rP2X1. C132S 
(∆ C3)  655  CTTTTCCTGGAGTGGAGCCACTGTCATCC (antisense) 
656  CGCACAGGCAACTCTGTGCCCTTCAATG (sense)  His-rP2X1. C149S 
(∆ C4)  657  CATTGAAGGGCACAGAGTTGCCTGTGCG (antisense) 
658  GGCACTGTGAAGACATCTGAGATCTTTGGTTGG (sense)  His-rP2X1. C159S 
(∆ C5)  659  CCAACCAAAGATCTCAGATGTCTTCACAGTGCC (antisense) 
660  GAGATCTTTGGTTGGTCTCCTGTAGAGGTGG (sense)  His-rP2X1. C165S 
(∆ C6)  661  CCACCTCTACAGGAGACCAACCAAAGATCTC (antisense) 
678  GCACCTACATGAAGAAGTCCCTCTATCACAAGATTC (sense) 
His-rP2X1. C217S 
(∆ C7)  679 
GAATCTTGTGATAGAGGGACTTCTTCATGTAGGTGC 
(antisense) 
680  CAACACCCCCTGTCCCCAGTCTTCAAC (sense)  His-rP2X1. C227S 
(∆ C8)  681  GTTGAAGACTGGGGACAGGGGGTGTTG (antisense) 
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Mutated 
construct  Primer  Sequence (5’→→→→ 3’) 
682  CCATTGACTGGAAGTCTGATCTGGACTGGC (sense)  His-rP2X1. C261S 
(∆ C9)  683  GCCAGTCCAGATCAGACTTCCAGTCAATGG (antisense) 
684  GGCACGTTCGGCACTCCAAACCCATCTAC (sense)  His-rP2X1. C270S 
(∆ C10)  685  GTAGATGGGTTTGGAGTGCCGAACGTGCC (antisense) 
686  GTGGCCACAGTGCTTTCTGATCTCTTATTGCTC (sense)  His-rP2X1. C353S 
(∆ C11)  687  GAGCAATAAGAGATCAGAAAGCACTGTGGCCAC (antisense) 
947  GAGAAGGCAGGAGAGCAATTCACAGAACTGGCAC (sense) 
His-rP2X2. N239Q 
948  GTGCCAGTTCTGTGAATTGCTCTCCTGCCTTCTC (antisense) 
 
 
8.1.2. Oligodeoxynucleotide primers used for sequencing 
 
Sequenced 
construct  Primer  Sequence (5’→→→→ 3’) 
565 
or 436 
(SP6) 
CATACACATACGATTTAGGTGACAC  
52 
(T7) 
TAATACGACTCACTATAGGG 
pNKS2 
72 AACTGTTGGGAAGGGCGATC 
78 AAGAGATCACAAAGCACTGT  P2X1. 
pNKS2  479 ACTCCAGGAAAAGCAGAA 
498 GACGACGACTGTATTGC 
499 CCACTGCTCTGACCTC 
P2X2. 
pNKS2 
515 GGGATTCGCACAGGGCAC 8. Appendix      
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8.1.3. Oligodeoxynucleotide primers used for insertion or deletion of a 
restriction site into constructs 
 
Construct  Primer  Sequence (5’→→→→ 3’) 
488  CACTGTGTACCCTATTATCATGGGGACTCCAAG (sense)  Deletion of Nco I 
from 
P2X2.pNKS2 
489 CTTGGAGTCCCCATGATAATAGGGTACACAGTG  (antisense) 
513 
GGCCTACGTCATCGGGTACGTATTTGTGTGGGAAAAGGGC 
(sense)  Insertion of Sna BI 
into P2X4.pNKS2 
514 
GCCCTTTTCCCACACAAATACGTACCCGATGACGTAGGCC 
(antisense) 
502 
GGTTCTGGTCTACGTCATTGGGTACGTATTTGTCTATGAAAAA
GG (sense)  Insertion of Sna BI 
into P2X1.pNKS2 
503 
CCTTTTTCATAGACAAATACGTACCCAATGACGTAGACCAGAA
CC (antisense) 
504  CTTCGTGTGGTACGTATTCATCGTGCAGAAAAGC (sense)  Insertion of Sna BI 
into P2X2.pNKS2  505  GCTTTTCTGCACGATGAATACGTACCACACGAAG (antisense) 
527 
GCTGCTGATTATCTCCTACTTTGTGGGGTACGTATTCTTGCAT
GAG (sense)  Insertion of Sna BI 
into P2X3.pNKS2 
528 
CTCATGCAAGAATACGTACCCCACAAAGTAGGAGATAATCAGC
AGC (antisense) 
525  GGATGGTGCTGGTCCGGAACAAGAAGGTGGG (sense)  Insertion of Bsp EI 
into P2X1.pNKS2  526  CCCACCTTCTTGTTCCGGACCAGCACCATCC (antisense) 
535  GTGAGCTGGAGCCATGGGCCAGGCG (sense)  Insertion of Nco I into 
P2X5.pNKS4  536  CGCCTGGCCCATGGCTCCAGCTCAC (antisense) 
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8.1.4. Oligodeoxynucleotide primers inserted into constructs 
 
Description  Primer  Sequence (5’→→→→ 3’) 
496  CGAAGTAGCCACCATGGCACACCACCACCACCACCA (sense) 
N-terminal 
hexahistidin tag  497 
CATGTGGTGGTGGTGGTGGTGTGCCATGGTGGCTACTTCGAC
GT (antisense) 
529 
CCGGAATCGGCGCCTGGGATTCGTGCACCGCATGGTGCAGC
TGCTCATCCTGCTTTACTTCGTGTGGTAC (sense)  First transmembrane 
domain of P2X2 
530 
GTACCACACGAAGTAAAGCAGGATGAGCAGCTGCACCATGCG
GTGCACGAATCCCAGGCGCCGATT (antisense) 
547 
AGCTTCAACAAACAACAAAGTCCGACGTCGAAGTAGCCACCAT
GGCACACCACCACCACCACCA (sense) 
N-terminal 
hexahistidin tag and 
Kozak sequence  548 
CATGTGGTGGTGGTGGTGGTGTGCCATGGTGGCTACTTCGAC
GTCGGACTTTGTTGTTTGTTGA (antisense) 
719  ATCAGGTTGATAGTAATAGACTAGT (sense)  Introduction of stop 
codons into C-
terminus of His-P2X2 
720  CTAGACTAGTCTATTACTATCAACCTGA (antisense) 
423 
AGCTAACAACAAAGAACAACAAACAACAAAGTCCGACGTCGAA
GTAGCCAC (sense) 
Kozak sequence 
424 
CATGGTGGCTACTTCGACGTCGGACTTTGTTGTTTGTTGTTCT
TTGTTGTT (antisense) 
 
 
8.2. Glossary of Abbreviation 
 
α ,β -met-ATP  α ,β -methyleneadenosine-5’-triphosphate 
Ach Acetylcholine 
ADP Adenosine-5’-diphosphate 
AMPA  α -Amino-3-3hydroxy-5-methyl-4-isoaxole propionic acid 
ATP Adenosine-5’-triphosphate 
ATP
4-  Fully ionized form of Adenosine-5’-triphosphate 
Bistris 2,2-Bis-(hydroxyethyl)-(iminotris)-(hydroxymethyl)  methane 
BN-PAGE  Blue native polyacrylamide gel electrophoresis 
BzATP Benzoylbenzonic-adenosine-5’-triphosphate 
C-terminus  carboxyl (COOH) terminus  
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propane-sulfonate 
CNS  Central nervous system 8. Appendix      
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DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic  acid 
DRG  Dorsal root ganglion 
DTT Dithiothreitol 
EC50  Concentration of agonist producing half maximal effect 
EDTA  Ethylenediamine tetra-acetic acid 
EnaC Epithelial  Na
+ channel 
Endo H  Endoglycosidase H 
ER Endoplasmatic  reticulum 
G protein  Guanine nucleotide-binding protein 
GABA  γ -aminobutyric acid 
Glu Glutamate 
GluR  Glutamate receptor subunit 
GlyR Glycine  receptor 
GT glucosyltransferase 
h hour 
HEK cells  Human embryonic kidney cells 
HEPES N-2-Hydroxyethylpiperazine-N’-2-ethansulphonic  acid 
5-HT3R  Ionotropic 5-Hydroxytryptamine (Serotonin) receptor 
IP Isoelectric  point 
IP3 Inositol-1,4,5-triphosphate 
kb Kilo  bases 
kD Kilo  Dalton 
Kir Inward-rectifier  K
+ channel 
LGICS  ligand-gated ion channel superfamily 
min Minute 
2-MeSATP 2-Methylthioadenosine-5’-triphosphate 
ms Milliseconds 
mscL  Mechanosensitive channel of E. Coli 
N-terminus Amino  (NH2) -terminus  
NA Noradrenaline 
nACHR  Nicotinic acetylcholine receptor 
Ni
2+ -NTA  Ni
2+.-Nitriloacetic acid 
NMDA N-Methyl-D-aspartate 
P2X  Ionotropic receptor for nucleotides 8. Appendix      
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P2Y  Metabotropic receptor for nucleotides 
PBS  Phosphate buffered saline 
PC 12 cells  Rat Phaeochromocytoma cell line 
PNGase F  Peptide:N-glycosidase F 
PNS  Peripheral nervous system 
PPADS Pyridoxalphosphate-6-azophenyl-2’,4’-disulfonic  acid 
pS Pico  Siemens 
RB2  Reactive Blue 2 
RNA Ribonucleic  acid 
RT-PCR  Reverse transcription polymerase chain reaction 
s Seconds 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Sulfo-SSHP Sulfosuccinimidyl-3-(4-hydroxyphenyl)propionate 
TM or M  Transmembrane domain 
TRIS Tris(hydroxymethyl)-aminomethane 
UDP Uridine-5’-diphosphate 
UTP Uridine-5’-triphosphate 
wt Wild-type 
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